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Abstract 
Industrial biocatalysis is a smart path towards more cost-effective and 
sustainable chemical processes. However, there are still some drawbacks in terms of 
enzyme stability, molecule recycling and mass transfer matters among others that limit 
the progress of heterogeneous biocatalysis. In order to overcome these issues, micro-
scale approaches and tailor-made designs of heterogeneous biocatalysts are needed 
to make more efficient the final industrial reactions. Inspired by the natural 
compartmentalization of metabolic pathways inside the living cells, we assembled 
molecular systems into artificial solid supports to build functional biomaterials called 
artificial metabolic cells. Based on this concept, different micro-architectures were 
developed for the co-immobilization of multi-enzyme systems and the expensive 
cofactors on solid materials. The integration of all molecules in the solid phase enabled 
the recycle and reuse of the heterogeneous biocatalysts, decreasing costs and waste. 
The scope of this strategy was expanded to engineer artificial metabolic cells based on 
different enzymes (dehydrogenases, oxidades, ketoreductases and ω-transaminases) 
with their corresponding cofactors (NADH, FAD+, NADPH and PLP). Parallely, we 
developed several techniques to aid and guide the design process of these 
heterogeneous biocatalysts. Firstly, a synthetic-biological platform was developed to 
easily screen different materials and binding chemistries for the protein immobilization. 
Secondly, fluorescence microscopy was applied to analyze the distribution of enzymes 
and cofactors onto the porous microparticles at single-particle level and with spatio-
temporal resolution. Finally, artificial metabolic cells were successfully tested in 
continuous flow reactions for the asymmetric synthesis of several chiral amines and 
alcohols.  
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Resumen 
En los dos últimos siglos tras la revolución industrial, el cambio de nuestro 
modelo socio-económico ha incrementado exponencialmente la demanda de 
productos químicos para diferentes fines como agricultura, biomedicina y construcción. 
El uso del petróleo en la industria ha sido (y sigue siendo) el epicentro para satisfacer 
las necesidades de nuestra sociedad. Sin embargo, el aumento del consumo de 
combustibles fósiles ha provocado una aceleración en la degradación de nuestro 
medio ambiente. La biocatálisis ha surgido como una herramienta eficaz para combatir 
el desgaste de nuestro planeta a la vez que permite el avance tecnológico de forma 
sostenible hacia un modelo bioeconómico. 
La biocatálisis consiste en el uso de enzimas como catalizadores de reacciones 
químicas que permite la obtención de productos de interés. Estas proteínas se 
encuentran de forma natural en las células de todos los seres vivos llevando a cabo 
reacciones metabólicas que permiten el progreso de la vida. Además de los 
biocatalizadores enzimáticos, existen catalizadores no biológicos que realizan 
funciones equivalentes. Sin embargo, las enzimas presentan una serie de 
características que les hacen catalizadores únicos: presentan una excelente capacidad 
catalítica y una amplia selectividad química. Además, las enzimas trabajan a 
condiciones fisiológicas de pH y temperatura debido a su evolución natural en el 
interior de las células. Otra de sus características más destacables es la capacidad de 
producir compuestos enantioméricamente puros, que es fundamental para la 
fabricación de productos farmacéuticos. 
Los procesos biocatalíticos pueden realizarse fundamentalmente con células que 
contienen las enzimas en su interior o con enzimas purificadas. La biocatálisis con 
células es más utilizada en procesos que necesitan cofactores, ya que éstas los 
contienen de forma natural mientras que la suplementación con cofactores exógenos 
supone un alto coste económico. Pero las limitaciones en el transporte de sustratos y 
productos desde y hacia el interior celular, junto a la laboriosa purificación del producto 
final, hacen que este método sea menos eficiente. Por otro lado, las enzimas pueden 
ser expresadas in vivo y posteriormente purificadas para su uso como biocatalizadores 
aislados. Aunque los procesos downstream son más livianos en este caso, las 
enzimas pueden presentar una baja estabilidad y/o actividad al encontrarse 
desprotegidas fuera de su ambiente natural. 
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Durante las últimas décadas, las estrategias de ingeniería de proteínas, la 
inmovilización de enzimas purificadas y el descubrimiento de nuevas enzimas han 
permitido el acceso a una amplia gama de estrategias para el desarrollo de nuevos 
biocatalizadores. Las técnicas computacionales y genéticas para el diseño de enzimas 
han abierto las puertas a diversas variantes de la misma enzima con propiedades 
mejoradas. Así mismo, la inmovilización de enzimas en soportes sólidos 
(biocatalizadores heterogéneos) ha sido crucial para poder reciclar el biocatalizador y 
aumentar su estabilidad durante el proceso de reacción. Sin embargo, los 
biocatalizadores heterogéneos siguen presentando problemas de estabilidad, 
limitación de reusos y baja eficiencia que se agravan a nivel industrial. En este 
contexto, es importante que el proceso biocatalítico sea robusto, sostenible y 
económico para asegurar su éxito. 
El enfoque que se plantea en esta tesis doctoral para abordar estas cuestiones 
es el diseño de biocatalizadores heterogéneos autosuficientes mimetizando a las 
células naturales. Inspirados en la distribución espacial de las rutas metabólicas 
intracelulares, se han desarrollado estructuras micrométricas llamadas células 
artificiales metabólicas que pueden sintetizar productos químicos de forma más 
eficiente a nivel industrial. 
En primer lugar, se ha estudiado la estrategia para la inmovilización de proteínas 
en soportes sólidos. Tradicionalmente, los biocatalizadores heterogéneos han sido 
desarrollados probando de forma empírica la inmovilización de una enzima en 
diferentes soportes. Este proceso puede durar semanas hasta encontrar el soporte 
adecuado con la química de unión correcta para unir la enzima al soporte de forma 
orientada, funcional y estable. En el primer capítulo experimental (capítulo 3) de esta 
tesis se describe una nueva metodología con la que se podrían examinar diferentes 
tipos de inmovilización de enzimas en diferentes materiales en unas horas. En estos 
estudios se ha utilizado principalmente la proteína verde fluorescente (sGFP) como 
modelo debido a su fácil detección. Para controlar la orientación de la proteína cuando 
ésta se inmoviliza, se ha desarrollado un kit de cuatro plásmidos que codifican para la 
sGFP etiquetada con diferentes polipéptidos (poly-(6x)His, poly-(6x)Cys, poly-(6x)Lys) 
y sin etiquetar.   
Sin embargo, la expresión y purificación de las enzimas es otro proceso que 
conlleva diversos protocolos consumiendo a su vez tiempo y recursos. Para solventar 
este problema, hemos aplicado una estrategia de biología sintética que utiliza 
          Resumen 
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extractos celulares aislados para producir proteínas in vitro de forma más rápida y 
sencilla. Este método conocido como cell-free protein synthesis (CFPS) se basa en 
extraer de la célula toda la maquinaria transcripcional y traduccional necesaria para 
poder llevar a cabo la síntesis de proteínas en sólo unas horas. Además, estos 
extractos celulares se pueden almacenar por largos periodos de tiempo conservando 
su funcionalidad, se pueden transportar en recipientes pequeños y además pueden 
expresar proteínas que in vivo no es posible producir.  
La combinación de estos tres elementos, ADN, soportes materiales y extractos 
celulares da lugar a la síntesis in vitro e inmovilización de proteínas en un solo paso 
(CFPS-i). Éste método se puede realizar en un microtubo o en una placa multipocillos 
para obtener la proteína de interés unida de forma orientada a diferentes soportes 
mediante diferentes químicas de inmovilización. En concreto, en este trabajo se 
estudió la inmovilización de sGFP en soportes de agarosa, metacrilato, nanopartículas 
de oro y nanopartículas de sílica. Las químicas de unión de la proteína al soporte que 
se estudiaron son enlaces de coordinación con metales, enlaces covalentes 
irreversibles, enlaces disulfuro, intercambio iónico y química click. Además, el proceso 
de CFPS-i fue monitorizado en tiempo real mediante microscopía de fluorescencia 
para comprobar la eficiencia de este sistema.  
Esta estrategia versátil para el diseño de nuevos biomateriales y biocatalizadores 
se aplicó a sistemas con varias proteínas. Para ello se expresaron e inmovilizaron al 
mismo tiempo y sobre el mismo soporte la proteína sGFP etiquetada con poly-(6x)Cys 
y la enzima alcohol deshidrogenasa (Bs-ADH) etiquetada con poly-(6x)His, usando dos 
químicas de unión diferente. Este experimento demuestra el alto potencial de la 
técnica CFPS-i para el diseño de células metabólicas artificiales basadas en cascadas 
enzimáticas. Finalmente, CFPS-i se aplicó también para el desarrollo de biosensores 
basados en anticuerpos. La proteína A, que es una proteína de unión universal a 
anticuerpos, se expresó e inmovilizó en un solo paso para posteriormente captar 
anticuerpos. 
El segundo capítulo experimental de la presente tesis (capítulo 4) se centró en la 
puesta a punto de la inmovilización de cofactores redox en soportes sólidos. 
Anteriormente, se habían descrito varios métodos para inmovilizar cofactores en la 
fase sólida del biocatalizador heterogéneo. Pero desafortunadamente se hallaron 
problemas de reuso del cofactor, baja actividad de la enzima hacia el cofactor 
inmovilizado y dificultades para aumentar la escala del proceso. Durante este trabajo, 
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nuestro grupo ha desarrollado una estrategia para inmovilizar los cofactores en 
soportes de forma reversible mediante interacciones electrostáticas. Este tipo de 
inmovilización permite que los cofactores fosforilados (con carga negativa) se 
encuentren en un equilibrio asociación-disociación entre la superficie del soporte (con 
carga positiva) y el centro activo de la enzima, pero sin abandonar el microambiente 
del soporte poroso. A continuación, se diseñó una arquitectura para poder co-
inmovilizar un sistema bi-enzimático y el cofactor NADH en la misma micropartícula. 
Para ello, una alcohol deshidrogenasa (Tt-ADH) fue inmovilizada covalentemente en 
micropartículas de agarosa funcionalizadas con grupos aldehídos. Posteriormente, se 
recubrió este biocatalizador con un polímero catiónico (PEI) para permitir la 
inmovilización del cofactor NADH y de una segunda deshidrogenasa (Cb-FDH) capaz 
de regenerar el cofactor. Los resultantes biocatalizadores heterogéneos se pusieron a 
prueba para la síntesis de un alcohol modelo, demostrando ser capaces de llevar a 
cabo la reacción durante al menos 4 ciclos manteniendo una conversión del 100% y de 
forma autosuficiente, es decir, sin adición exógena de cofactor. Mediante técnicas de 
microscopía de fluorescencia se analizó el progreso de la reacción en cada 
micropartícula. Aprovechando la autofluorescencia del cofactor se pudo monitorizar in 
situ el consumo de éste dentro de la micropartícula, pues la forma reducida del 
cofactor NADH presenta mayor fluorescencia que la forma oxidada (NAD+). 
Además de la inmovilización del cofactor, también se analizó el efecto de la 
distribución espacial de la enzima inmovilizada. En las células, las enzimas están 
distribuidas espacialmente para optimizar al máximo su función. Por tanto, estudiamos 
si la distribución de las enzimas inmovilizadas en las micropartículas afecta al progreso 
de las reacciones que catalizan. Para este estudio se inmovilizó una oxidasa (Tt-NOX), 
que al ser dependiente de oxígeno podría presentar problemas difusionales en el 
interior del biocatalizador heterogéneo. Nuestra hipótesis fue corroborada al 
determinar una mayor velocidad cinética en los biocatalizadores que presentaban la 
enzima inmovilizada de forma heterogénea en la parte externa de las micropartículas. 
Por el contrario, cuando la enzima estaba distribuida homogéneamente a través de la 
micropartícula, la velocidad cinética disminuía. Este sistema también fue analizado a 
nivel microscópico. En este caso, se consiguió monitorizar tanto la inmovilización de 
dos cofactores redox (NADH y FAD+) como el consumo de NADH dentro de la célula 
metabólica artificial. 
Una vez que tuvimos un diseño eficiente para la co-inmovilización de los 
cofactores expandimos nuestra estrategia a otro tipo de reacciones, concretamente a 
          Resumen 
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reducciones asimétricas de cetonas. En el capítulo 5, co-inmovilizamos mediante 
intercambio iónico una cetoreductasa (KRED P1-A04) junto al cofactor NADPH. Este 
tipo de inmovilización de la enzima fue elegido de entre varios métodos utilizando 
diferentes soportes activados con diferentes grupos funcionales. La estrategia de 
unión reversible es aún más sostenible, ya que además de reusar el biocatalizador 
permite el reciclaje del soporte (de alto coste económico) cuando la enzima se 
inactiva. La actividad de este biocatalizador autosuficiente también fue constatada 
utilizando técnicas de microscopía de fluorescencia en tiempo real. Utilizando 
diferentes sustratos, se demostró que la misma enzima puede realizar la reducción del 
sustrato y la regeneración del cofactor de forma autosuficiente. Durante estos 
estudios, se halló un fenómeno interesante que relaciona el tamaño de las células 
metabólicas artificiales con su actividad catalítica. En las micropartículas más grandes 
se observó una tasa de actividad más baja que en las micropartículas de menor 
tamaño. Estos datos correlacionan con la cantidad de enzima inmovilizada que se 
detectó tras hacer estudios de microscopía confocal sobre la distribución espacial de la 
enzima inmovilizada. Las micropartículas más pequeñas presentaron una mayor 
congregación de enzimas y, por tanto, una mayor actividad. Por último, las células 
metabólicas artificiales basadas en cetoreductasa y NADPH fueron empacadas en un 
microreactor de flujo. Durante su funcionamiento, el microreactor mantuvo más del 
80% de conversión durante 120 horas con tasas de reciclaje del cofactor cercanas a 
los requerimientos industriales. Estos resultados demostraron que nuestro diseño de 
co-inmovilización de enzimas y cofactores es eficiente y robusto incluso operando en 
flujo, condiciones más similares a las de uso en industria. 
Por último, la misma estrategia de co-inmovilización se aplicó a otra enzima 
cetoreductasa (KRED P2-D11) que demostró ser más estable en presencia de 
solventes orgánicos. Sin embargo, en este caso la célula artificial metabólica no era 
eficiente porque la enzima no podía regenerar el cofactor. 
En el capítulo 6 de esta tesis doctoral y, a diferencia de los trabajos anteriores, 
se amplió la técnica de co-inmovilización a cofactores que no participan en 
redacciones de oxido-reducción como por ejemplo pyridoxal-5’-fosfato (PLP). Las 
enzimas transaminasas (dependientes de PLP) han cobrado un papel importante en la 
biocatálisis en los últimos años debido a su intervención en la síntesis de productos 
farmacológicos. Por este motivo, se co-inmovilizó una transaminasa altamente activa y 
estable (He-TA) junto con el PLP en soportes de metacrilato. En primer lugar, se 
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exploraron diferentes tipos de co-inmovilización para la enzima y el cofactor. Una vez 
más, el mejor resultado se obtuvo con una estrategia basada en el diseño de co-
inmovilización desarrollado en el capítulo 4. Primero, la transaminasa se unió de forma 
covalente al soporte. Posteriormente, se cubrió con el polímero PEI para la co-
inmovilización del PLP. Las reacciones de transaminación se llevaron a cabo en 
reactores de flujo continuo durante más de 50 ciclos manteniendo al menos un 90% de 
conversión. Cabe destacar que estas células metábolicas artificiales llevaron a cabo 
síntesis de aminas a 1.4 mL x min-1, el flujo más alto conseguido y reportado hasta el 
momento para reacciones biocatalíticas con enzimas y cofactores co-inmovilizados. 
En vista de estos prometedores resultados, la misma técnica de co-
inmovilización se aplicó a otras dos enzimas transaminasas (Cv-TA y (Pf-TA)  con 
diferentes afinidades por el PLP. La enzima que presenta menor afinidad por el PLP, 
mostró ser la más ineficiente en reacciones en flujo. En último lugar, se eligió la 
transaminasa con mejores resultados para realizar en flujo continuo la síntesis de 
aminas de alto valor comercial empleando células metabólicas artificiales.  
En definitiva, durante los trabajos presentados en esta tesis doctoral se ha 
demostrado que el diseño racional de biocatalizadores heterogéneos y su análisis a 
nivel de una sola partícula son esenciales para mejorar el funcionamiento de las 
reacciones biocatalíticas y poder aplicarlas a nivel industrial. 
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1. BIOCATALYSIS 
Chemical reactions can happen spontaneously, but this process often takes a long time 
to be accomplished because of the high energy requirements. In order to overcome 
such issue, catalysts are molecules which are able to diminish the energy barriers of 
the reaction to speed up the transformation of a chemical substance into another one. 
Noteworthy, the catalysts remain unaltered after each reaction cycle. In nature, 
enzymes are the essential biological catalysts to perform both catabolic and anabolic 
reactions that form the cell metabolism to sustain life.1 These protein-based catalysts 
present unique properties compared to chemical catalysts: a) since enzymes are 
naturally present in cells, they catalyze reactions under physiological conditions (pH 
and temperature) and are biocompatible; b) enzymes are greener catalysts because 
they are biodegradable and they do not produce waste products in excess; c) enzymes 
are capable to catalyze a broad spectrum of reactions, many of which are extremely 
complex to perform by chemical synthesis; d) the regio-, stereo- and chemoselectivity 
of reactions catalyzed by enzymes are also greater than the chemically-catalyzed 
reactions.1 
Biotechnology has been using enzymes as biocatalysts since millennia ago already to 
produce certain foods (e. g. wine, bread, cheese and beer) by using whole-cell 
fermentations. Generally, microbial cells are preferred over plant and animal cells as 
biocatalysts due to their simplicity and easy handling. However, whole-cells 
biotransformations show some inconveniences in terms of product purification, 
resistance to harsh conditions, production of toxic by-products and diffusion 
limitations.2 In the 1960s and 1970s, enzymes started to be isolated from cells to 
accomplish cell-free bioconversions. Fundamentally, free enzymes arrived to the 
general public of our society as additives in commercial detergents.3 But the 
breakthrough of industrial enzymes started at the end of the past century with the 
emergence of directed-evolution of enzymes.4, 5 These advances have driven the use 
of isolated enzymes for the synthesis of non-natural chemical compounds, the 
biomanufacturing of pharmaceuticals intermediates and their application in medical 
therapy. 
The success of catalysis at industrial level depends ultimately on its sustainability at the 
three levels; economy, society and ecology.6, 7 Although biotechnology is not 
necessarily more sustainable than organic chemistry, biocatalysis has demonstrated to 
be cleaner, safer and sometimes more efficient by continuously replacing traditional 
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chemical processes at industry in the last decades. In this sense, modern biocatalysis 
faces the transition from the petro-based economy to the renewable bio-based 
economies; addressing our society evolution but diminishing the human footprint in the 
world.3, 7  
In an industrial context, enzymes still show undesirable features inherent to their 
natural origin.8, 9 On the one hand, the high solubility of enzymes in aqueous solutions 
limits their reuse and recycling for in-line reactions, more dramatically for continuous-
flow operations. On the other hand, the low stability at industrial conditions (extreme 
pH, high temperature, non-polar solvents, high substrates and products concentrations) 
challenges their implementation as free biocatalysts. Moreover, the multi-step protocols 
to produce and purify isolated enzymes are very time-consuming. Finally, natural 
enzymes show a restricted reactivity towards non-natural substrates.10 Fortunately, 
new strategies for the rational development of biocatalysts, high-troughput screening 
and computational analysis are cooperating to sort out these drawbacks. Firstly, the 
novel protein engineering techniques are the in vitro directed evolution based on 
random mutagenesis of amino acids followed by cycles of selection from the resulting 
protein libraries.4 Likewise, the growing number of available enzymes expands the 
catalytic reaction repertoire and eases the assembly of one-pot multi-enzyme cascade 
reactions to access more sophisticated synthetic schemes.11, 12 Moreover, recent 
developments on metadata analysis as omics sciences (e. g. metagenomics13), 
computational protein engineering and the more recent high resolution analysis 
methods among others, let the rapid and extensive enhance of biocatalysts 
properties.14, 15 Secondly, the progress of enzyme immobilization on solid surfaces 
during the last fifty years has been a huge advance to overcome the solubilization 
problems of free enzymes, allowing their reuse during several batch reactions and their 
incorporation in the growing field of flow reactions.16-18 
 
2. ENZYME IMMOBILIZATION 
Enzyme immobilization refers to the state of enzyme molecules confined into or 
attached to solid materials where enzymes are in a different phase from the reactants, 
but substrates and products can diffuse between the solid and liquid phase. These 
enzymatic systems are dubbed as heterogeneous biocatalysts. Hence, during the 
immobilization process, the enzyme becomes water-insoluble (solid) and presents 
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different properties compared to homogeneous biocatalysts (soluble enzyme) dissolved 
in an aqueous-liquid phase.19 
Enzyme immobilization provides many advantages to overcome the limitations of free 
enzymes:20 
 The solid-liquid composition of the heterogeneous biocatalysts facilitates the 
handling and separation of the product from the biocatalyst when the reaction is 
completed, minimizing the contamination of the product and simplifying the 
downstream processes. 
 Enzyme inactivation triggered by inactivating agents (temperature, pH and 
organic solvents) can be minimized when the protein is immobilized, which 
allows using heterogeneous biocatalysts for longer operational times. 
Additionally, immobilized enzymes can be storaged for a long-term due its high 
stability. 
 The facile separation of the immobilized enzymes (solid) from the reaction bulk 
(liquid) make possible the reuse and recycle of the biocatalyst and ease their 
integration into continuous flow systems. This is an essential concern for a cost-
efficient application and intensification of enzymatic processes. 
For those reasons, enzyme immobilization has been the most endorsed solution to 
defeat the solubility and robustness issues of free enzymes.21 However, there are still 
some inconveniences derived from enzyme immobilization. Since enzymes are 
enclosed in a solid structure, mass transfer issues have to be solved in some cases. 
Moreover, the vast majority of enzymes lose activity when immobilized because of 
conformational distortions. Economically, the high price of the carrier is a limiting factor 
to implement enzyme biocatalysis in industry. In order to alleviate those drawbacks, 
many different studies about immobilization procedures, carrier materials and 
immobilization chemistries have come to light in the last five decades.16-18, 21, 22 
 
2.1. Methodologies for enzyme immobilization 
Hitherto, no immobilization protocol has proved to be universal for the enhancement of 
both activity and stability of the immobilized enzymes. In consequence, enzyme 
immobilization is still an empirical exercise based on trial-and-error experiments rather 
than a rational design. Underlying disciplines as materials science, protein structure, 
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enzymology and reactor engineering must converged during the fabrication of 
heterogeneous biocatalysts.23 
The main immobilization chemistries between the enzyme and the carrier can be 
divided into reversible and irreversible immobilization (Figure 1). On the one hand, 
enzymes can be reversibly immobilized by hydrophobic, electrostatic or the called 
weak interactions (van der Waals and hydrogen bonds) with the surface of the carriers. 
Reversible immobilization can be easily reverted by changing the media conditions. 
This is an attractive point to reuse costly carriers because when enzymes become 
inactive, the carrier can be regenerated and reloaded with fresh enzyme. However, 
operational use may suffer from lixiviation issues that may decrease the long-term 
operational performance of the heterogeneous biocatalysts. On the other hand, 
irreversible immobilization involves covalent interactions to bind irreversibly the enzyme 
on the carrier surface. Therefore, the lixiviation issue is overcomed because the 
enzyme cannot be physically detached from the carrier. Despite the carrier cannot be 
regenerated once the enzyme is inactive, irreversible immobilization is frequently 
adopted to prolong the stability of the biocatalyst. Multivalent attachments foment the 
rigidification of the enzyme and consequently stabilize the enzyme structure.24 As 
consequence, the operational life-time of the biocatalyst may significantly increase 
since the enzyme remains active for longer times. Nonetheless, the rigidification of 
enzymes must be balanced because a severe rigidification may cause a dramatic 
decrease of the protein activity. 
Basically, the most used immobilization chemistries are the following: 
 Physical adsorption: This is the most straightforward and oldest technique used 
to immobilize proteins. The physical adsorption is achieved by non-specific 
forces as hydrophobic or ionic reversible interactions.25 Hydrophobic adsorption 
has been used since more than a century ago,26 but the interaction can be 
disrupted under certain conditions (e. g. organic solvents, detergents). Ionic 
adsorption is usually preferred because enzymes surfaces are rich in charged 
residues (acid or basic) that establish strong interactions with the carrier surface 
activated with complementary charged groups. Nevertheless, the immobilized 
enzyme can be still removed by modifying the ionic strength or the pH.27, 28  
 Affinity immobilization: This type of reversible immobilization relies on the 
selectivity and complementarity of biomolecules;29 e. g. antibodies and 
antigens, avidin and biotin, polyhistidine tag and metal ions (Co2+, Cu2+, Zn2+ or 
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Ni2+) hormones and receptors, lectins and glycosilated molecules, DNA and 
DNA-binding protein domains among others. The protein is usually genetically 
modified and the carrier is activated with the corresponding group before the 
immobilization process. The minimal conformational changes and the control of 
protein orientation during affinity immobilization turn out in a high enzymatic 
activity of the biocatalyst.30 Unfortunately, the biocatalyst operational stability is 
low upon the immobilization protocol due to potential lixiviation of the enzyme. 
 Covalent binding: Reversible (usually imine or disulfide bonds)31 and irreversible 
covalent binding are applied to attach proteins to carriers. Although reversible 
covalent bounds (Schiff´s bases) are frequently reduced to become irreversible. 
The side chains of lysine, cysteine, tyrosine, histidine, arginine and glutamic / 
aspartic acid can perform a nucleophilic attack to the reactive groups (epoxy, 
aldehyde, vinyl and cyanogen bromide groups) of the carrier for the covalent 
binding.24, 32-34 Afterwards, the enzyme remains bound to the carrier by 
multipoint covalent attachment which is a strong linking but does not specifically 
orient the enzyme.24 Covalent binding offers benefits in terms of operational 
stability32 and reuse which are crucial for industrial biocatalytic processes. 
However, the irreversible nature of the immobilization does not allow the recycle 
of the expensive carriers when enzyme activity tends to zero. 
 Entrapment/encapsulation: Unlike the previous immobilization strategies, the 
entrapment and encapsulation are not carried out on a prefabricated matrix 
(carrier). In other words, this is a bottom-up approach. Typically, entrapment 
strategies need the presence of enzymes during the synthesis of the carrier. 
The most common carriers are polymeric matrices,35, 36 hollow fibers37 and 
microcapsules.38 Entrapment physically confines the enzymes into 
micro/nanometric structures where the latter can freely move inside the 
materials without direct contact with the carrier. For this reason, this type of 
immobilization can be considered as a reversible approach although the carrier 
can be hardly reused. In some cases, the physical interactions between the 
enzymes and the matrices are so strong that the immobilization is considered 
quasi-irreversible. This is the case of enzyme entrapment into metal-organic 
frameworks where the enzyme is intimately interplaying with the interaction 
network that sustains the carrier architecture.39 A particular case of entrapment 
is the encapsulation of proteins into capsules or vesicles. In this architecture, 
during the encapsulation the enzymes are retained into the lumen spaces of the 
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vesicles formed by a membrane. Depending on the composition we distinguish 
between liposomes, colloidosomes and proteinosemes built with lipids, 
nanoparticles and proteins, respectively.  
 Crosslinked aggregates: This carrier-free immobilization methodology relies on 
the irreversible intermolecular cross-linkages between a cross-linking agent 
(commonly, glutaraldehyde) and the lysine residues of enzymes.40 Cross-linked 
enzyme aggregates (CLEAs) are primarily prepared by precipitation of enzymes 
with organic solvents (acetone, ethanol or butanol), ammonium sulfate or other 
precipitating agents, followed by the cross-linking step. The great advantage of 
CLEAs is the lack of expensive carriers to immobilize enzymes41 in an 
irreversible manner that avoids the enzyme lixiviation.42 Nevertheless, loss of 
activity and mass transfer limitations are the main disadvantages of the high 
enzyme crowding on CLEAs. In the last years other cross-linked aggregates 
have been reported such as metal-phosphate biominerals that can also 
aggregate enzymes giving rise to highly active and stable heterogeneous 
biocatalysts. Unfortunately, their mechanical stability is too low for industrial 
application and their uses have been restricted for sensing or biomedical 
applications.43 
 
Figure 1. Scheme of main enzyme immobilization chemistries. 
 
2.2.  Materials for the fabrication of carriers 
The selection of a suitable material for enzyme immobilization is the key to ultimately 
optimize the performance of the heterogeneous biocatalysts. However, an universal 
material has not been described for all different applications of immobilized enzymes. 
Ideally, the material should be hydrophilic, inert, biocompatible, endurable to microbial 
attack, inexpensive and resistant to physico-chemical degradation.16, 18, 22 Porous 
Reversible Irreversible
Adsorption Aff inity Covalent Encapsulation Entrapment Covalent Cross-linking
Enzyme immobilization
Recyclable carrier Non-recyclable carrier
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carriers are mostly chosen because their high surface area enables high enzyme 
loading and the enzymes are protected from the reaction bulk. Nowadays, 
nanostructures are also getting momentum in virtue of their quick synthesis, large 
surface area and fluent movement. Materials are chiefly classified into organic and 
inorganic according to their chemical composition: 
 Organic materials: These carriers are commonly subclassified into natural and 
synthetic polymers according to their origin.  
- Natural polymers present interesting properties as high protein affinity, non-
toxicity, hydrophilic nature and biodegradability for food industry, 
pharmaco-medical applications and agricultural procedures. The most 
common natural polymers are cellulose, agarose, pectins, chitin, chitosan, 
proteins (gelatin, albumin and collagen) and alginate.44, 45 
- Synthetic polymers are sometimes chosen as a result of their low cost, high 
stability and resistant to biodegradation. Polymethacrylate,46 
polyacrylamide and silicone are some examples of synthetic polymers for 
enzyme immobilization. 
 Inorganic materials: Despite of these materials can be also subdivided as 
natural (silica, bentonite and activated carbon) and synthetic (glass, zeolite47 
and ceramics). The most widely used inorganic material for enzyme 
immobilization is silica.48, 49 This material can be easily synthesized and 
activated with a plethora of reactive groups via silanization. Since silica is pretty 
stable to high temperatures, inert and low-cost, this material has been broadly 
used for industrial manufacturing and also for biomedical purposes.50 
 
During the works developed in this PhD thesis, a broad spectrum of carrier materials, 
activation of the carriers and immobilization chemistries were applied for enzyme 
immobilization (Table1). 
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Table 1. Carriers applied for protein immobilization during this work. 
 
 
3. SYNTHETIC BIOLOGY 
Science has benefited from natural systems by mimicking their structures, properties 
and functions (e. g. biocatalytic routes). Almost two centuries ago, organic chemistry 
started to synthesize natural products rather than just analyzing and isolating them 
from natural samples.51, 52 Following that roadmap, the emerging field of synthetic 
Name Material
Number of 
reactive 
groups
Reactive groups
Particle
diameter
(µm)
Pore 
diameter
(nm)
Preparation 
protocol
AG-DVS 
Agarose
Mono-
functionalization
Vinyl groups 50-150 200 Page 121
AG-Co Cobalt chelates 50-150 200 Commercialsource
AG-PEI600 Aminated groups 50-150 300 Page 121
AG-TEA Aminated groups 50-150 200 Page 89
AG-Oct Octyne groups 50-150 200 This work (Page 56)
AuNRs Gold Thiol groups 0.05 Non-pororous Page 55
Pu-E
Methacryllate
Epoxy groups 150-300 120-180 Commercialsource
Pu-G Aldehyde groups 150-300 120-180 Page 121
SiO2NPs
Silica dioxide
Hydroxyl groups 0.1 Non-pororous Page 55
Glass surface Hydroxyl groups - Non-pororous
Commercial
source
AG-Co/S
Agarose
Bi-
functionalization
Cobalt chelates and 
thiol groups 50-150 200
This work 
(Page 56)
AG-G/PEI25 Aldehyde and aminated groups 50-150 200 Page 89
AG-DVS/PEI25 Vinyl andaminated groups 50-150 200 Page 89
AG-DEAE/G Aldehyde andaminated groups 50-150 200 Page 121
EC-Co2+/eA
Methacryllate
Cobalt chelates and 
aminated groups 100-300 10-20
This work 
(Page 156)
EC-Co2+/PEI60 Cobalt chelates and aminated groups 100-300 10-20
This work
(Page 156)
Pu-Co2+/eA Cobalt chelates and aminated groups 150-300 120-180
This work
(Page 155)
Pu-Co2+/hA Cobalt chelates and aminated groups 150-300 120-180
This work
(Page 155)
Pu-G/PEI25 Aldehyde groups and aminated groups 150-300 120-180 Page 90
Pu-DEAE/E Epoxides and aminated groups 150-300 30-60 Page 121
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biology develops nature-like systems for applications in biomedicine, biochemical 
synthesis and biotechnology.53 This discipline has focused on two main approaches; a 
top-down strategy and a bottom-up strategy. The first approach is based on diminishing 
the multiple functions of an organism to maintain the essential properties of a living 
entity. The bottom-up approach starts from scratch and tries to build complex artificial 
entities by assembling biological and non-biological molecules.52, 54 In this PhD thesis, 
the bottom-up approach was applied to design and engineering protein-based micro-
systems with metabolic functionalities. This bottom-up approach can be dubbed as in 
vitro synthetic biology because non-living elements are normally created.  
 
3.1.  Cell-free protein synthesis 
Proteins are the ultimately expression of biological function as enzymes. Thus, proteins 
represent many roles in chemical reactions as transporters, scaffolds, receptors, and 
protein signaling.55 For these reasons, the production of pure proteins has become in 
an interesting objective from different disciplines. Traditionally, proteins have been 
produced using host organisms as bacteria, yeast and less commonly animal and plant 
cells. However, these heterologous expression systems require multiple time-
consuming steps that include: cloning, transformation of the plasmid to compatible 
cells, selection of colonies hosting a foreign plasmid, culture growth for plasmid 
production, plasmid isolation, sequencing, transformation of the plasmid to compatible 
cells, culture growth for protein overexpression, harvesting, lysis and protein 
purification.56 
In 1961, Nirenberg and Matthaei conducted the protein expression in a test tube rather 
in living cells.57 They separated the cytoplasm from the cell membrane and they used 
the resulting cell extracts to perform the in vitro transcription and translation of proteins 
which is called cell-free protein synthesis (CFPS). Almost any class of cell can be used 
to prepared cell extracts for CFPS. The most conventional sources are E. coli, wheat 
germ and rabbit reticulocite, but also Thermus sp., Leishmania tarentolae, insect cells 
and even human cells have been used.58, 59 Prokaryotic cells are more convenient to 
improve the productivity and scalability of CFPS. However, protein folding and post-
translational modifications are more feasible in eukaryotic cells which are still emerging 
for preparation of cell extracts.60 
Cell extracts basically contain the enzymatic machinery like ribosomes, the ATP 
regeneration system, aminoacyl-tRNA synthases and translation factors (initation, 
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elongation and termination factors). All these elements are used in their soluble form 
together with the substrates (amino acids and nucleotides), tRNAs for the 20 natural 
amino acids, energy cofactors (ATP, GTP, CoA, NAD+ among others), and the DNA 
template to transcript and translate the target polypeptide (Figure 2). DNA templates 
can be added in three different forms: circular plasmid, linearized plasmid or linear 
PCR product. On the one hand, plasmids are of general choice because of the higher 
susceptibility of linear DNA fragments to be cleavaged by endonucleases.61 On the 
other hand, linear DNA fragments are simpler since cloning steps (digestion, ligation, 
transformation to cells, culture growth, plasmid isolation and sequencing) are 
avoided.62  
 
Figure 2. Cell-free protein synthesis. 1) Starting from a living cell, cell extracts are produced 
and stored for further on-demand CFPS. 2) Cell extracts must be supplemented with the fresh 
mix of substrates and the DNA template which is added to trigger the CFPS reaction. 3) The 
transcription of mRNA and the translation into proteins are accomplished in the same test tube 
to finally obtain the desired protein.  
 
Hitherto, two main methods have been optimized to accomplish the CFPS. The cell 
lysate-based CFPS described above has been utilized since fifty years ago due its 
more facile preparation at lower cost. The second method was more recently described 
by Shimizu et al. and was named as PURE system.63, 64 This cell-free system is 
reconstituted with purified components and contains His-tagged versions of all proteins 
which make easier the purification of the synthesized protein.64 Due to the His-tag, the 
protein synthesis machinery can be immobilized onto microbeads to facilitate the 
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purification of the synthesized protein since it remains soluble in the supernatant.65 
Both systems are commercially available nowadays, but also many protocols for cell 
extracts preparation have colonized the field of CFPS in the last years.66 
 
 
3.1.1. Applications of CFPS 
CFPS is the synthetic-biological tool that has received the greatest interest from the 
scientific community because of the wide spectrum of applications.49, 66-69 Due to the 
easy manipulation of cell extracts, fast sampling and direct monitoring, new 
applications are growing everyday. The most relevant strategies which can be involved 
on biocatalyst design are following summarized: 
 Protein evolution: In vivo directed evolution has already shown a high potential 
for enzyme improvement, but applying CFPS for directed evolution of enzymes 
can definitively boost this strategy shortening time processes and financial 
costs.70-72 In the same way, in vitro biocatalyst prototyping by using CFPS has 
been a helpful tool to discover new enzymes and biosynthetic pathways 
optimizing the cycle design-build-test.67, 73 
 Incorporation of non-natural amino acids: The incorporation of non-natural 
amino acids into a specific site of the protein sequence has been addressed in 
vivo. But in vitro protein synthesis is more versatile to incorporate fluorescence-
labels, photoactivable probes, redox active groups and natural post-translational 
modifications into proteins, creating a new toolbox for protein engineering.74, 75 
Since the expression of unnatural proteins may result toxic for living cells, CFPS 
has proven to overcome this issue even obtaining high yields of non-natural 
proteins.76, 77 
 Therapeutics and vaccines: The synthesis of bioactive recombinant proteins 
has been improved by incorporation of CFPS. Exciting results on high-
throughput production and fast protein screenings support CFPS also for 
development of new drugs and biocatalyst-based therapies.78 Recent 
developments on microfluidic systems allow the production of protein-based 
therapeutics at the point-care.79-81 Therefore, CFPS is opening new frontiers for 
personalized protein therapeutics which are very important for orphan drugs. 
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 Diagnostics and biosensing: Biosensors are very sensitive devices principally 
used for clinical diagnosis, environmental monitoring and food safety. 
Frequently, specialized instruments and high economical budgets are needed.82 
Several biosensing platforms have been created in the very last years, by using 
user-friendly and inexpensive CFPS strategies.83 Thus, a new multivalent and 
robust biosensing platform has been developed for both biomedical and 
environmental purposes.84, 85 
 
3.2.  Cell-free metabolic engineering 
Cells are highly advanced microreactors in nature that constitute the ‘minimal building 
block of life’.86 Their complex spatial organization and compartmentalization has 
attracted the attention of synthetic biologists since cells are capable to perform 
thousands of different functions simultaneously with an exquisite selectivity.87 From a 
bottom-up approach, the intracellular components can be in vitro assembled to build a 
synthetic cell-mimic microstructure which is called ‘artificial cell’. However, if 
biosynthetic pathways are the only elements confined into microstructures, we may 
instead name these systems as artificial metabolic cells. This approach was born as 
‘systems biocatalysis’ based on the co-immobilization of isolated enzymes onto artificial 
carriers to perform cell-free metabolic pathways.88, 89 The strategy merges the most 
complex synthetic focus of chemistry with the simplest modular design of biological 
systems. Systems biocatalysis has been already tested for mimicking several natural 
enzymatic pathways as cell-free ethanol fermentation, glycolysis or carbohydrate 
synthesis.88 In this thesis, we went one step further integrating whole-enzyme 
cascades in the solid carrier and analyzing the resulting biocatalysts as single cells.  
Inspired by the organization and confinement of both catabolic and anabolic pathways 
within living cells, enzymes and also their cofactors were co-immobilized into artificial 
solid chassis to develop robust and self-sufficient heterogeneous biocatalysts called 
artificial metabolic cells (Figure 3).90-92 
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Figure 3. Development of artificial metabolic cells for advanced applications. The spatial 
organization and dynamics inside living cells are the basis for the design and engineering of 
artificial metabolic cells. These micro-structures not only help to better understand how cellular 
biology works, but also can perform industrially-interesting reactions in a more efficient fashion. 
 
In an industrial context, growing demands to access a wider spectrum of new products 
maintaining the smaller ecological footprint have pushed the transition framework from 
natural cells as biocatalysts to new cell-free approaches.93 Systems biocatalysis 
approaches for the co-immobilization of enzymes and cofactors (both natural and 
artificial) on different surfaces have been developed in the last years. For 
dehydrogenase-catalyzed reactions, several methodologies have been described to 
retain NAD(P)H in the solid phase.94 Artificial cofactors like nanoparticles and metal 
complexes may be also integrated in biocatalytic reactions.91 For instance, a lipase was 
covalently co-immobilized with metal nanoparticles into silanaceous mesoporous foam 
for tandem catalysis. Sadly, the enzyme was drastically inactivated due to the hard 
reaction conditions.95 In a more precise strategy, metal complexes were covalently 
tethered to the surface of immobilized enzymes, giving rise to heterogeneous 
biocatalysts capable of hydrolyzing and reducing nitroarene esters in a one-pot tandem 
reaction.96 
The last advances on protein engineering and immobilization techniques working 
synergistically with the focus of heterogeneous biocatalysts as self-sufficient artificial 
metabolic cells are poised to boost adapted and efficient biocatalystsfor sustainable 
chemistry purposes.97 
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4. SINGLE-PARTICLE STUDIES 
Notwithstanding the advance of characterization studies of heterogeneous biocatalysts 
at macroscopic level, the performance of enzymes and cofactors inside solid carriers is 
still a black-box. Unfortunately, the intraparticle characterization and analysis of 
immobilized enzymes have received much less attention. For this reason, 
heterogeneous biocatalysts show unpredictable mass transfer issues, unknown internal 
gradients and inactivation facts which are harsh to overcome.98, 99 Analogously to inside 
living cells, co-immobilized enzymes and cofactors on porous materials show a 
dynamic behavior. Therefore, the information elicited from the inside of microparticles 
is paramount to optimize the design and engineering of these self-sufficient 
heterogeneous biocatalysts (Figure 3).  
 
Figure 3. Scheme of information elicited from single-particle studies with spatio-temporal 
resolution.  
 
In the last twenty years, single-molecule100 and single-cell101 studies have been key to 
understand biological processes and subsequently to boost the biotechnological 
applications of synthetic biology. In parallel, single-particle studies of artificial metabolic 
cells pretend to decipher mass transfer effects and enzyme kinetics at micro-scale to 
enhance the biocatalytic processes at macroscopic level.102 On one hand, single-
particle studies reveal morphological features of the solid materials as size dispersion 
and shape defects which will influence the final properties of the heterogeneous 
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biocatalysts. On the other hand, more functional aspects as spatio-temporal 
performance of immobilized enzymes and cofactors can be monitored and analyzed at 
real time. Although the intraparticle analytical techniques are not well-established yet, 
single-particle studies are getting momentum in biocatalyst community.102, 103 These 
studies shine light on the extensive technical possibilities existing for microscopic 
characterization of artificial metabolic cells, which are much simpler and easier to 
control than living cells. 
Hitherto, the information elicited from single-particle studies of artificial metabolic cells 
can be sorted in four main areas: 
 Spatial distribution of immobilized enzymes across solid carriers: Immobilized 
enzymes have been traditionally assumed to be homogeneously distributed 
across the solid porous carriers. Consequently, the majority of immobilization 
protocols lack the control of the spatial distribution and also the orientation of 
the enzyme. Nonetheless, the 3D distribution and spatial localization of 
immobilized enzymes show a direct influence on the efficiency of the reaction 
kinetics.  
Over the last few decades, atomic force microscopy (AFM), low-temperature 
field-emission scanning electron microscopy (cryo-FESEM),104 spherical 
aberration (Cs)-corrected (STEM),105 micro infrared and RAMAN 
spectroscopy106 among others have been applied to obtain spatial information 
from immobilized proteins. Apart from these high-specialized techniques, 
fluorescence imaging by confocal laser scanning microscopy (CLSM) is often 
preferred due to the high versatility and resolution with easy handling. The 
fluorophores can be either genetically encoded (e. g. fluorescent proteins) or 
organic labels (e. g. rhodamine). The use of fluorescent proteins allowed the 
analysis of the effects of immobilization rates on spatial distribution of 
immobilized enzymes.107 Moreover, the kinetics of an immobilized multi-enzyme 
system was studied by the spatial distribution of fluorophore-labeled 
enzymes.108 
 Stability of immobilized enzymes using spectroscopic methods: Enzyme 
immobilization is a well-known methodology to achieve a higher stabilization of 
the biocatalysts because of the enzyme rigidification. Conventionally, stability of 
the enzyme is determined through bulk studies where the samples are 
incubated in presence of the inactivating agent and the averaged enzymatic 
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activity is monitored along the time. These macroscopic studies lose the spatial 
resolution needed to analyze the enzyme stability at single-particle level. AFM 
has been used to perform spectroscopic studies that predict the thermal stability 
of immobilized proteins.109 Likewise, the combination of fluorescence lifetime 
imaging and spatial resolved fluorescence polarization was also applied to 
determine the fluorescence anisotropy of immobilized proteins as innovative 
strategy to analyze the stability of immobilized enzymes.110 
 Reaction kinetics of immobilized enzymes: The activity of biocatalysts is 
conventionally monitored by measuring either the depletion of substrates or the 
formation of products from the bulk solution. Due to the heterogeneity of the 
sample, all the microparticles immobilizing enzymes show different spatio-
temporal kinetics. Monitoring and imaging the enzyme activity during the 
operational process (in operando studies) provide substantial information that is 
otherwise inaccessible. To this aim, many fluorogenic substrates are 
commercially available as useful reporter systems.111 These fluorogenic 
substrates are enzymatically transformed into fluorescent products which are 
read out to monitor the system kinetics.112, 113 CLSM benefits from fluorescence 
to record the local synthesis of products. The bi-enzymatic system formed by 
glucose oxidase and horseradish peroxidase has been the most studied 
immobilized cascade by using fluorogenic substrates.114, 115 
Harnessing the autofluorescence of cofactors, enzymatic reactions performed 
by cofactor-dependent enzymes can be monitored by a label-free strategy. 
FAD(H) and NAD(H) are excellent cofactors for these studies, because 
cofactor-enzyme electron transfer causes fluorescence fluctuations that may be 
attributed to different conformations states. The fluorescence intensity is higher 
for the reduced form than for the oxidized one. This phenomenon was profited 
using soluble NAD+ to created pH micro-gradients with microelectrodes and 
monitored the local activity of an immobilized alcohol dehydrogenase.116 The 
transition from soluble NAD+ to NADH was recorded and imaged to monitor the 
immobilized enzyme kinetics. However, monitoring the cofactor utilization with 
spatial resolution is underexploited.  
 Oxygen and pH resolution within immobilized enzymes: Mass transfer effects 
are sometimes limiting the scope of heterogeneous biocatalysts. O2 and pH are 
two variables specially affected by the concentration gradients between the bulk 
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liquid and the solid carrier surface.103, 117 In order to assess the significance of 
the diffusional limitations, the concentration gradients should be measured in 
the bulk solution and in the internal microenvironment of the particle at real-
time.23, 103 The intraparticle consumption of O2 by immobilized oxidases was 
measured by labeling the carrier with an O2-sensitive luminophore.117 This 
stategy was further used to optimize the geometrical properties of carriers 
(avoiding O2 transfer limitations) during the design of heterogenous 
biocatalysts.118 
Fluorophore-labeling was also applied to immobilized enzymes in order to 
quantify acidification effects inside the microparticles during biocatalytic 
reactions.119 In addition, CLSM was once more applied in a pioneer study to 
characterize different biocatalysts by measuring and imaging the intraparticle 
pH.120 
 
5. FLOW BIOPROCESSES 
In this age, biocatalysis is a robust tool to accomplish sustainable chemical processes. 
Until the early 20th century, biocatalytic reactions were carried out in batch reactors 
which are flexible and simple. Nevertheless, the modern industry demands the 
intensification of the process to achieve high space-time yields. Flow-reactors can be 
more productive, better controlled and more sustainable than reactions in batch.121-123 
In the last two decades, the concept of flow chemistry has been quickly developed in 
academia and also transferred to industry. The methodology involves a fluid containing 
the starting materials that is pumped at known flow rates through plug-flow reactors, 
where the chemical reaction takes place to finally yield a stream of product. The pump 
can be semi-continuous (e. g. syringe that needs refilling with the starting material) or 
continuous which do not require refilling and hypothetically can work indefinitely.122 The 
foremost advantages of flow biocatalysis are time and costs. Flow biotransformations 
are accelerated, from hours to minutes, as a result of the higher liquid-solid contact 
surface which allows larger synthesis of products in smaller equipments with higher 
space-time yields, up to 650-fold in comparison with batch reactions.123, 124 The 
continuous flow nature facilitate a faster homogenization of the temperature (heating or 
cooling) and the diffusion of gases (O2, N2, H2, CO2).125 Moreover, flow reactors are 
normally modular allowing a flexible increment of production volume by adding more 
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reactors either in series or in parallel. In consequence, energy requirements and waste 
are drastically reduced due to higher efficiencies derived from a better process 
control.123 
Flow reactors migth be tube-in-tube reactors, cartridges, micro- or mesofluidic devices, 
reactor coils and packed-bed reactors. Microreactors are getting popular for organic 
synthesis even at industrial scale. The most highlighted benefits are the high 
surface/volume ratio, the energy efficiency, the easy mobility of process plants, the 
plug-and-play process configuration and the rapid process development.126, 127 In the 
very last two years, a new type of 3D-printed flow reactors (known as ‘reactionwares’) 
were developed for efficient continuous transaminations in microreactors.128 However, 
more conventional packed-bed reactors (PBR) are the most used type of flow reactor 
by reason of easy-handling and high stability. PBRs are usually constituted by a tube 
filled with particles of immobilized enzymes remaining in fixed positions. The particles 
are suspended and moving constantly through the reaction medium which must be 
pumped at high flow rates to achieve mass transfers. Since the particles keep a 
continuous movement, the clogging of the bed and the poor distribution of the flow are 
avoided.123 Consequently, PBRs are usually the most nearby approximation to a plug 
flow reactor (PFR). The PFR is a model used in chemical engineering to describe a 
flowing system of cylindrical geometry. The main assumption is that the whole content 
is completely mixed in the radial direction, but no mixing happens in the axial direction 
(not with the elements downstream or upstream). Then, the residence time is the same 
for all the elements inside the reactor.123 
Flow biocatalysis may be performed using whole-cells, immobilized enzymes or free 
enzymes. Immobilized enzymes are mostly chosen for flow biotransformations because 
the downstream processes are simpler, the reaction is performed faster than using 
whole-cells and immobilized enzymes are retained and reused unlike free enzymes.122 
Flow-chemistry contributes to the progress of many synthetic applications. 
Pharmaceutical industry was the first one to exploit the power of flow biocatalysis to 
sustainable manufacturing fine chemicals.129-131 Currently, flow biocatalysis is an 
increasingly trending topic to enhance biocatalytic transformations obtaining high 
conversion yields. Lipase-catalyzed amidations and esterifications have been 
accomplished in flow-reactors.132, 133 Dehydrogenases,134 lyases,135 phosphatases and 
aldolases,136 among others have been incorporated to flow-biocatalysis as well. 
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Noteworthy, transaminations have greatly impacted on flow biocatalysis in the last 
years.128, 137-140 
REFERENCES 
1. Illanes, A. Enzyme biocatalysis: principles and applications. Springer. 2008.  
 
2. Schmid-Dannert, C., López-Gallego, F. Advances and opportunities for the 
design of self-sufficient and spatially organized cell-free biocatalytic systems. 
Current Opinion in Chemical Biology. 2019, 49: 97-104.  
 
3. Blamey, J. M., Fischer, F., Meyer, H. P., Sarmiento, F., Zinn, M. Enzymatic 
biocatalysis in chemical transformations: a promising and emerging field in 
green chemistry practice. In Biotechnology of microbial enzymes. Academic 
Press. 2017, 14: 347-403.  
 
4. Moore, J. C., Jin, H. M., Kuchner, O., Arnold, F. H. Strategies for the in vitro 
evolution of protein function: enzyme evolution by random recombination of 
improved sequences. Journal of Molecular Biology. 1997, 272: 336-347.  
 
5. Minshull, J., Willem Stemmer, P. C. Protein evolution by molecular breeding. 
Current Opinion in Chemical Biology. 1999, 3: 284-290.  
 
6. Fessner, W. D. Biocatalysis: from discovery to application. Springer. 2000.  
 
7. Sheldon, R. A., Woodley, J. M. Role of biocatalysis in sustainable chemistry. 
Chemical Reviews. 2018, 118: 801-838.  
 
8. Chapman, J., Ismail, E. A., Dinu, Z. C. Industrial applications of enzymes: 
recent advances, techniques, and outlooks. Catalysts. 2018, 8: 1443-1454.  
 
9. Schmid, A., Dordick, J. S., Hauer, B., Kiener, A., Wubbolts, M., Witholt, B. 
Industrial biocatalysis today and tomorrow. Nature. 2001, 409: 258-268.  
 
10. Homaei, A. A., Sariri, R., Vianello, F., Stevanato, R. Enzyme immobilization: an 
update. Journal of Chemical Biology. 2013, 6: 185-205.  
 
11. García-Junceda, E., Lavandera, I., Rother, D., Schrittwieser, J. H. 
(Chemo)enzymatic cascades - nature's synthetic strategy transferred to the 
laboratory. Journal of Molecular Catalysis B: Enzymatic. 2015, 114: 1-6.  
 
12. Sanchez-Moreno, I., Oroz-Guinea, I., Iturrate, L., Garcia-Junceda, E. 
ChemInform abstract: multienzyme reactions. ChemInform. 2013, 44.  
 
13. Lorenz, P., Eck, J. Metagenomics and industrial applications. Nature Reviews 
Microbiology. 2005, 3: 510-516.  
 
14. Bommarius, A. S. Biocatalysis: a status report. Annual Review of Chemical and 
Biomolecular Engineering. 2015, 6: 319-345.  
 
Chapter 1 
- 30 - 
 
15. Bornscheuer, U. T., Huisman, G. W., Kazlauskas, R. J., Lutz, S., Moore, J. C., 
Robins, K. Engineering the third wave of biocatalysis. Nature. 2012, 485: 185-
194.  
 
16. Datta, S., Christena, L. R., Rajaram, Y. R. S. Enzyme immobilization: an 
overview on techniques and support materials. 3 Biotech. 2013, 3: 1-9.  
 
17. Guisán, J. M. In Immobilization of enzymes and cells. Humana Press. 2006.  
 
18. Sheldon, R. A., Van Pelt, S. Enzyme immobilisation in biocatalysis: why, what 
and how. Chemical Society Reviews. 2013, 42: 6223-6235.  
 
19. Hanefeld, U., Gardossi, L., Magner, E. Understanding enzyme immobilisation. 
Chemical Society Reviews. 2009, 38: 453-468.  
 
20. Katchalski-Katzir, E. Immobilized enzymes, learning from past successes and 
failures. Trends in Biotechnology. 1993, 11: 471-478.  
 
21. Bickerstaff, G. In Immobilization of enzymes and cells. Humana Press. 1996.  
 
22. Mohamad, N. R., Marzuki, N. H. C., Buang, N. A., Huyop, F., Wahab, R. A. An 
overview of technologies for immobilization of enzymes and surface analysis 
techniques for immobilized enzymes. Biotechnology, biotechnological 
equipment. 2015, 29: 205-220.  
 
23. Bolivar, J. M., Eisl, I., Nidetzky, B. Advanced characterization of immobilized 
enzymes as heterogeneous biocatalysts. Catalysis Today. 2016, 259: 66-80.  
 
24. Grazú, V., Abian, O., Mateo, C., Batista-Viera, F., Fernández-Lafuente, R., 
Guisán, J. M. Stabilization of enzymes by multipoint immobilization of thiolated 
proteins on new epoxy-thiol supports. Biotechnology and Bioengineering. 2005, 
90: 597-605.  
 
25. Jesionowski, T., Zdarta, J., Krajewska, B. Enzyme immobilization by adsorption: 
a review. Adsorption. 2014, 20: 801-821.  
 
26. Nelson, J. M., Griffin, E. G. Adsorption of invertase. Journal of the American 
Chemical Society. 1916, 38: 1109-1115.  
 
27. Mateo, C., Abian, O., Fernandez-Lafuente, R., Guisan, J. M. Reversible 
enzyme immobilization via a very strong and nondistorting ionic adsorption on 
support–polyethylenimine composites. Biotechnology and Bioengineering. 
2000, 68: 98-105.  
 
28. Mateo, C. et al. Very strong but reversible immobilization of enzymes on 
supports coated with ionic polymers. In Immobilization of enzymes and cells. 
Springer. 2006, 22: 205-216.  
 
29. Roy, I., Gupta, M. N. Bioaffinity immobilization. In Immobilization of enzymes 
and cells. Springer. 2006, 107-116.  
 
30. Andreescu, S., Bucur, B., Marty, J. L. Affinity immobilization of tagged enzymes. 
In Immobilization of enzymes and cells. Springer. 2006, 97-106.  
Chapter 1 
- 31 - 
 
 
31. Ovsejevi, K., Manta, C., Batista-Viera, F. Reversible covalent immobilization of 
enzymes via disulfide bonds. In Immobilization of enzymes and cells. Springer. 
2013, 89-116.  
 
32. López-Gallego, F., Fernandez-Lorente, G., Rocha-Martin, J., Bolivar, J. M., 
Mateo, C., Guisan, J. M. Stabilization of enzymes by multipoint covalent 
immobilization on supports activated with glyoxyl groups. In Immobilization of 
enzymes and cells. Springer. 2013, 59-71.  
 
33. López-Gallego, F., Guisán, J. M., Betancor, L. Glutaraldehyde-mediated protein 
immobilization. In Immobilization of enzymes and cells. Springer. 2013, 33-41.  
 
34. Mateo, C., Grazu, V., Palomo, J. M., López-Gallego, F., Fernandez-Lafuente, 
R., Guisan, J. M. Immobilization of enzymes on heterofunctional epoxy 
supports. Nature Protocols. 2007, 2: 1022.  
 
35. Reetz, M. T. Practical protocols for lipase immobilization via sol–gel techniques. 
In Immobilization of enzymes and cells. Springer. 2013, 241-254.  
 
36. Sassolas, A., Hayat, A., Marty, J.-L. Enzyme immobilization by entrapment 
within a gel network. In Immobilization of enzymes and cells. Springer. 2013, 
229-239.  
 
37. Ji, X., Wang, P., Su, Z., Ma, G., Zhang, S. Enabling multi-enzyme biocatalysis 
using coaxial-electrospun hollow nanofibers: redesign of artificial cells. Journal 
of Materials Chemistry B. 2014, 2: 181-190.  
 
38. Rother, C., Nidetzky, B. Enzyme immobilization by microencapsulation: 
methods, materials, and technological applications. Encyclopedia of Industrial 
Biotechnology. 2014.  
 
39. Chen, W. H., Vázquez-González, M., Zoabi, A., Abu-Reziq, R., Willner, I. 
Biocatalytic cascades driven by enzymes encapsulated in metal–organic 
framework nanoparticles. Nature Catalysis. 2018, 1: 689-695.  
 
40. Cao, L., Langen, L. V., Sheldon, R. A. Immobilised enzymes: carrier-bound or 
carrier-free? Current Opinion in Biotechnology. 2003, 14: 387-394.  
 
41. Sheldon, R. A. Characteristic features and biotechnological applications of 
cross-linked enzyme aggregates (CLEAs). Applied microbiology and 
biotechnology. 2011, 92: 467-477.  
 
42. Velasco-Lozano, S., López-Gallego, F., Mateos-Díaz Juan, C., Favela-Torres, 
E. Cross-linked enzyme aggregates (CLEA) in enzyme improvement – a 
review. Biocatalysis. 2016, 1: 166-177.  
 
43. Lee, S. W., Cheon, S. A., Kim, M. I., Park, T. J. Organic-inorganic hybrid 
nanoflowers: types, characteristics, and future prospects. Journal of 
nanobiotechnology. 2015, 13: 54-63.  
 
Chapter 1 
- 32 - 
 
44. Klein, M. P., Scheeren, C. W., Lorenzoni, A. S. G., Dupont, J., Frazzon, J., 
Hertz, P. F. Ionic liquid-cellulose film for enzyme immobilization. Process 
Biochemistry. 2011, 46: 1375-1379.  
 
45. Zucca, P., Fernandez-Lafuente, R., Sanjust, E. Agarose and its derivatives as 
supports for enzyme immobilization. Molecules. 2016, 21: 1577-1601.  
 
46. Palomo, J. M., Muñoz, G., Fernández-Lorente, G., Mateo, C., Fernández-
Lafuente, R., Guisán, J. M. Interfacial adsorption of lipases on very hydrophobic 
support (octadecyl–Sepabeads): immobilization, hyperactivation and 
stabilization of the open form of lipases. Journal of Molecular Catalysis B: 
Enzymatic. 2002, 19-20: 279-286.  
 
47. Díaz, J. F., Balkus, K. J. Enzyme immobilization in MCM-41 molecular sieve. 
Journal of Molecular Catalysis B: Enzymatic. 1996, 2: 115-126.  
 
48. Blanco, R. M., Terreros, P., Fernández-Pérez, M., Otero, C., Dıáz-González, G. 
Functionalization of mesoporous silica for lipase immobilization: 
Characterization of the support and the catalysts. Journal of Molecular Catalysis 
B: Enzymatic. 2004, 30: 83-93.  
 
49. Carlson, E. D., Gan, R., Hodgman, C. E., Jewett, M. C. Cell-free protein 
synthesis: applications come of age. Biotechnology Advances. 2012, 30: 1185-
1194.  
 
50. Bharti, C., Nagaich, U., Pal, A. K., Gulati, N. Mesoporous silica nanoparticles in 
target drug delivery system: A review. International journal of pharmaceutical 
investigation. 2015, 5: 124-133.  
 
51. Yeh, B. J., Lim, W. A. Synthetic biology: lessons from the history of synthetic 
organic chemistry. Nature Chemical Biology. 2007, 3: 521-525.  
 
52. Boldt, J. Synthetic biology: origin, scope and ethics. Minding nature. 2010, 3.   
 
53. Hodgman, C. E., Jewett, M. C. Cell-free synthetic biology: thinking outside the 
cell. Metabolic Engineering. 2012, 14: 261-269.  
 
54. Xu, C., Hu, S., Chen, X. Artificial cells: from basic science to applications. 
Materials Today. 2016, 19: 516-532.  
 
55. Whittaker, J. W. Cell-free protein synthesis: the state of the art. Biotechnology 
Letters. 2013, 35: 143-152.  
 
56. Gräslund, S. et al. Protein production and purification. Nature Methods. 2008, 5: 
135-146.  
 
57. Nirenberg, M. W., Matthaei, J. H. The dependence of cell-free protein synthesis 
in E. coli upon naturally occurring or synthetic polyribonucleotides. Proceedings 
of the National Academy of Sciences. 1961, 47: 1588-1602.  
 
58. Mikami, S., Kobayashi, T., Masutani, M., Yokoyama, S., Imataka, H. A human 
cell-derived in vitro coupled transcription/translation system optimized for 
Chapter 1 
- 33 - 
 
production of recombinant proteins. Protein Expression and Purification. 2008, 
62: 190-198.  
 
59. Mureev, S., Kovtun, O., Nguyen, U. T. T., Alexandrov, K. Species-independent 
translational leaders facilitate cell-free expression. Nature Biotechnology. 2009, 
27: 747-752.  
 
60. Zemella, A., Thoring, L., Hoffmeister, C., Kubick, S. Cell-free protein synthesis: 
pros and cons of prokaryotic and eukaryotic systems. ChemBioChem. 2015, 16: 
2420-2431.  
 
61. Yang, H. L., Ivashkiv, L., Chen, H. Z., Zubay, G., Cashel, M. Cell-free coupled 
transcription-translation system for investigation of linear DNA segments. 
Proceedings of the National Academy of Sciences. 1980, 77: 7029-7033.  
 
62. Schinn, S. M., Broadbent, A., Bradley, W. T., Bundy, B. C. Protein synthesis 
directly from PCR: progress and applications of cell-free protein synthesis with 
linear DNA. New Biotechnology. 2016, 33: 480-487.  
 
63. Shimizu, Y. et al. Cell-free translation reconstituted with purified components. 
Nature Biotechnology. 2001, 19: 751-755.  
 
64. Shimizu, Y., Kanamori, T., Ueda, T. Protein synthesis by pure translation 
systems. Methods. 2005, 36: 299-304.  
 
65. Kojima, T. et al. Immobilization of proteins onto microbeads using a DNA 
binding tag for enzymatic assays. Journal of Bioscience and Bioengineering. 
2016, 121: 147-153.  
 
66. Chong, S. Overview of cell-free protein synthesis: historic landmarks, 
commercial systems, and expanding applications. Current protocols in 
molecular biology. 2014, 108: 16.30.1-16.30.11.  
 
67. Karim, A. S., Jewett, M. C. A cell-free framework for rapid biosynthetic pathway 
prototyping and enzyme discovery. Metabolic Engineering. 2016, 36: 116-126.  
 
68. Villarreal, F., Tan, C. Cell-free systems in the new age of synthetic biology. 
Frontiers of Chemical Science and Engineering. 2017, 11: 58-65.  
 
69. Liu, W.-Q., Zhang, L., Chen, M., Li, J. Cell-free protein synthesis: recent 
advances in bacterial extract sources and expanded applications. Biochemical 
Engineering Journal. 2019, 141: 182-189.  
 
70. Fischlechner, M., Schaerli, Y., Mohamed, M. F., Patil, S., Abell, C., Hollfelder, 
F. Evolution of enzyme catalysts caged in biomimetic gel-shell beads. Nature 
Chemistry. 2014, 6: 791-796.  
 
71. Nishikawa, T., Sunami, T., Matsuura, T., Yomo, T. Directed evolution of 
proteins through in vitro protein synthesis in liposomes. Journal of nucleic acids. 
2012, 2012: 1-11.  
 
Chapter 1 
- 34 - 
 
72. Stapleton, J. A., Swartz, J. R. Development of an in vitro compartmentalization 
screen for high-throughput directed evolution of [FeFe] hydrogenases. PLOS 
ONE. 2010, 5: 1-8.  
 
73. Swartz, J. Developing cell-free biology for industrial applications. Journal of 
Industrial Microbiology and Biotechnology. 2006, 33: 476-485.  
 
74. Dumas, A., Lercher, L., Spicer, C. D., Davis, B. G. Designing logical codon 
reassignment – expanding the chemistry in biology. Chemical Science. 2015, 6: 
50-69.  
 
75. Chin, J. W. Expanding and reprogramming the genetic code. Nature. 2017, 550: 
53-60.  
 
76. Goerke, A. R., Swartz, J. R. High-level cell-free synthesis yields of proteins 
containing site-specific non-natural amino acids. Biotechnology and 
Bioengineering. 2009, 102: 400-416.  
 
77. Martin, R. W. et al. Cell-free protein synthesis from genomically recoded 
bacteria enables multisite incorporation of noncanonical amino acids. Nature 
Communications. 2018, 9: 1-9.  
 
78. Salehi, A. S. M., Smith, M. T., Bennett, A. M., Williams, J. B., Pitt, W. G., Bundy, 
B. C. Cell-free protein synthesis of a cytotoxic cancer therapeutic: onconase 
production and a just-add-water cell-free system. Biotechnology Journal. 2016, 
11: 274-281.  
 
79. Georgi, V. et al. On-chip automation of cell-free protein synthesis: new 
opportunities due to a novel reaction mode. Lab on a Chip. 2016, 16: 269-281.  
 
80. Husser, M. C., Vo, P. Q. N., Sinha, H., Ahmadi, F., Shih, S. C. C. An automated 
induction microfluidics system for synthetic biology. ACS Synthetic Biology. 
2018, 7 (3): 933-944.  
 
81. Sullivan, C. J. et al. A cell-free expression and purification process for rapid 
production of protein biologics. Biotechnology Journal. 2016, 11: 238-248.  
 
82. Perumal, V., Hashim, U. Advances in biosensors: principle, architecture and 
applications. Journal of Applied Biomedicine. 2014, 12: 1-15.  
 
83. Wen, K. Y. et al. A cell-free biosensor for detecting quorum sensing molecules 
in P. aeruginosa - infected respiratory samples. ACS Synthetic Biology. 2017, 6: 
2293-2301.  
 
84. Salehi, A. S. M. et al. Cell-free protein synthesis approach to biosensing hTRβ-
specific endocrine disruptors. Analytical Chemistry. 2017, 89: 3395-3401.  
 
85. Salehi, A. S. M. et al. Biosensing estrogenic endocrine disruptors in human 
blood and urine: a rapid cell-free protein synthesis approach. Toxicology and 
Applied Pharmacology. 2018, 345: 19-25.  
 
Chapter 1 
- 35 - 
 
86. Buddingh’, B. C., Van Hest, J. C. M. Artificial cells: synthetic compartments with 
life-like functionality and adaptivity. Accounts of Chemical Research. 2017, 50: 
769-777.  
 
87. Mehta, S., Zhang, J. Illuminating the cell’s biochemical activity architecture. 
Biochemistry. 2017, 56: 5210-5213.  
 
88. Fessner, W.-D. Systems Biocatalysis: Development and engineering of cell-free 
“artificial metabolisms” for preparative multi-enzymatic synthesis. New 
Biotechnology. 2015, 32: 658-664.  
 
89. Tessaro, D., Pollegioni, L., Piubelli, L., D’arrigo, P., Servi, S. Systems 
biocatalysis: an artificial metabolism for interconversion of functional groups. 
ACS Catalysis. 2015, 5: 1604-1608.  
 
90. López-Gallego, F., Jackson, E., Betancor, L. Heterogeneous systems 
biocatalysis: the path to the fabrication of self-sufficient artificial metabolic cells. 
Chemistry – A European Journal. 2017, 23: 17841-17849.  
 
91. Schmidt, S., Castiglione, K., Kourist, R. Overcoming the incompatibility 
challenge in chemoenzymatic and multi-catalytic cascade reactions. Chemistry 
– A European Journal. 2018, 24: 1755-1768.  
 
92. Velasco-Lozano, S., Benítez-Mateos, A. I., López-Gallego, F. Co-immobilized 
phosphorylated cofactors and enzymes as self-sufficient heterogeneous 
biocatalysts for chemical processes. Angewandte Chemie International Edition. 
2017, 56: 771-775.  
 
93. Lee, J. W., Na, D., Park, J. M., Lee, J., Choi, S., Lee, S. Y. Systems metabolic 
engineering of microorganisms for natural and non-natural chemicals. Nature 
Chemical Biology. 2012, 8: 536-546.  
 
94. Liu, W., Wang, P. Cofactor regeneration for sustainable enzymatic biosynthesis. 
Biotechnology Advances. 2007, 25: 369-384.  
 
95. Engström, K. et al. Co-immobilization of an enzyme and a metal into the 
compartments of mesoporous silica for cooperative tandem catalysis: an 
artificial metalloenzyme. Angewandte Chemie International Edition. 2013, 52: 
14006-14010.  
 
96. Filice, M., Romero, O., Gutiérrez-Fernández, J., De Las Rivas, B., Hermoso, J. 
A., Palomo, J. M. Synthesis of a heterogeneous artificial metallolipase with 
chimeric catalytic activity. Chemical Communications. 2015, 51: 9324-9327.  
 
97. Schmidt-Dannert, C., Lopez-Gallego, F. A roadmap for biocatalysis – functional 
and spatial orchestration of enzyme cascades. Microbial Biotechnology. 2016, 
9: 601-609.  
 
98. Bommarius, A. S., Paye, M. F. Stabilizing biocatalysts. Chemical Society 
Reviews. 2013, 42: 6534-6565.  
 
99. Dicosimo, R., Mcauliffe, J., Poulose, A. J., Bohlmann, G. Industrial use of 
immobilized enzymes. Chemical Society Reviews. 2013, 42: 6437-6474.  
Chapter 1 
- 36 - 
 
 
100. Peterman, E. J. G., Wuite, G. J. L. Single molecule analysis. Humana Press. 
2018.  
 
101. Yuan, G.C. et al. Challenges and emerging directions in single-cell analysis. 
Genome Biology. 2017, 18: 1-8.  
 
102. Benítez-Mateos, A. I., Nidetzky, B., Bolivar, J. M., López-Gallego, F. Single-
particle studies to advance the characterization of heterogeneous biocatalysts. 
ChemCatChem. 2018, 10: 654-665.  
 
103. Bolivar, J. M., Consolati, T., Mayr, T., Nidetzky, B. Shine a light on immobilized 
enzymes: real-time sensing in solid supported biocatalysts. Trends in 
Biotechnology. 2013, 31: 194-203.  
 
104. Hoenger, A. High-resolution cryo-electron microscopy on macromolecular 
complexes and cell organelles. Protoplasma. 2014, 251: 417-427.  
 
105. Mayoral, A., Arenal, R., Gascón, V., Márquez-Álvarez, C., Blanco, R. M., Díaz, 
I. Designing functionalized mesoporous materials for enzyme immobilization: 
locating enzymes by using advanced TEM techniques. ChemCatChem. 2013, 
5: 903-909.  
 
106. López-Gallego, F., Yate, L. Selective biomineralization of Co3(PO4)2-sponges 
triggered by His-tagged proteins: efficient heterogeneous biocatalysts for redox 
processes. Chemical Communications. 2015, 51: 8753-8756.  
 
107. Bolivar, J. M., Hidalgo, A., Sánchez-Ruiloba, L., Berenguer, J., Guisán, J. M., 
López-Gallego, F. Modulation of the distribution of small proteins within porous 
matrixes by smart-control of the immobilization rate. Journal of Biotechnology. 
2011, 155: 412-420.  
 
108. Rocha-Martín, J., Rivas, B. D. L., Muñoz, R., Guisán, J. M., López-Gallego, F. 
Rational co-immobilization of bi-enzyme cascades on porous supports and their 
applications in bio-redox reactions with in situ recycling of soluble cofactors. 
ChemCatChem. 2012, 4: 1279-1288.  
 
109. Gregurec, D., Velasco-Lozano, S., Moya, S. E., Vázquez, L., López-Gallego, F. 
Force spectroscopy predicts thermal stability of immobilized proteins by 
measuring microbead mechanics. Soft Matter. 2016, 12: 8718-8725.  
 
110. Orrego, A. H., García, C., Mancheño, J. M., Guisán, J. M., Lillo, M. P., López-
Gallego, F. Two-photon fluorescence anisotropy imaging to elucidate the 
dynamics and the stability of immobilized proteins. The Journal of Physical 
Chemistry B. 2016, 120: 485-491.  
 
111. Turunen, P., Rowan, A. E., Blank, K. Single-enzyme kinetics with fluorogenic 
substrates: lessons learnt and future directions. FEBS Letters. 2014, 588: 3553-
3563.  
 
112. Aguanno, E., Altamura, E., Mavelli, F., Fahr, A., Stano, P., Luisi, L. P. Physical 
routes to primitive cells: an experimental model based on the spontaneous 
Chapter 1 
- 37 - 
 
entrapment of enzymes inside micrometer-sized liposomes. Life. 2015, 5: 969-
996.  
 
113. Wang, L. et al. Single-step fabrication of multi-compartmentalized biphasic 
proteinosomes. Chemical Communications. 2017, 53: 8537-8540.  
 
114. Piwonski, H. M., Goomanovsky, M., Bensimon, D., Horovitz, A., Haran, G. 
Allosteric inhibition of individual enzyme molecules trapped in lipid vesicles. 
Proceedings of the National Academy of Sciences. 2012, 109: 1437-1443.  
 
115. Tang, T. Y. D. et al. Gene-mediated chemical communication in synthetic 
protocell communities. ACS Synthetic Biology. 2018, 7: 339-346.  
 
116. O'brien, J. C., Shumaker-Parry, J., Engstrom, R. C. Microelectrode control of 
surface-bound enzymatic activity. Analytical Chemistry. 1998, 70: 1307-1311.  
 
117. Bolivar, J. M., Consolati, T., Mayr, T., Nidetzky, B. Quantitating intraparticle O2 
gradients in solid supported enzyme immobilizates: Experimental determination 
of their role in limiting the catalytic effectiveness of immobilized glucose 
oxidase. Biotechnology and Bioengineering. 2013, 110: 2086-2095.  
 
118. Bolivar, J. M., Schelch, S., Pfeiffer, M., Nidetzky, B. Intensifying the O2-
dependent heterogeneous biocatalysis: Superoxygenation of solid support from 
H2O2 by a catalase tailor-made for effective immobilization. Journal of Molecular 
Catalysis B: Enzymatic. 2016, 134: 302-309.  
 
119. Spieß, A., Schlothauer, R. C., Hinrichs, J., Scheidat, B., Kasche, V. pH 
gradients in immobilized amidases and their influence on rates and yields of β-
lactam hydrolysis. Biotechnology and Bioengineering. 1999, 62: 267-277.  
 
120. Spiess, A. C., Kasche, V. Direct measurement of pH profiles in immobilized 
enzyme carriers during kinetically controlled synthesis using CLSM. 
Biotechnology Progress. 2001, 17: 294-303.  
 
121. Wiles, C., Watts, P. Continuous flow reactors: a perspective. Green Chemistry. 
2012, 14: 38-54.  
 
122. Britton, J., Majumdar, S., Weiss, G. A. Continuous flow biocatalysis. Chemical 
Society Reviews. 2018, 47: 5891-5918.  
 
123. Tamborini, L., Fernandes, P., Paradisi, F., Molinari, F. Flow bioreactors as 
complementary tools for biocatalytic process intensification. Trends in 
Biotechnology. 2018, 36: 73-88.  
 
124. Jones, E., Mcclean, K., Housden, S., Gasparini, G., Archer, I. Biocatalytic 
oxidase: batch to continuous. Chemical Engineering Research and Design. 
2012, 90: 726-731.  
 
125. Ley, S. V., Fitzpatrick, D. E., Myers, R. M., Battilocchio, C., Ingham, R. J. 
Machine-assisted organic synthesis. Angewandte Chemie International Edition. 
2015, 54: 10122-10136.  
 
Chapter 1 
- 38 - 
 
126. Jensen, K. F. Flow chemistry - microreaction technology comes of age. AIChE 
Journal. 2017, 63: 858-869.  
 
127. Wohlgemuth, R., Plazl, I., Žnidaršič-Plazl, P., Gernaey, K. V., Woodley, J. M. 
Microscale technology and biocatalytic processes: opportunities and challenges 
for synthesis. Trends in Biotechnology. 2015, 33: 302-314.  
 
128. Peris, E. et al. Tuneable 3D printed bioreactors for transaminations under 
continuous-flow. Green Chemistry. 2017, 19: 5345-5349.  
 
129. Adamo, A. et al. On-demand continuous-flow production of pharmaceuticals in 
a compact, reconfigurable system. Science. 2016, 352: 61-67.  
 
130. Devine, P. N., Howard, R. M., Kumar, R., Thompson, M. P., Truppo, M. D., 
Turner, N. J. Extending the application of biocatalysis to meet the challenges of 
drug development. Nature Reviews Chemistry. 2018, 2: 409-421.  
 
131. Jiménez-González, C. et al. Key green engineering research areas for 
sustainable manufacturing: a perspective from pharmaceutical and fine 
chemicals manufacturers. Organic Process Research & Development. 2011, 
15: 900-911.  
 
132. Le Joubioux, F., Bridiau, N., Sanekli, M., Graber, M., Maugard, T. Continuous 
lipase-catalyzed production of pseudo-ceramides in a packed-bed bioreactor. 
Journal of Molecular Catalysis B: Enzymatic. 2014, 109: 143-153.  
 
133. Tamborini, L., Romano, D., Pinto, A., Bertolani, A., Molinari, F., Conti, P. An 
efficient method for the lipase-catalysed resolution and in-line purification of 
racemic flurbiprofen in a continuous-flow reactor. Journal of Molecular Catalysis 
B: Enzymatic. 2012, 84: 78-82.  
 
134. Šalić, A., Zelić, B. ADH-catalysed hexanol oxidation with fully integrated NADH 
regeneration performed in microreactors connected in series. RSC Advances. 
2014, 4: 41714-41721.  
 
135. Ender, F. et al. Microfluidic multiple cell chip reactor filled with enzyme-coated 
magnetic nanoparticles — an efficient and flexible novel tool for enzyme 
catalyzed biotransformations. Journal of Flow Chemistry. 2016, 6: 43-52.  
 
136. Babich, L., Hartog, A. F., Van Hemert, L. J. C., Rutjes, F. P. J. T., Wever, R. 
Synthesis of carbohydrates in a continuous flow reactor by immobilized 
phosphatase and aldolase. ChemSusChem. 2012, 5: 2348-2353.  
 
137. Contente, M. L., Dall'oglio, F., Tamborini, L., Molinari, F., Paradisi, F. Highly 
Efficient Oxidation of Amines to Aldehydes with Flow-based Biocatalysis. 
ChemCatChem. 2017, 9: 3843-3848.  
 
138. Contente, M. L., Paradisi, F. Self-sustaining closed-loop multienzyme-mediated 
conversion of amines into alcohols in continuous reactions. Nature Catalysis. 
2018, 1: 452-459.  
 
139. Gruber, P. et al. Enzymatic synthesis of chiral amino-alcohols by coupling 
transketolase and transaminase-catalyzed reactions in a cascading continuous-
Chapter 1 
- 39 - 
 
flow microreactor system. Biotechnology and Bioengineering. 2018, 115: 586-
596.  
 
140. Planchestainer, M., Contente, M. L., Cassidy, J., Molinari, F., Tamborini, L., 
Paradisi, F. Continuous flow biocatalysis: production and in-line purification of 
amines by immobilised transaminase from Halomonas elongata. Green 
Chemistry. 2017, 19: 372-375.  

 - 41 - 
 
 
Chapter 2 
 
Background and objectives 
 
 
 
 
 
 
 
 
 

Chapter 2 
- 43 - 
 
1. BACKGROUND 
The research in industrial biotechnology has been highly boosted around the world in 
the last decades. Many findings have been made in the use of enzymes as catalytic 
tools to sustainably manufacture demanded chemicals and materials from our 
developed society, aiming at replacing the conventional manufacturing that exploits 
fossil raw material. Protein engineering and enzyme cascades have allowed improving 
the operational yields of more complex synthetic schemes under non physiological 
conditions. Parallely, enzyme immobilization on solid supports has driven 
heterogeneous biocatalysis towards more economic pathways throguh easing the 
recycling and enhancing the robutness of the biocatalyts. More recently, a revolution in 
chemical manufacturing is happening thanks to the innovations in continuous flow 
biocatalysis. However, the efficiency of these top-down approaches is often rather low 
due to the lack of orcherstration and tunning between the individual enzymes that form 
the biosynthetic system. Likewise, the continuous supply of expensive additives (i.e 
cofactors) during the biocatalytic reactions hampers the scaling-up of theses process 
due to economic reasons. In this context tailor-made design studies and fast assembly 
strategies are unmet to fabricate more efficient and robust multi-functional 
heterogeneous biocatalysts. New efforts to contribute to the fundamental knowledge 
and technological develoment on this subject will contribute to establish and speed-up 
a safe path for the technological transfer from lab scale to industrial scale assuming the 
productivity and economy criteria posed by chemical industry .  
These days, synthetic biology is getting momentum in the scientific community not only 
as a novel field itself but also as a new advanced tool to go beyond the limits of classic 
engineering strategies in biocatalysis and biotechnology. Applying those principles, the 
supervisor of this thesis Dr. López-Gallego visualized heterogeneous biocatalysts as 
artificial metabolic cells which are constituted by sub-micrometric particles rationally 
assembled and whose ultimate goal is to efficiently develope anabolic and catabolic 
reactions in flow. 
Since I was motivated and keen on biocatalysis and synthetic biology, I was selected to 
join the Heterogeneous Biocatalysis team as PhD student on March 2016. The 
research group leaded by Dr. López-Gallego was founded in CIC biomaGUNE (San 
Sebastián, Spain), an international institute for research on biomaterials and where the 
work presented on this PhD thesis was mainly conducted. I started to work as part of 
the project BIOPROTOGEL (BIO2014-61838-EXP) on the development of applications 
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of cell-free protein synthesis and immobilization for biosensing, biomedicine and 
biocatalysts prototyping. Then, I focused on the co-immobilization of multienzyme 
cascades and cofactors, as well as evolving single-particle strategies to optimize the 
performance of self-sufficient heterogeneous biocatalysts at microenvironments. This 
second part of my PhD thesis was funded by the project HETMUBI (BIO2015-69887-R) 
related to the development of multifunctional heterogeneous biocatalysts as new 
horizons for synthetic biology in solid state. 
 
2. OBJECTIVES 
My PhD thesis, here presented, was born with the aim to advance on the fabrication of 
self-sufficient heterogeneous biocatalysts characterized at single-particle level. The 
main goal of this thesis is therefore the fabrication and the characterization of 
artificial metabolic cells based on multi-enzymes systems co-immobilized with the 
required cofactors on porous microparticles to perform the continous synthesis of 
amine and alcohols without the exogeneous addition of cofactors. To achieve the 
main objective, this PhD thesis has addressed the following goals: 
1. The development of a prototyping-screening platform to make easier, quicker 
and massive the site-directed immobilization of proteins to optimize the 
fabrication of  protein-based biomaterials and biocatalysts. 
2. The co-immobilization of phosphorylated cofactors with enzyme systems on the 
same solid carrier to make self-sufficient heterogeneous biocatalysts. 
3. To expand the strategy described in the goal 2 to develop more complex multi-
enzyme systems as artificial metabolic cells for the synthesis of chiral alcohols 
and amines. 
4. To understand how co-immobilized multi-enzyme systems and their cofactors 
work at micro-scale inside the solid particles with spatio-temporal 
characterization. 
5. The integration of self-sufficient heterogeneous biocatalysts into flow reactors to 
test the potential applicability and feasibility under current industrial 
requirements. 
The first task of this PhD thesis was to search into the state of the art of the main 
subjects in this work: biocatalysis, protein immobilization, flow biochemistry and 
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synthetic biology. A summarized description and the nexus among all of them are 
compiled  in Chapter 1. 
Considering the lack of easy-and-quick screening strategies to study protein 
immobilization and orientation, cell-free protein synthesis was combined with protein 
immobilization and published in Paper I. A genetic toolkit of plasmids for tagging 
proteins with different polipeptide-tags was also developed and incorporated into this 
novel platform. This strategy was applied for the immobilization of fluorescent proteins, 
enzymes and antibody-binding proteins onto different materials. The co-expression and 
co-immobilization of different proteins on the same carrier was also achieved. 
Encouraged to explore deeply the effects of the co-expression of different enzymes by 
cell-free protein synthesis, we collaborate with the Synthetic and Reconstructive 
Biology group of Prof. Mansy. The work carried out in CIBIO (Trento, Italy) was funded 
by a travelling fellowship (JCSTF-180501) that I received from The Company of 
Biologists (Journal of Cell Science). The objectives reached in this experimental part 
are presented in Chapter 3.  
To the aim of engineering artificial metabolic cells, our group developed a cutting-edge 
strategy to co-immobilize phosphorylated cofactors on PEI-coated carriers. This 
platform was tested for a bi-enzyme system with two dehydrogenases that were co-
immobilized with the cofactor. This pioneering work was published in Paper II. 
Considering the potential of cofactor co-immobilization observed, we also fabricated a 
microstructure co-immobilizing two different redox cofactors and an oxidoreductase 
onto the same solid carrier, demostrating the wide-ranging applicability of this 
methodology. For this system, we controlled the enzyme immobilization rate to tune the 
distribution of the enzymes across the porous carrier. The work developed in 
collaboration with Dr. Bolivar and Prof. Nidetzky is still ongoing and the results will be 
collected in Paper III. Finally, we investigated the state of the art of single-particle 
studies in order to characterize these heterogeneous biocatalysts and the reviewed 
information was collected in Paper IV.  Due to the scarce sub-particle studies to design 
heterogeneous biocatalysts, we developed and applied microscopy and analytical 
tecniques to aid and guide the biocatalyst characterization step. All these results are 
summarized in Chapter 4.  
Once enzymes and cofactors were efficiently co-immobilized onto solid carriers, we 
expanded this strategy to perform assymetric reduction of prochiral ketones. To this 
end, a ketoreductase-based biocatalyst was engineered by co-immobilizing the 
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enzyme and the cofactor on a positively-charged carrier. Single-particle studies were 
applied during the design and engineering process of the biocatalyst. Finally, the 
biocatalyst was tested in flow-reactions. The project was carried out in collaboration 
with the company EntreChem S.L., and the results are compiled in Paper V. Due to the 
satisfactory results obtained, the strategy was also applied  for pharmaceutical 
synthesis using another more stable ketoreductase. Paper VI shows the work in 
partnership with the group of Prof. Berglund, the company EntreChem S.L. and the 
groupg of Prof. Kroutil. This work is deeply described in Chapter 5. 
Since amines are industrially relevant, transaminases are becoming popular in organic 
synthesis. That demand aroused our motivation to fabricate self-sufficient 
heterogeneous biocatalyts based on transaminases from different organisms. In this 
case, the required coenzyme is not a redox cofactor but a phosphorylated cofactor. In 
addition, as indicated in the previous chapter, flow-biochemistry intensifies biocatalytic 
industrial processes. Therefore, we optimized the cofactor and enzyme immobilization 
conditions for flow-biocatalysis. Finally, the synthesis of high-valuable amines at the 
highest flow-rate ever reported for co-immobilized enzymes and cofactors was reported 
in Paper VII. This final work described in Chapter 6 was carried out in collaboration 
with the group of Prof. Paradisi from the University of Nottingham (United Kingdom). 
This fruitful collaboration was supported by a travelling fellowship (N. 38377) from 
COST action CM1303. 
 
3. SCIENTIFIC OUTCOME 
These research findings has been published in the following scientific articles: 
 Paper I: Benítez-Mateos, A. I., Llarena, I., Sánchez-Iglesias, A., López-Gallego, 
F. Expanding one-pot cell-free protein synthesis and immobilization for on-
demand manufacturing of biomaterials. ACS Synthetic Biology. 2018, 7: 875-
884. 
 Paper II: Velasco-Lozano, S., Benítez-Mateos, A. I., López-Gallego, F. Co-
immobilized phosphorylated cofactors and enzymes as self-sufficient 
heterogeneous biocatalysts for chemical processes. Angewandte Chemie 
International Edition. 2017, 56: 771-775. 
 Paper III: Benítez-Mateos, A. I., Huber, C., Bolivar, J. M., Nidetzky, B., López-
Gallego, F.  Spatial distribution effects on the kinetic properties of co-
immobilized enzymes and cofactors. Manuscript in preparation. 
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 Paper IV: Benítez-Mateos, A. I., Nidetzky, B., Bolivar, J. M., López-Gallego, F. 
Single-particle studies to advance the characterization of heterogeneous 
biocatalysts. ChemCatChem. 2018, 10: 654-665.  
 Paper V: Benítez-Mateos, A. I., San Sebastian, E., Ríos-Lombardía, N., Morís, 
F., González-Sabín, J., López-Gallego, F. Asymmetric reduction of prochiral 
ketones by using self-sufficient heterogeneous biocatalysts based on NADPH-
dependent ketoreductases. Chemistry – A European Journal. 2017, 23: 16843-
16852.  
 Paper VI: Marx, L., Ríos-Lombardía, N., Farnberger, J. F., Kroutil, W., Benítez-
Mateos, A. I., López-Gallego, F., Morís, F., González-Sabín, J., Berglund, P. 
Chemoenzymatic approaches to the synthesis of the calcimimetic agent 
cinacalcet employing transaminases and ketoreductases. Advanced Synthesis 
& Catalysis. 2018, 360: 2157-2165.  
 Paper VII: Benítez-Mateos, A. I., Contente, M. L., Velasco-Lozano, S., Paradisi, 
F., López-Gallego, F. Self-sufficient flow-biocatalysis by coimmobilization of 
pyridoxal 5′-phosphate and ω-transaminases onto porous carriers. ACS 
Sustainable Chemistry & Engineering. 2018, 6: 13151-13159.  
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Chapter 3 
 
One-pot cell-free protein synthesis and immobilization 
for protein-carrier screening 
 
Expression, purification and immobilization of proteins are arduous work-up 
processeswhich may take a long time for the screening and further development of bio-
molecule based materials. In this chapter, a molecular toolbox based on cell-free 
protein synthesis and oriented immobilization in one pot is proved to speed up the 
process from weeks to hours. A modular set of plasmids was constructed to fuse the N-
terminal of superfolded green fluorescent protein (sGFP) with different peptide tags 
(poly(6X)Cys, poly(6X)His, and poly(6X)Lys), which drive the selective immobilization 
of the protein on the tailored material (agarose microbeads with different functionalities, 
gold nanorods and silica nanoparticles). This system also enables the incorporation of 
azide-based amino acids into the nascent protein for its site-directed immobilization 
through copper-free click reactions. Moreover, sGFP and an enzyme were co-
expressed and co-immobilized by different binding chemistries on the same material. 
Finally, this technology has been expanded to the synthesis and oriented 
immobilization of proteins through antibody-binding proteins as a prototyping platform 
for the fabrication of more complex artificial metabolic cells.
The work presented in this chapter was published in ACS Synthetic Biology.1 

  Chapter 3 
 
 
- 51 - 
 
1. INTRODUCTION  
Cell-free protein synthesis (CFPS) in solution2 is an emerging alternative to the 
conventional time-consuming methodologies for protein expression by using 
heterologous hosts as E. coli or S. cerevisiae. CFPS is an in vitro transcription-
translation system which can synthesize proteins at mg x mL-1 concentration in several 
hours.3 It is becoming a powerful and versatile technique to readily synthesize well-
folded proteins and active enzymes, even toxic proteins which cannot be expressed 
using living hosts.4-6 Despite of these unique features, this synthetic biological strategy 
still suffers a bottleneck when scaling-up the process to an industrial environment. 
Operational complexities like either inhibitory by-products or depletion of substrates 
and energy make it extremely impractical for high-scale protein production. Many 
efforts on improving the energy recycling systems7, 8 and several compartmentalization 
strategies9, 10 are currently alleviating those drawbacks. Contrastingly, in vitro protein 
expression system is an efficient approach in terms of both time and resources for 
R&D analysis and screenings of protein expression at lab scale. Recently, many 
advances have been reported for prototyping and microarrays of in vitro protein 
expression in solution.11-16  
Once proteins have been synthesized, their immobilization is one of the major 
challenges of biomaterial manufacturing. In order to facilitate the fabrication of protein-
based materials, CFPS and protein immobilization have been coupled in one pot 
(CFPS-i). The achievement of this goal requires the development of methodologies that 
selectively immobilize the nascent protein. To this aim, the immobilization chemistry 
must be orthogonal to the protein synthesis, avoid unspecific interactions between the 
protein synthesis machinery and the solid material, and correctly orient the protein to 
guarantee the functionality of the resulting biomaterial. A previous work showed CFPS-i 
of membrane proteins fused to GFP at their C-terminal and immobilized on PVDF 
membranes through hydrophobic interactions.17 Unfortunately, this kind of hydrophobic 
interaction is not very selective to expand this technique for new applications. Protein 
tagging with polypeptides or protein domains is the most widespread strategy to purify 
proteins for biochemical and structural studies. Furthermore, the tag serves to control 
the orientation of proteins when immobilized on solid materials.18, 19 Nowadays we have 
access to a large variety of peptide tags and domains that selectively bind silver,20 
gold,21-23 nickel oxide24 and iron oxide25 through coordination and covalent bonds; silica 
particles26 through ionic interactions; biopolymeric particles such as agarose 
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microbeads27 through multivalent interactions based on hydrogen and Van der Waals 
bonds; and even oil-droplets28 through hydrophobic interactions. 
In several pioneering works, CFPS-i was utilized for the fabrication of self-assembling 
protein microarrays as NAPPA technology,29 PISA method30 and other protein array-
based approaches.17, 31, 32 One of the most well-known immunoassay technologies is 
the antibody microarray which is essentially based on functional immobilized antibodies 
onto solid surfaces.33 To this end, the proper orientation of the immobilized 
inmunoglobulins is key for the correct recognition of the antigen.34 Protein A and 
protein G contain an IgG-binding domain which is harnessed as an affinity IgG 
purification method. Furthermore, proteins A/G are specifically bound to the Fc region 
of the IgG allowing the orientation of the antibody during its immobilization.22 This 
concept was further extended to the protein synthesis and selective immobilization by 
using (6x)-Histag.35-37 These systems have been successfully applied for drug 
discovery38 and protein engineering.39  
Due to its extreme selectivity and biocompatibility, click reactions have also been 
exploited for bioconjugation of molecules and protein engineering.40-42 Click chemistry 
has been already applied in cell-free protein synthesis for direct protein−protein click 
conjugation using Cu(I)-catalyzed cycloadditions and unnatural amino acids.43 Similarly, 
virus-like particles (VLP) were assembled by using this technology after CFPS.44 For 
that reasons, click chemistry could be another interesting approach to drive the 
immobilization of the newly synthesized protein onto materials. As far as we know, 
CFPS and copper-free click chemistry-mediated immobilization onto porous carriers 
has not been previously combined in one-pot.   
The design, prototyping and development of biomaterials (mainly based on immobilized 
proteins on solid carriers) is paramount to fabricate heterogeneous biocatalysts, 
biosensors45 and new therapeutics.46  In the present chapter, cell-free protein synthesis 
has been coupled to the protein immobilization in one-pot, using different binding 
chemistries that assure the selective immobilization of the nascent protein. Harnessing 
the different chemical functionalities on the material surface, a novel toolkit was 
developed to synthesize and immobilize on-demand proteins on a plethora of 
materials. Firstly, a set of plasmids coding the desired protein with different polypeptide 
tags was designed for the selective immobilization onto solid materials. This system 
was further tested for the co-expression and selective co-immobilization of multi-protein 
systems on the same material. Secondly, unnatural amino acids were added to the 
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CFPS reaction to immobilize the nascent protein by click-chemistry. Finally, this 
strategy was also expanded to the fabrication of antibody-based materials mediated by 
protein A.22, 33, 34 Bringing together all these strategies, an efficient screening and 
prototyping platform was developed for protein engineering and synthetic biology.  
 
2. EXPERIMENTAL SECTION 
2.1. Materials 
AuNR and SiO2NP were supplied by the colloidal nanofabrication platform from CIC-
biomaGUNE. Agarose-based materials monofunctionalized with cyclooctyne groups 
and heterofunctionalized with both disulfide and cobalt-chelates groups were fabricated 
using plain agarose microbeads purchased from ABT technologies (Madrid, Spain). 
TALON Metal Affinity Resin was acquired from Clontech Laboratoires, Inc.  S30 / T7 
High-yield protein expression system was supplied by Promega Corporation (Fitchburg, 
WI). Rhodamine B isothiocyanate, dibenzocyclooctyne-amine, anti-rabbit IgG (whole 
molecule)–alkaline phosphatase antibody produced in goat, 4-nitrophenyl phosphate 
disodium salt hexahydrate (pNPP), 5,5′-dithiobis(2-nitrobenzoic acid), 1,4-dithiothreitol 
(DTT), 2-2’-2’’-2’’’-(ethane-1,2-diyldinitrilo)tetraacetic acid (EDTA), cyanogen bromide-
activated sepharose 4B, L-Lysine, L-Cysteine, L-Histidine, p-nitrophenyl phosphate 
(pNPP), amicon ultra 0.5 mL centrifugal filters 10 kDa, kanamycin, horseradish 
peroxidise (HRP), Ampliflu Red, maltose, magnesium glutamate, polyethylene glycol 
(PEG8000), flavin-adenine-dinucleotide sodium salt (FAD+), adenosine-5’-triphosphate 
(ATP), guanosine-5’-triphosphate (GTP), citydine-5’-triphosphate (CTP), uridine-5’-
triphosphate (UTP), transfer RNA (tRNAs), coenzyme A (CoA), cyclic adenosine 
monophosphate (cAMP), folinic acid, spermidine, 3-phosphoglyceric acid (3-PGA), 
silver nitrate (AgNO3, ≥ 99.0%), hexadecyltrimethylammonium bromide (CTAB, ≥ 99.0 
%), hydrogen tetrachloroaurate trihydrate (HAuCl4, ≥ 99.9%), L-ascorbic acid (AA, ≥ 
99.0 %), sodium borohydride (NaBH4, ≥ 96.0%), hydrochloric acid (HCl, 37%), 
tetraethyl orthosilicate (TEOS, 99%), ammonium hydroxide (NH4OH, 29%), ethanol 
(EtOH, ≥ 99.8 %) and primers were acquired from Sigma-Aldrich (St. Louis, IL). 
Nicotinamide-adenine-dinucleotide sodium salt (NAD+) was purchased from GERBU 
Biotechnik GmbH (Wieblingen, Germany). Click-it L-azidohomoalanine (AHA) was 
supplied by Thermo Fisher Scientific. Micro Bio-spinTM chromatographic columns were 
from BIORAD. 6-channel μ-Slide VI 0.4 was purchased from ibidi (Planegg, Germany) 
and epoxy methacrylate microbeads Lifetech ECR8204 were kindly donated by Purolite 
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Ltd (Llantrisant, UK). The plasmid his-proa_pET28b was donated by Dr. C. Araya-
Callís and Dr. R. P. Richter. All other reagents were of analytical grade unless 
otherwise specified.  
 
2.2. Methods 
 
2.2.1. Gene cloning 
The plasmid pET28b(+) (Novagen) was used for cloning and protein expression. The 
genetic construction his-sgfp_pET28b47 and his-adh_pET28b48 were developed in 
previous works. The plasmid encoding his-proa gene was already reported in a recent 
publication.49 We designed eight primers (Table 1) for cloning cys-sgfp, lys-sgfp and 
untagged-sgfp genes using the plasmid his-sgfp_pET28b as template.  
Table 1. List of primers for the genetic constructions. 
 
Firstly, the sequence upstream of the sgfp gene was amplified by PCR using primers 3 
and 8 for the construction of cys-sgfp_pET28b. Secondly, the downstream sequence 
was amplified with primers 7 and 4. Finally, an overlapping PCR was performed by 
using primers 3 and 4, and the previous PCR products as megaprimers. The vector 
pET28b was digested with the restriction enzymes NcoI and XhoI. Afterwards, the 
overlapping PCR product and the digested vector were purified and ligated by 
homologous recombination in E. coli strain DH10β (laboratory stock). The same 
procedure was carried out for the genetic construction of lys-sgfp_pET28b with primers 
3 and 6; 5 and 4; 3 and 4, respectively. Cloning of untagged-sgfp_pET28b was 
accomplished with primers 1 and 2 for the amplification of untagged-sgfp sequence. 
The resulting PCR product and the vector were further digested with NcoI and XhoI. 
After the dephosphorylation and purification, DNA fragments were ligated and 
Number Primer name Sequence
Length 
(bp)
Tm
(ºC)
1 up_T7p_F GCGTAGAGGATCGAG 15 51,5
2 down_T7t_R CCGGATATAGTTCC 14 35,0
3 NcoI_sGFP_F AAACCATGGAACATATGAGCAAAGGAGAAG 30 71,3
4 lacI_pET_F AACTTAATGGGCCCGCTAACAG 22 66,8
5 AccII_down_T7t_R CGTCCCATTCGCCATCC 17 67,8
6 LysTAG_F AAAAAAAAAAAAAAAAAAAGCAGCGGCCTGGTG 33 76,0
7 LysTAG_R TTTTTTTTTTTTTTTTTTGCTGCTGCCCATG 31 74,1
8 CysTAG_F TGTTGTTGTTGTTGTTGTAGCAGCGGCCTGGTG 31 79,1
9 CysTAG_R ACAACAACAACAACAACAGCTGCTGCCCATG 33 81,5
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transformed in BL21-Gold (DE3). All molecular biology protocols were performed using 
standard methods. 50  
 
2.2.2. Synthesis of nanomaterials  
The colloidal nanofabrication platform from CICbiomaGUNE prepared the 
nanoparticles as follows. Milli-Q water (resistivity 18.2 MΩ x cm-1 at 25 °C) was used in 
all experiments.  
 
 Synthesis of gold nanorods (AuNRs): AuNRs were prepared using Ag-assisted 
seeded growth.51, 52 Seeds were prepared by fast reduction of 0.25 mM HAuCl4 
(5 mL) with freshly prepared 10 mM NaBH4 (0.3 mL) in aqueous 100 mM CTAB 
solution. After 30 minutes, 24 µL of seed solution were added to 10 mL of 
growth solution containing 100mM CTAB, 0.5 mM HAuCl4, 0.8 mM ascorbic 
acid, 0.12 mM AgNO3, and 19 mM HCl. The mixture was left undisturbed at 
30°C for 2 hours. The solution was centrifuged twice (8000 rpm, 30 min) to 
remove excess AgNO3, AA and HCl, and redispersed in 15mM CTAB. 
 
 Synthesis of silica nanoparticles (SiO2NP): SiO2NP were synthesized by Stöber 
method.53, 54 4.5 mL of TEOS were added to 100 mL of a mixture of ethanol, 10 
M water and ammonium hydroxide (1 M in NH3) under vigorous stirring. The 
mixture was stirred for 12 hours at room temperature. The SiO2NP were 
washed three times with ethanol by centrifugation at 5000 rpm. 
The fabricated nanoparticles were then characterized by transmission electron 
microscopy (TEM) with a JEOL JEM-1400PLUS transmission electron microscope 
operating at an acceleration voltage of 120 kV (Figure 1). 
 
 
Figure 1. TEM imaging of AuNR (A) and SiO2NP (B).  
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2.2.3. Preparation of heterofunctional cobalt and thiol activated agarose 
100 mg of epoxy agarose microbeads (6BCL) were partially modified with 500 mM IDA 
(pH 11.0) for 3 hours and then filtered and washed with excess of water. Epoxy-
carboxyl was mixed with 10 mM Na2S dissolved in 100 mM NaHCO3 solution (pH 10) 
for 1 hour. Later on, the thiolated support was filtered and washed. Such support 
(carboxyl-thiol) was incubated with a solution of 10 mM DTNB dissolved in 50 mM 
KH2PO4 (pH 8) for 2 hours. The resulting support was finally activated with cobalt by 
mixing with 30 mg x mL-1 of CoCl2 in H20 during at least 1 hour (Figure 2). All the steps 
during the functionalization of the support were carried out under mild stirring. The 
washing steps were performed at least 10 times with 20 volumes of water to make sure 
that soluble chemicals were fully removed. 
Figure 2. Protocol for the activation of heterofunctional cobalt and thiol activated 
agarose.  
 
2.2.4. Preparation of AG-Oct (agarose activated with cyclooctyne groups)  
0.3 grams of dry cyanogen bromide-activated sepharose (4BCL) were mixed with 10 
mL of 1 mM HCl and incubated for 30 minutes at 25 ºC. The activated resin was filtered 
and incubated with 3 mL of 1 mM dibenzocyclooctyne-amine in water. As negative 
control, the activated resin was incubated with 50 mM of -mercaptoethanol to 
decorate the agarose surface with inert hydroxyl groups (Figure 3).  
 
Figure 3. Protocol for the activation of agarose microbeads with cyclooctyne groups.   
 
2.2.5. In vitro cell-free protein synthesis and immobilization (CFPS-i) 
CFPS system was composed of 40% of S30 Premix Plus and 30% of T7/S30 cell 
extracts. In case of click reactions, we mixed 40% of S30 Premix without amino acids, 
10% of amino acid mixture minus methionine, 10% of amino acid (methionine or L-
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AHA) and 30% of T7/S30 cell extracts. 1 μg of DNA template and 1 mg of carriers were 
added to the cell lysate-based expression system at final volume of 50 μL, unless 
otherwise specified. The reactions were performed at 37 ºC and 1200 rpm for 12 hours 
in an Eppendorf Thermomixer R, unless otherwise specified. 1 mM CTAB was added 
to CFPS-i reactions with methacrylate microbeads activated with epoxy groups (Pu-E) 
and AuNR to avoid unspecific hydrophobic interactions and particle aggregation, 
respectively. Once the CFPS-i was finished, protein-based biomaterials can be easily 
purified from the reaction mixture by rapid and low-cost vaccum filtration using mini 
Bio-spin chromatography columns. In case of CFPS-i of Lys-sGFP by drop-casting, the 
reactions were incubated at 37 ºC without shaking inside a humidity chamber to avoid 
the evaporation of the reaction mix.  
 
2.2.6. In vitro cell-free protein synthesis using ‘lab-made’ cell extracts 
In collaboration with the group of Prof. Mansy, ‘lab-made’ cell extracts were prepared 
following the previously reported protocol by Sun et al.55 The reaction mix contained 
45% of cell extracts, 12 mM maltose, 5 mM  magnesium glutamate, 2% PEG8000, 0.15 
mM FAD+, 1.5 mM amino acids mixture, 9.6% energy solution (700 mM HEPES pH 8, 
21 mM ATP, 21 mM GTP, 12.6 mM CTP, 12.6 mM UTP, 2.8 mg x ml-1 tRNAs, 3.64 mM 
CoA, 4.62 mM NAD+, 10.5 mM cAMP, 0.95 mM folinic acid, 14 mM spermidine, 420 
mM 3-PGA), 5 nM adh_pET28b and 5 nM nox_pET22a at final reaction volume of 10.5 
µL. The CFPS reactions were performed at 30 ºC for 17 hours in a PCR thermocycler. 
 
2.2.7. On line monitoring the enzyme cascade after the CFPS using ‘lab-made’ 
cell extracts  
Once the CFPS reaction was accomplished, 5 µg x mL-1 HRP, 1 mM NAD+, 1 mM 
ethanol and 0.4 mM Ampliflu Red were added to the previous CFPS reaction mixture 
until reaching a final volume of 12 µL. The samples were incubated at 30 ºC in a Rotor-
Gene Q (Qiagen) for 2 hours. The fluorescence (λexc: 571 nm and λem: 585 nm) was 
monitored every 30 seconds for 2 hours. 
 
2.2.8. Fluorescence microscopy imaging 
After CFPS-i was performed, 10 μL of the reaction mixture were placed inside a 
channel of a 6-channel μ-slide. The sGFP fluorescence was detected by using a Colibri 
LED illumination system incorporated into the fluorescence microscope (Axio Observer 
ZEISS). The sGFP fluorescence was observed using λexc: 470 nm and λem: 500-557 
nm. In order to better visualize the nanoparticles, the confocal microscope LSM510 
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was used for AuNRs and SiO2NPs with an excitation laser at 488 nm and the emission 
filter LP505. Images were analysed and processed with the software ZEN2012. 
 
2.2.9. In vivo expression of sGFP  
Briefly, 1 mL of an overnight culture of E. coli BL21-Gold cells transformed with the 
plasmid was inoculated in 50 mL of LB medium containing kanamycin (30 μg x mL-1). 
Such culture was incubated at 37 °C and 200 rpm until the OD600nm reached 0.6. At that 
point, the culture was induced with 1 mM IPTG. Cells were grown at 37 °C for 3 hours 
and then harvested by centrifugation at 10000 g during 30 minutes at 4 ºC. After 
sonication and centrifugation to discard cell debris, the His-sGFP concentration in the 
resulting protein solution was determined by measuring fluorescence in a VarioskanTM 
Flash Multimode Reader (Thermo Scientific) using 384-well plates.  
 
2.2.10. Rhodamine-labeling of proteins 
Inmunoglobulin G chemically conjugated with alkaline phosphatase (AP-IgG) was 
labeled with rhodamine B isothiocyanate following a modified protocol previously 
described elsewhere.56 The protein solution in 100 mM sodium bicarbonate buffer at 
pH 8 was mixed (1:1 molar ratio) with a rhodamine B isothiocyanate solution in DMSO 
(1 mg x mL-1) and incubated 1 hour with gentle agitation at 25 ºC in darkness. This step 
allows the acylation reaction between the primary amines from proteins and the 
isothiocyanates groups from rhodamine B to form a thiourea. Later, the unreacted 
rhodamine B was eliminated by filtering the mix solution trough a tangential 
ultrafiltration unit (10 kDa) using 25 mM sodium phosphate buffer at pH 7 until the flow-
through solution was colourless. 
 
2.2.11. Alkaline phosphatase activity assay 
The substrate pNPP was dissolved 10 mg x mL-1 in 50 mM Tris-HCl buffer (pH 8.5). 
The reaction mixture containing 0.5 mM MgCl2 and 1 mg x mL-1 of pNPP was added to 
10 μL of a solution (90.6 μM) or suspension (0.2 mg of immobilizate) of IgG in a final 
volume of 100 µL. The reaction was incubated in darkness for 30 minutes at 37 ºC. 
Then, the absorbance of the product p-nitrophenol was monitored at 405 nm in a 
VarioskanTM Flash Multimode Reader using 96-well plates. For both soluble and 
immobilized enzyme the activity was measured under orbital shaking integrated into 
the reader.   
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2.2.12. ADH activity assay  
200 µL of a reaction mixture containing 100 mM acetone and 0.25 mM NADH in 25 mM 
sodium phosphate buffer at pH 7.0 were incubated with 20 µL of suspension (0.2 mg of 
immobilizate) at 25 ºC. The activity of ADH was spectrophotometrically measured in a 
VarioskanTM Flash Multimode Reader using 96-well plates. The absorbance at 340 nm 
which decreased because of the enzymatic oxidation of NADH, was monitored along 
the time and under orbital shaking integrated into the reader.  
 
 
3. RESULTS AND DISCUSSION 
3.1. Development of a plasmid toolkit containing different polypeptide tags 
A set of plasmids enconding sGFP fused to the N-terminal with different polypeptide 
tags was developed due to its great broad of applications.57 In these genetic 
constructions, both the sGFP and the tag sequences can be easily exchanged by 
others just by enzymatic digestion (Figure 4A). Hence, the modular design of this 
genetic toolbox enables to easily fuse any target protein with any polypeptide tag. 
Specifically three plasmids expressing sGFP harboring at its N-terminal poly-(6x)His 
(His-sGFP), poly-(6x)Lys (Lys-sGFP) or poly-(6x)Cys (Cys-sGFP) peptides were 
designed to prove the modularity of this architecture. Additionally, we also genetically 
engineered a plasmid encoding untagged sGFP as control (Figure 4B).  
 
 
Figure 4. Genetic constructions. A) The pET28b plasmid map encoding sgfp gene. B) The 
plasmid tool-kit showing the restriction enzymes needed to modularly exchange the target 
protein and the tag. 
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After transformation in E. Coli strain BL21, all plasmids similarly expressed in vivo the 
sGFP tagged with the different tags (Figure 5). According to previous results, sGFP 
expression remained unaltered regardless the position (N- or C-terminal) of the tag.58 
Nevertheless, the in vitro expression of the untagged-sGFP using the commercially 
available T7/S30 cell extracts was significatly more efficient than the expression of the 
tagged variants which presented different expression levels among them (Figure 5). 
The in vitro expression of Lys-sGFP was lower than His-sGFP, and significantly much 
lower than Cys-sGFP. These data correlate with the amino acids content in the sGFP 
primary sequence; 20 lysines, 11 Histidines and 2 cysteines, which suggests that either 
the amino acid or tRNAs pools may be the limiting factor to achieve high protein yields 
of the tagged sGFP variants.  
 
Figure 5. Expression levels of tagged sGFP variants. On the left, SDS-PAGE of soluble 
fractions after cell disruption by sonication. First line correspond to molecular weight markers 
(BioRad Precision Plus Protein All Blue Standard). On the rigth, the sGFP fluorescence was 
monitored on-line for 12 hours by StepOne™ Real-Time PCR System (Thermo Scientific) using 
λex: 494 nm and λem: 518 nm. The empty plasmid pET28b was used as negative control. 
 
In order to improve the portability and robustness of this system, the commercial 
preparation of cell extracts was freeze-dried according to recent studies.59, 60 We 
pleasantly achieved the same protein synthesis yield after 12-hour reactions using 
either freeze-dried or no freeze-dried cell extracts. Although the synthesis rate was 
2.63 times slower using the freeze-dried cell extracts rather than the no freeze-dried 
solution (Figure 6). Therefore, this strategy would be a portable device due to the 
endurance at high dehydration-rehydration conditions, although the freeze-drying 
should be optimized. 
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Figure 6. Comparing CFPS kinetics by using freeze-dried and no freeze-dried cell 
extracts.  The freeze-dried T7/S30 cell extracts and S30 premix plus were rehydrated with the 
plasmid solution in a final reaction volume of 25 µL. These cell extracts were stored at -20ºC but 
no longer than a week before their reconstitution. sGFP fluorescence was on-line monitored by 
RT-PCR for 12 hours. Data below (Vs) show the initial rates of His-sGFP synthesis in the range 
of 0.5 to 4 hours. 
 
3.2.  Optimization of one-pot CFPS-i by using His-sGFP and AG-Co 
To demostrate that protein synthesis and immobilization can occur orthogonally and 
simultaneously, we synthesized His-sGFP using T7/S30 cell extracts in presence of 
porous agarose particles activated with cobalt-chelates (AG-Co). Expectedly, protein 
synthesis was not observed when empty pET28b was used as negative control (Figure 
7). Conversely, when the CFPS system was incubated with the plasmid encoding the 
untagged-sgfp gene and the microbeads, the fluorescence appeared but remained in 
the reaction bulk without selectively colonizing the microbeads (Figure 6).  
 
              
Figure 7. Control reactions of CFPS-i. Fluorescence microscopy images show the overlay of 
brightfield and sGFP signals after 12 hours of CFPS. 
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Finally, only when the plasmid his-sgfp_pET28b and AG-Co were incubated with the 
cell-free extracts, we observed the selective confinement of the fluorescence in the 
microbead surface (Figure 8A). These experimental results evidence the in vitro 
synthesis and concurrent selective immobilization of the protein but only when the 
protein tag/microbead pair is properly selected. To better understand the dynamics of 
this two-step/one-pot process, we performed the synthesis and immobilization of His-
sGFP immobilized on AG-Co by measuring sGFP fluorescence along the time (Figure 
8B). The on-line monitoring of the process reveals that sgfp gene under the control of 
T7 promoter is transcribed and translated producing a His-tagged nascent protein that 
is subsequently immobilized on the AG-Co. As we can see from the time-course 
images, fluorescence is barely accumulated in the bulk during the entire process 
(Figure 8B). This fact suggests that the immobilization rate is higher than the synthesis 
rate, converting the latter into the rate-limiting step. Despite CFPS reactions in solution 
normally reach the maximum protein yields in 2-4 hours,61, 62 the accumulation of the 
nascent proteins inside the porous microbeads continued for more than 12 hours and 
never reached a plateau. Furthermore, the larger microbeads were more efficient in 
recruiting the nascent proteins due to their higher surface (Figure 8B).  
 
Figure 8. On-line monitoring CFPS-i kinetics by fluorescence microscopy.                                     
A) Fluorescence microscopy images overlaying brightfield and sGFP signals before (left) and 
after (right) the CFPS-i reaction was completed. B) sGFP fluorescence inside the microbeads 
and in the background (the reaction medium outside the microbeads) as a function of time. 
Microbeads were grouped according to their size. The fluorescence value at each time point 
corresponds to the average fluorescence of 3 microbeads. Reactions were carried out in the 
fluorescence microscope without shaking.  
 
Once the CFPS-i system was demonstrated to be functional, we reused the cell 
extracts by separating the loaded microbeads and incubating the cell extracts with 
fresh and empty microbeads, substrates and reagents. Unfortunately, the protein 
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synthesis yield diminished 96.0% after the second reuse (Figure 9). We hypothesized 
that some fundamental elements for protein synthesis remained bound to the 
microbeads.  
 
Figure 9. Reuse of CFPS machinery. CFPS-i of His-sGFP on AG-Co was quantified with a 
calibration curve (y = 1252.5x + 74.8; R2 = 0.99) obtained from AG-Co with different loads of in 
vivo expressed His-sGFP. The data show the average of 5 microbeads. The final reaction 
volume was 25 µL. 
 
3.3. Polypeptide tags as linkers to drive protein immobilization on a plethora 
of materials 
First of all, the high selectivity of one-pot CFPS-i strategy was tested in simultaneous 
presence of two different materials (agarose and methacrylate) with different surface 
functionalizations. For this purpose, cys-sgfp_pET28b was incubated with CFPS 
system and two materials, AG-Co and methacrylate microbeads activated with epoxy 
groups (Pu-E). The nascent Cys-sGFP was exclusively immobilized on Pu-E (Figure 
10), as result of the specific interaction between the thiol groups of the Cys-tag and the 
epoxy groups of the carrier. 
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Figure 10. CFPS-i of Cys-sGFP in presence of AG-Co and Pu-E. A) Scheme of the selective 
binding between the Cys-GFP and Pu-E (black) in presence of AG-Co (pink). B) Fluorescence 
microscopy images overlaying brightfield and sGFP signals before and after the CFPS-i 
reaction was accomplished.  
 
Expanding the scope of the CFPS-i methodology, the synthesis of Cys-sGFP and Lys-
sGFP was coupled to their selective immobilization on gold nanorods (AuNRs) and 
silica nanoparticles (SiO2NPs), respectively (Figure 11). Cys-sGFP was efficiently 
immobilized on AuNRs due to the formation of thiol-gold covalent bonds (Figure 11A). 
This binding chemistry has been extensively exploited in the biofunctionalization of 
gold-based nanomaterials.21 Likewise, Lys-sGFP was selectively and stably absorbed 
on SiO2NPs through the ionic interaction between the positive charges of the -NH2 
group of the poly-(6x)Lys and the negatively charged surface of these nanoparticles 
(Figure 11B), accordingly to the results obtained with other basic domains and tags 
fused to the protein of interest.63  
 
Figure 11. CFPS-i of sGFP onto on-demand materials by selective polypeptide-tags. A) 
Cys-sGFP. B) Lys-sGFP. From left to right, scheme of the selective binding between the 
polypeptide-tagged sGFP and the nanoparticle; fluorescence microscopy images overlaying 
brightfield and sGFP signals for the control reaction with untagged sGFP (- Cystag / - Lystag) 
and for the reaction with polypeptide-tagged sGFP (+ Cystag / + Lystag). All microscopy images 
were taken after a washing step with 10 mM sodium phosphate buffer at pH7.0. 
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In both cases, the untagged sGFP was synthesized but not immobilized on 
nanoparticles (Figure 11). The interaction between the Lys-tag and the silica surface 
was proven to be very selective, since the untagged-sGFP was not bound to the 
SiO2NPs. However, minor unspecific interactions were observed between proteins from 
the CFPS machinery and the SiO2NPs (Figure 12).  
 
Figure 12. SDS-PAGE of CFPS-i of Lys-sGFP on SiO2NP. The molecular weight markers are 
BioRad Precision Plus Protein All Blue Standard. Line 1: immobilized proteins on SiO2NP after 
CFPS-i reaction with the plasmid untagged-sgfp_pET28b. Line 2: immobilized proteins on 
SiO2NP after CFPS-i reaction with the plasmid lys-sgfp_pET28b.  
 
In addition, the pool of free amino acids contained in the S30 premix plus was not 
competing with the polypeptide-tagged sGFP for the reactive groups of the carrier. This 
fact was demonstrated by incubation of in vivo expressed sGFP (cell debris without 
purification step) with the corresponding materials and a solution of the free amino 
acid. After 12 hours of incubation, similar protein immobilization yields were achieved in 
presence/absence of free amino acids in the reaction bulk. Likewise, the protein 
immobilization kinetics followed a similar trend in both cases (Figure 13). 
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Figure 13. Comparing immobilization yields of in vivo expressed tagged sGFP adding or 
not external free amino acids. 1 mL (0.02 mg x mL-1) of cell extracts from in vivo expression of 
tagged sGFP was incubated with the appropriate carrier and the same concentration of the free 
amino acid (0.3 mM) that CFPS-i reactions included. sGFP fluorescence of 200 µL from the bulk 
was measured in a 96-well plate using a VarioskanTM Flash Multimode Reader. From left to 
right, striped bars correspond to cell extracts (C.E.) with His-sGFP incubated with AG-Co and 
free L-Histidine, Cys-sGFP incubated with Pu-E and free L-Cysteine and Lys-sGFP incubated 
with SiO2NPs and free L-Lysine. White bars represent the relative fluorescence of control 
reactions without adding free amino acids. 
 
CFPS-i reaction was also carried out by drop-casting the corresponding plasmid to 
express Lys-sGFP and the cell-free protein synthesis machinery on the top of glass 
slides. The reaction mixture was incubated for 12 hours. Herein, the protein synthesis 
was successfully accomplished since fluorescence was detected in drops containing 
either tagged or untagged proteins after the reaction time (Figure 14). After the 
washing step, the drops containing the plasmid encoding Lys-sGFP displayed 
fluorescence spots on the glass, while no fluorescence was detected in those drops 
that in vitro expressed the untagged protein, since it was removed from the surface 
during the washing step (Figure 14). These experimental data corroborate that the Lys-
tag drives the protein immobilization on silica-based materials and expand its utilization 
to other solid architectures. In spite of the low robustness which can be expected from 
an ionic interaction, the immobilization of oriented proteins using CFPS-i by drop-
casting has been demonstrated even after washing the biomaterial. Furthermore, this 
technology skips the chemical functionalization steps of glass slides required for the 
conventional proceedings to prepare protein-based microarrays.64  
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Figure 14. CFPS-i of Lys-sGFP onto glass slides. CFPS of A) Lys-sGFP and B) untagged 
sGFP. From left to right, scheme of the selective binding; macroscopic view of the drop-casting 
after a 12-hour CFPS-i reaction by using an UV transilluminator (λex: 470 nm);  fluorescence 
microscopy images overlaying brightfield and sGFP signals after CFPS-i reaction but before a 
washing step; and after both CFPS-i reaction and a washing step with milli-Q water. 
 
3.4. Polypeptide tags to selectively co-immobilize proteins on the same carrier 
by using CFPS-i 
The co-immobilization of different enzymes on the same carrier is a common strategy 
to assemble complex biological machineries like multi-enzyme systems.65-68 In order to 
gain selectivity during the co-immobilization protocol, the toolbox of polypeptide-tags 
herein developed was applied to simultaneously synthesize two different proteins and 
selectively co-immobilize them on the same carrier through two different immobilization 
chemistries. As a proof of concept, Cys-sGFP and an alcohol dehydrogenase from 
Bacillus stearothermophilus tagged with 6 histidines at its N-terminal (Bs-ADH) were 
synthesized in vitro. In order to evaluate the orthogonality of the toolbox for CFPS-i, a 
new agarose-based heterofunctional carrier activated with both cobalt-chelates and 
disulfide groups (AG-Co/S) was prepared (Figure 2). This new surface theoretically 
allows the co-immobilization of Cys- and His-tagged proteins simultaneously through 
two different immobilization chemistries based on reversible covalent disulfide and 
reversible metal coordination bonds, respectively (Figure 15A). This concept was 
proved by incubating the heterofunctional carrier with the corresponding DNA plasmids 
and the cell-free extracts for the one-pot co-expression and co-immobilization of His-
Bs-ADH and Cys-sGFP. As a control reaction, we also expressed only Cys-sGFP in 
presence of the heterofunctional carrier. To demonstrate the co-expression and co-
immobilization of these two proteins, the fluorescence of Cys-sGFP was visualized 
(Figure 15B) and quantified (Figure 15B) by fluorescence microscopy.  
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Figure 15. Co-expression and co-immobilization of two different proteins by two different 
chemistries. A) Scheme of the immobilization of Cys-sGFP (up) and the co-immobilization of 
Cys-sGFP and Bs-ADH (down) on AG-Co/S. B) Microsocopy images overlaying brightfield and 
sGFP signals after the CFPS-i reaction. C) sGFP fluorescence mean values correspond to the 
average of 5 microbeads after the CFPS-i reactions were completed (12 hours). 
 
These experiments showed that Cys-sGFP and Bs-ADH are co-expressed and co-
immobilized on the same microbeads. However when we performed the CFPS-i using 
only the plasmid for the expression of Cys-sGFP, the fluorescence intensity per 
microbead was 4.22 times higher than when using the two different plasmids (Figure 
15C). This dissimilarity points out a possible competition between the two transcribed 
mRNA for the ribosomal machinery that may diminish the specific final yields for both 
Cys-sGFP and Bs-ADH. Karim and Jewett observed a similar decreasing effect on the 
protein expression levels when they tried the cell-free co-expression of several 
enzymes.39 According to Park et al., mRNA species must compete for a finite pool of 
ribosomes and aminoacyl-tRNAs when CFPS reaction mixtures are primed with 
several DNA templates, leading to an unequal expression level of different proteins. 
Indeed, sGFP fluorescence was reported to be inversely proportional to translation 
rates of the co-expressed genes.69 Besides the fluorescence of the immobilized Cys-
sGFP reveals its proper folding and structurally innocuous immobilization, in vitro 
synthesized and immobilized Bs-ADH was catalytically active after CFPS-i (Figure 16).  
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Figure 16. ADH activity assay. ADH activity of the biocatalyst containing co-immobilized His-
Bs-ADH and Cys-sGFP (white circles) and the control reaction without proteins (black squares) 
was tested. 
 
The multimeric nature of Bs-ADH was not a hurdle for its successful expression and in 
situ immobilization by using the CFPS-i system, validating the feasibility of this 
technology for quick and easy preliminary tests of enzyme co-immobilization. These 
results also guide the design of more complex biological micro-architectures for 
engineering artificial metabolic cells. 
Additionally, the orthogonality and selectivity of these two immobilization chemistries 
was demonstrated by selective elution of Bs-ADH in presence of EDTA, while the Cys-
sGFP remained attached to the surface. Alike, Cys-sGFP was eluted to the solution by 
using thiolated compounds (Figure 17). Hence, such orthogonality allow the modular 
assembly of multi-enzyme systems where one enzyme can be easily replaced by other 
(or by the same enzyme) when the first enzyme becomes inactive. 
 
Figure 17. Selective elution of Cys-sGFP and Bs-ADH from the heterofunctional agarose. 
A) Overlay of brightfield and sGFP signals imaging. From left to right, images before the elution, 
after the elution with EDTA and after the elution with EDTA and DTT. B) ADH activity of the 
biocatalyst before (white circles) and after (black squares) EDTA and DTT elution. 
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3.5. CFPS for prototyping of enzyme cascades 
Encouraged by the previous protein co-expression results, the co-expression of two 
enzymes was tested by CFPS in the same tube. For this purpose, the cell-free extracts 
were prepared in the laboratory55 in collaboration with the group of Prof. Mansy instead 
of using cell extracts from a commercial source. The preparation of ‘lab-made’ cell 
extracts decreases the costs of using CFPS, becoming more feasible the 
implementation of CFPS as a regular tool for high-throughput screenings of enzymes at 
prototyping scale. 
Two plasmids encoding genes to produce NADH oxidase from Thermus thermophilus 
(Tt-NOX)67 and Bs-ADH were incubated with the CFPS system to simultaneously 
express the two enzymes (Figure 18A). The tetrameric (Bs-ADH) and the dimeric (Tt-
NOX) enzymes perform a redox cascade reaction that may be monitored by 
exogenously adding a third enzyme, horseradish peroxidase (HRP) from a commercial 
source. HRP transforms the fluorogenic substrate Ampliflu Red into the product 
Resorufin which is easily monitored by its fluorescence (Figure 18B). 
 
Figure 18. Co-expression of an enzyme cascade by CFPS. A) Two plasmids were incubated 
overnight with the CFPS system at 30ºC. B) After CFPS, the enzyme cascade was completed 
by adding substrates and HRP to monitor the final fluorescent product, resorufin. 
 
The production of resorufin was monitored during two hours by using a Rotor-Gene Q 
(Figure 19). The results show an increase on fluorescence only when all components 
of the enzyme cascade were present in the reaction tube.  
In spite of further analysis are needed to develop a robust prototyping platform using 
CFPS, this preliminary study reveals the promising potential of this synthetic biological 
tool for quick-and-easy assays to test a whole enzyme cascade in one pot. Therefore, 
this study contributes to the recently emerging applications of CFPS for biocatalysts 
development.70    
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Figure 19. Monitoring the Resorufin production by the in vitro synthesized enzyme 
cascade. The table shows the conditions of each reaction mixture. 
 
3.6. Incorporation of non-natural amino acids through CFPS to enable oriented 
protein immobilization mediated by copper-free click chemistry 
In order to go beyond the chemistry offered by the nature, CFPS reactions have been 
already used for incorporating non-natural amino acids into target proteins.43, 44 In many 
cases this non-natural amino acids are used as hubs to conjugate the target protein 
with other molecules or with solid materials. In this context, amino acids containing 
azides are extensively used to lead the immobilization of in vivo expressed proteins on 
surfaces activated with alkyne groups through click chemistry.71 However, most of click 
chemistry schemes rely on copper(I)-catalyzed reactions, and the copper might 
negatively affect the in vitro protein synthesis. In this work, we have overcome the 
potential toxicity of the copper by expanding CFPS-i to copper-free click chemistry 
reactions. Here, we have incorporated non-natural amino acids harboring azide groups 
into the nascent proteins to drive their immobilization on materials functionalized with 
cyclooctyne groups. To this aim, we firstly activated agarose microbeads with 
cyclooctyne groups (AG-Oct) through a new surface chemistry protocol starting from 
commercially available agarose microbeads activated with cyanogen bromide (Figure 
2). Figure 18 shows that protein synthesis fails when neither methionine nor L-AHA (L-
azidohomoalanine) is included in the amino acid mixture. As expected, fluorescence 
can be detected neither in the bulk nor inside the microbeads. Furthermore, when the 
protein is synthesized with methionine, the protein is produced but the immobilization 
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on AG-Oct does not occur, remaining the nascent protein in the reaction bulk. Similarly, 
when the protein is synthesized with L-AHA but incubated with agarose microbeads 
activated with hydroxyl groups instead of AG-Oct, sGFP fluorescence is only detected 
in the reaction bulk.  
These experimental data demonstrate that the synthesis and bio-orthogonal copper-
free click immobilization of sGFP is only possible when azide side chains are displayed 
in the protein surface and the agarose surface is activated with cyclooctyne groups 
(Figure 20). The incorporation of non-natural amino acids for protein-based 
biomaterials manufacturing has been already described.6, 72, 73 However, the protein 
synthesis have been here coupled with a cyclooctyne/azide click immobilization in one-
pot concurrent process, unlike two-pot conventional methods where firstly azide- or 
alkyne-amino acids are incorporated either in vivo or in vitro into the protein. Then, the 
modified protein is purified and incubated with solid particles functionalized either with 
alkyne or azide groups.43, 74 
 
Figure 20. CFPS-i of sGFP incorporating AHA by copper-free click chemistry. 
Fluorescence microscopy imaging overlaying brightfield and sGFP signals after the CFPS-i was 
completed. The images show the reaction in presence of each amino acid: Met (methionine) or 
AHA (L-azidohomoalanine) and the agarose microbeads activated or not with cyclooctyne (Oct) 
groups. 
 
According to the sGFP X-ray structure (PDB: 2B3P), L-AHA might be introduced at 
position 1, 76, 86 and 216 of the protein primary sequence. Positions 1, 76 and 86 
cluster at the bottom part of the β-barrel where N- and C-terminal are located, while 
position 216 is located at the hollow of the barrel facing the chromophore (Figure 21). 
Due to that distribution of residues, the resulting protein can adopt different molecular 
orientations during the immobilization process. Likely, the protein is mainly oriented 
through the bottom part since the amino acid in position 1 is more exposed to the 
solvent. Subsequently, this strategy can be a potential tool for further protein 
orientation screenings.  
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Figure 21. X-ray structure of sGFP. Met are represented in orange. 
 
For a more precise site-selective immobilization, the CFPS-i developed here could be 
coupled to cell-free AMBER system by using specific tRNAs to insert non-natural 
amino acids in unique positions.75 To sum up, cooper-free click immobilization based 
on cyclooctyne/azide pairs is compatible with the protein synthesis according to the 
broad bio-orthogonality of this chemistry.76  
 
3.7. Antibody orientation and immobilization by two-pot CFPS-i 
The demonstrated plasticity of the methodology presented in this chapter encorauged 
us to develop a novel strategy for oriented antibody immobilization. In order to conceive 
a wide-ranging device for oriented-immobilization of inmunoconjugates, Protein A was 
synthesized and immobilized by using CFPS-i. Materials functionalized with ProA mean 
a universal platform for binding to the Fc region of any immunoglobulin G (IgG).77 A 
previously reported plasmid that encodes Protein A tagged with poly-(6x)His (His-ProA) 
at its N-terminal under the control of the T7 promoter was utilized.49 In a first attempt, 
the plasmid, the cell-free extracts, AG-Co and an IgG chemically conjugated with both 
rhodamine and alkaline phosphatase (AP-IgG-Rh) were incubated in one test tube to 
perform the CFPS-i of His-ProA and the subsequent AP-IgG-Rh capture in one-pot. 
The fluorescence and the enzyme activity conjugated to the IgG enabled to trace the 
antibody capture reaction. Unfortunately, the antibody was not able to be bound to the 
microbeads functionalized with the nascent His-ProA under the protein synthesis and 
immobilization conditions (data not shown).  
In the light of the previous unsatisfactory result, His-ProA was firstly expressed and 
immobilized on AG-Co in one pot (Figure 22A) and afterwards AP-IgG-Rh was 
incubated with that biomaterial in a second pot (Figure 22B). As a result, the 
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fluorescence of the AP-IgG-Rh was uniformly distributed on the AG-Co immobilizing 
His-ProA, pointing an optimal antibody density for antigen recognition as previously 
reported for the direct immobilization of IgG on porous agarose particles.18, 78 Hence, 
we demonstrated that His-ProA can be synthesized and immobilized in one-pot 
retaining its capacity to selectively capture conjugated IgG, giving rise a two-step 
process for the site-directed immobilization of inmunoconjugates on solid carriers. 
These results suggest that the protein synthesis conditions inhibit the affinity interaction 
between the Fc region of the antibody and the His-ProA.  
 
Figure 22. Two-pot fabrication of antibody-based biomaterials. A) CFPS-i of His-ProA 
(brown) on AG-Co (pink). B) Capturation of IgGs (blue) which are labeled with rhodamine 
(orange star) and by ProA immobilized on AG-Co. On the upper side, the schemes of protein 
immobilization. On the bottom side, the fluorescence microscopy images overlaying brigthfield 
and fluorescence (λexc: 530 nm, λem: 615-700 nm).   
 
As control, when AP-IgG-Rh was incubated with AG-Co lacking the His-ProA, 
fluorescence was neither visualized inside the microbeads and enzyme activity was not 
detected neither after sample washing (Figure 23). However, the labeled antibody was 
not quantitatively captured by the microbeads immobilizing His-ProA; 43% of the 
offered antibody was captured (Figure 23). 
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Figure 23. Alkaline phosphatase activity of control reactions for AP-IgG-Rh 
immobilization. AP-IgG-Rh was incubated with AG-Co and AG-Co containing His-ProA. 
Alkaline phosphatase activity was measured in the flow-through (grey bars) of the 
immobilization and in a suspension of microbeads (white bars) after the His-ProA 
immobilization. 
 
Nevertheless, combining the last advances on CFPS of either antibody fragments79, 80 
or whole functional antibodies81, 82 with the technique described here, the fabrication of 
antibody-based biomaterials could be successfully accomplished in one-pot. Ultimately, 
the optimization of CFPS-i of antibodies can contribute to develop innovative 
immunological screening platforms for manufacturing tailor-made biosensors, pull-
down systems83 and immunotherapy.84 
 
4. CONCLUSION 
Cell-free protein synthesis and immobilization has been successfully coordinated in 
one pot controlling the orientation and the immobilization chemistry of the nascent 
proteins. In vitro synthesis of different proteins has been performed orthogonally to a 
variety of solid materials as carriers and allowed screening a diversity of immobilization 
chemistries to selectively attach the nascent protein to the carrier (Table 2). Some of 
those protein-material pairs were designed and fabricated for first time. 
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Table 2. Description of protein-material pairs tested by using one-pot CFPS-i. 
 
Three main strategies were exploited for CFPS and orientation of selective protein 
immobilization: a toolkit of interchangeable polypeptide-tags; coupling the introduction 
of non-natural amino acids and click chemistry; and the synthesis of the IgG-binding 
His-ProA for site-directed immobilization of antibodies. The flexibility showed by those 
results supports this platform as a suitable prototyping technology for manufacturing 
protein-based materials. Taking advantage of its short processing time and versatility, 
this platform offers the opportunity to develop quick and easy assays for enzyme 
expression and immobilization screening onto a wide-ranging spectrum of materials. 
This system has already showed to be suitable for the production of multimeric 
enzymes and immobilized biological conjugates (IgG-ProA). Moreover, the co-
expression and selective co-immobilization of a protein and an enzyme was for first 
time achieved by CFPS-i strategy, as far as we know. What is more, this technology is 
fully portable since it requires neither specialized equipment nor sophisticated 
infrastructures. However, the optimal synthesis of larger multimeric proteins and the in 
situ formation of biological complexes through specific protein-protein interactions will 
be some of the most important challenges this technology will must face in the near 
future.  
 
 
 
 
 
Tagged protein Binding material Binding interaction Elution reagent
His-sGFP AG-Co Metal coordination bond Imidazol
Bs-ADH AG-Co/S Metal coordination bond Imidazol
His-ProA AG-Co Metal coordination bond Imidazol
Cys-sGFP
Pu-E Covalent -
Au-NRs Covalent -
AG-Co/S Thiol exchange DTT
Lys-sGFP
SiO2NPs Ion exchange Sodium chloride
Glass slide Ion exchange Sodium chloride
sGFP containing AHA AG-Oct Copper-free click chemistry -
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Chapter 4 
 
Optimizing the co-immobilization of enzymes and redox 
cofactors to develop artificial metabolic cells 
 
A new concept of artificial metabolic cells was developed in this chapter. The reversible 
immobilization of phosphorylated cofactors (FAD+ and NAD+) onto PEI-coated agarose 
microbeads was firstly optimized. In order to develop self-sufficient heterogeneous 
biocatalysts, covalent immobilization of enzymes was followed by electrostatic 
adsorption of cofactors onto the positively charged polymer attached to the carrier 
surface. To proof this principle, two dehydrogenases were co-immobilized with NAD+ to 
asymmetrically reduce a model prochiral ketone, giving rise to 100% of conversion 
yield during 4 reaction cycles and without adding exogenous cofactor. This principle 
was expanded to the co-immobilization of an O2-dependent oxidase and two cofactors 
(NADH and FAD+). The spatial localization of the enzyme across the carrier was tuned 
by controlling the immobilization kinetics to get a heterogeneous distribution. For the 
better understanding of these systems, in operando analysis by using fluorescence 
microscopy at single-particle level were coupled to the rational design. 
 
The co-immobilization of two dehydrogenases and NAD+ was published in Angewandte 
Chemie.1 The co-immobilization of an oxidase with NADH and FAD+ is in preparation. 
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1. INTRODUCTION 
Biocatalysis is a smart path towards more cost-effective and environmentally friendly 
chemical processes.2 Furthermore, the most interesting reactions in industrial 
biocatalysis are mainly catalyzed by cofactor-dependent enzymes such as NAD(P)H-
dependent reductases and oxidases, PLP-dependent transaminases and FAD+-
dependent oxygenases.3-6 Consequently, the regeneration and reutilization of the 
expensive cofactors is a key requirement for the implementation of enzymatic 
processes at large scale.7, 8 Hitherto, whole cells are still preferred as biocatalysts for 
those cofactor-dependent reactions because of their high efficiency and re-usability 
without exogenous addition of cofactors. However, whole cells often produce undesired 
metabolic by-products which may be toxic and difficult to separate.9 Many endeavours 
have been invested in cell-free systems based on enzymatic and chemical reactions to 
regenerate the cofactors10, 11 allowing their use in catalytic amounts, but they still must 
be exogenously added. Bio-inspired pioneering works have immobilized biological or 
artificial cofactors (mostly NADH) and enzymes on solid materials as cell-free systems 
aiming at their solid phase recycling and reusability for several operational cycles.7, 12-14  
Genereally, the success of these works have been limited because the immobilized 
cofactors show limited turnover numbers,15 the enzymatic activity towards the 
immobilized cofactors is low,16 the enzymes and cofactors can be hardly reused16, 17 
and the fabrication of these systems is hardly scalable.18 
Due to its easy handling and recycling, a more promising approach for industry is the 
electrostatic adsorption of the cofactors and enzyme systems to solid and porous 
materials in organic media.19 These solid materials modified with polyelectrolytes that 
display positive charges allow the electrostatic interactions with phosphorylated 
cofactors that are negatively charged under the binding conditions. As result, the 
cofactor was physically adsorbed through reversible ionic interactions which allow the 
cofactor molecules simultaneously existing attached to the solid surface and free in the 
porous space.20 Based on such association-dissociation equilibrium, the cofactor 
becomes accessible for the immobilized enzymes but concurrently may also be 
released to the reaction bulk, leaving the solid surface. This strategy has been proven 
profitably in organic media19 but fails in aqueous media owing to the lixiviation of both 
NAD(P)H and enzymes.21 In a recent work, a multi-enzyme system and NADH have 
been co-immobilized into a membrane-based hollow nanofibers doped with 
polyallylamine to transform CO2 into methanol in aqueous media.22 Unfortunately, the 
cofactor regeneration in each cycle was very low (total turnover number (TTN) = 1), 
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although the enzymes and cofactor could be reused up to 10 cycles without activity 
loss.  
The micro-architecture design for the cofactor immobilization is as important as the 
rational design for the enzyme immobilization.23, 24 Traditionally, enzymes have been 
immobilized by trial-and-error approaches and characterized at macroscopic level 
based on observable parameters. These averaged measurements are collected from 
information gathered at the liquid bulk solution without considering the spatial 
heterogeneity of the sample. Frequently, the distribution of immobilized enzymes may 
affect positively/negatively to the efficiency of the heterogeneous biocatalyst. 
Immobilized enzymes might be inhibited by phisico-chemical changes inside 
microparticles (e.g. pH gradients,25 substrates/product gradients24) or suffer substrate 
transfer limitations.26, 27 Specifically, immobilized oxygen-dependent enzymes suffer 
loss of activity because of diffusional restrictions in the inner regions of the 
microparticles which have been studied at intra-particle level.28-30 In the scenario of 
multi-enzymes cascades, the proper localization of each enzyme on different 
microparticles and the spatial distribution inside a single-particle was also 
demonstrated to make the difference during redox reactions.31-33 More recently, rational 
design and single-particle/single-molecule studies have demonstrated to have an 
impact on the catalytic yield of the heterogeneous biocatalysts.23, 29 These microscopic 
studies have received less attention, but reveal vital information about the spatio-
temporal performance at the intra-particle environment of the heterogeneous 
biocatalysts. 
In this chapter, a new design is proposed by assembling enzymes and cofactors into 
artificial solid supports to build artificial metabolic cells. To this end, the co-
immobilization of both enzyme and cofactors have been rationally designed and 
optimized to perform more efficient chemical reactions. Thus, fluorescence techniques 
were implemented for the spatio-temporal monitoring of enzyme kinetics at single-
particle level for a better understanding of enzyme behavior inside artificial metabolic 
cells. 
 
2. EXPERIMENTAL SECTION 
2.1. Materials 
Substrates and reagents as 2,2,2-trifluoroacetophenone (TFAF), N-succinimidyl-3-(2-
pyridyldithio)-propionate, FAD+, sodium formate, fluorescein isothiocyanate (FITC), 
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rhodamine B isothiocyanate, polyethyleneimine 25 kDa (PEI25), NaBH4, triethylamine 
(TEA), kanamycin, ampicillin, amicon ultra 0.5 mL centrifugal filters 10 kDa were 
acquired from Sigma-Aldrich (St. Louis, IL). NAD+ and Nicotinamide-adenine-
dinucleotide-reduced sodium salt (NADH) were purchased from GERBU Biotechnik 
GmbH (Wieblingen, Germany). 1,4-butanediol diglycidyl ether (BDE) was purchased 
from Thermo Scientific-Alfa Aesar (Karlsruhe, Germany). Plain agarose microbeads 
were purchased from ABT technologies (Madrid, Spain) to fabricate the derivatives. 
TALON Metal Affinity Resin was acquired from Clontech Laboratoires. PD-10 columns 
were from GE healthcare.  Inc. 8-well μslides were purchased from ibidi (Planegg, 
Germany). All other reagents and solvents were of analytical grade or superior. 
 
2.2. Methods 
 
2.2.1. Activation of carriers:  
 AG-DVS/PEI25 (6BCL agarose activated with vinyl groups and coated with 
polyethileneimine). AG-DVS was prepared by strictly following the protocol 
described by dos Santos et al.34 Then, AG-DVS/PEI25 was prepared by mixing 
100 mg of AG-DVS and 1 mL of a PEI solution (25 kDa, at final concentration of 
10 mg x mL-1) in 100 mM bicarbonate buffer at pH 10 under orbital agitation for 
1 hour at 25 ºC. Finally, the AG-DVS/PEI25 was washed 5 times with 10 
volumes of water and stored at 4 ºC. The supports modified with PEI were 
characterized by using N-succinimidyl-3-(2-pyridyldithio)-propionate that 
specifically reacts with the primary amines and the product can be quantified by 
measuring absorbance at 343 nm.35 
 AG-G/PEI25 (6BCL agarose microbeads activated with glyoxyl groups and 
coated with polyethileneimine). AG-G was prepared as described elsewhere.36 
Then, AG-G/PEI25 was prepared by mixing 100 mg of AG-G and 1 mL of a PEI 
solution (25 kDa, at final concentration of 10 mg x mL-1) in 100 mM bicarbonate 
buffer solution at pH 10 under orbital agitation for 1 hour at 25 ºC. Later on, 
solid NaBH4 was added (1 mg x mL-1) and incubated for 30 min at 4 ºC. Finally, 
the AG-GPEI was washed 5 times with 10 volumes of water and stored at 4 ºC. 
 AG-TEA (6BCL agarose activated with triethylamine). Agarose activated with 
epoxy groups was modified with 1 M triethylamine in 50 % water/acetone at pH 
12 for 24 hours at 25 ºC, following a previously reported protocol.36 
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 Pu-G/PEI25 (purolite activated with glyoxyl and coated with polyethileneimine). 
The same protocol carried out to prepare AG/PEI25 was followed but using Pu-
G as starting carrier. 
 
2.2.2. Expression and purification of enzymes  
Alcohol dehydrogenase from Thermus thermophilus (Tt-ADH)37, formate 
dehydrogenase from Candida boidinii (Cb-FDH)38 and Tt-NOX39 were overexpressed in 
E. coli as follows. Shortly, 1 mL of an overnight culture of E. coli BL21 transformed with 
the respective plasmid (adh_pET22a, fdh_pET28b and nox_pET22a) was inoculated in 
a 50 mL of LB medium containing kanamycin (30 μg x mL-1) for Cb-FDH, and ampicillin 
(100 μg x mL-1) for Tt-ADH and Tt-NOX. For the overexpression of Tt-ADH and Tt-
NOX, the resulting culture was incubated at 37 °C and 200 rpm until the OD600nm 
reached 0.6. At that point, the culture was induced with 1 mM IPTG. Cells were grown 
at 37 °C for 3 hours and then harvested by centrifugation at 10000 g during 30 minutes 
at 4 ºC. For Cb-FDH, the resulting culture was incubated at 21 °C with energetic 
shaking until the OD600nm reached 0.6, and then the culture was induced with 1 mM 
IPTG. Cells were grown at 21 °C for 18 hours and then harvested by centrifugation at 
10000 g during 30 minutes at 4 ºC.  
 
2.2.3. Protein purification  
The resulting pellets (0.5 g) were resuspended in 5 mL of binding buffer (25 mM 
sodium phosphate at pH 7). Cells were broken by sonication (LABSONIC P, Sartorius 
Stedim biotech) at 30% of amplitude (1 second ON, 1 second OFF) during 30 minutes. 
The suspension was centrifuged at 10000 g during 30 minutes at 4 ºC. For Cb-FDH the 
supernatant containing the enzyme was collected and passed through a TALON resin 
equilibrated with binding buffer. Following the protein binding to the column, the column 
was washed three times with binding buffer before the protein elution with elution buffer 
(binding buffer supplemented with 300 mM imidazole). The eluted protein was gel-
filtered by using PD-10 columns to remove the imidazole and exchange. In case of Tt-
ADH, the sonicated crude extract that contains the enzyme was incubated at 70 ºC 
during 1 hour to remove all mesophilic proteins, the thermophilic one remain at the 
supernatant and was separated by centrifugation at 10000 g during 30 min at 4 ºC. For 
Tt-NOX, the sonicated crude extract was incubated at 80 ºC during 45 minutes. The 
protein solution was then centrifugated at 10000 g during 30 minutes at 4 ºC to 
separate Tt-NOX in the supernatant. 
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The purification process of Cb-FDH, Tt-ADH and Tt-NOX was followed by SDS-PAGE 
(Figure 1). 
 
Figure 1. SDS-PAGE of protein purifications. All molecular weight markers are BioRad 
Precision Plus Protein All Blue Standard. A) Cb-FDH. Line A1: crude extract, line A2: soluble 
fraction after cell disruption by sonication, line A3: elution fraction, line A4: pure Cb-FDH (band 
40 kDa). B) Tt-ADH. Line B1: pure Tt-ADH (band 27 kDa), line B2: Soluble fraction after cell 
disruption by sonication. C) Tt-NOX. Line C1: pure Tt-NOX (band 27 kDa), line C2: soluble 
fraction after cell disruption by sonication. 
 
2.2.4. Protein quantification  
Protein concentration was quantified by Bradford protein assay40 adapted to 96-well 
plates. Briefly, 5 µL of enzyme solution were mixed with 200 µL of Bradford reagent 
and incubated at room temperature for 5 min. Then the absorbance was measured at 
595 nm and the protein content was estimated employing a calibration curve using 
BSA as a standard. 
 
2.2.5. Enzymatic activity assays  
The enzymatic activities were spectrophotometrically measured in 96-well plates by 
monitoring the absorbance at the corresponding wavelenght in a VarioskanTM Flash 
Multimode Reader. One unit of activity was defined as the amount of enzyme that was 
needed to either reduce or oxidize 1 μmol of the corresponding nicotinamide cofactor at 
25 ºC at pH 7. 
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 Tt-ADH activity. 200 µL of a reaction mixture containing 10 mM of TFAF, 0.25 
mM of NADH in 25 mM sodium phosphate buffer at pH 7 were incubated with 5 
µL of enzymatic solution or suspension at 25 ºC. The decrease in the 
absorbance was monitored at 340 nm.  
 Cb-FDH activity. 200 μL of 1 mM NAD+ and 100 mM formic acid in 25 mM 
sodium phosphate buffer at pH 7 were incubated with 5 μL of enzymatic 
solution at 25 ºC. The increase in the absorbance was monitored at 340 nm.  
 Tt-NOX activity. 200 μL of 0.15 mM FAD+ and 0.2 mM NAD+ in 25 mM sodium 
phosphate buffer at pH 7 were incubated with 20 μL of enzymatic solution at 25 
ºC. The increase in the absorbance was monitored at 340 nm. 
 
2.2.6. Enzyme immobilization:  
 Co-immobilization of Tt-ADH and Cb-FDH on AG-G/PEI25. 10 mL of Tt-ADH 
(0.078 mg x mL-1) in 100 mM sodium bicarbonate buffer at pH 10 were mixed 
with 1 gram of AG-G and incubated at room temperature with orbital shaking for 
2 hours. Immobilization course was followed spectrophotometrically by 
measuring the activity of both suspension and supernatant. Later, the 
suspension was filtered and 10 mL of a PEI solution (10 mg x mL-1) in the same 
buffer were added. After 1 hour of incubation at room temperature, 1 mg x mL-1 
solid NaBH4 was added and incubated 30 minutes at 4 ºC. Then, the 
suspension was filtered and washed 5 times with 10 mL of 10 mM sodium 
phosphate buffer at pH 7. Afterwards, the immobilization of the second enzyme 
was conducted by adding 10 mL of Cb-FDH solution (4.5 mg x mL-1) in 10 mM 
sodium phosphate buffere at pH 7 and incubating 1 hour at room temperature 
with orbital shaking. Then, the suspension was filtered and the solid was 
incubated with 10 mL of 30 mM BDE at pH 7 for 1 hour at room temperature. 
Finally, the suspension was filtered and washed twice with 5 volumes of 10 mM 
sodium phosphate buffer at pH 7 and stored at 4 ºC. 
 Immobilization of Tt-NOX on AG-G/PEI25. 10 mL of Tt-NOX (0.1 mg x mL-1) in 
100 mM sodium bicarbonate buffer at pH 10 were mixed with 1 gram of AG-G 
and incubated at room temperature under orbital shaking for 3 hours. 
Immobilization course was followed spectrophotometrically by measuring the 
activity of both suspension and supernatant. In case of homogeneous 
immobilization (slow immobilization process), 10 or 100 mM hydroxylamine was 
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added to the suspension. Later on, PEI-coating was performed as described 
above. 
 
2.2.7. Parameters of immobilized enzymes: 
 
 Protein load. The amount of protein that has been immobilized per gram of 
carrier. This parameter is defined as mg x g-1. 
 
 Immobilization Yield. The percentage of enzyme that has been immobilized 
from the initial enzyme solution which was offered to the carrier. This parameter 
was calculated by using values of either the enzymatic activity (U x mL-1) or the 
protein concentration (mg x mL-1). 
  (%) = ቆ
 enzymeoffered − enzymesupernatant
enzymeoffered
ቇ  x 100 
 
 Final expressed activity. The measured activity of the immobilized enzyme on 
the carrier after washing. This parameter is defined as U x gcarrier-1. 
 
 Specific activity. The activity of the soluble/immobilized enzyme per miligram of 
enzyme.  
- Soluble enzyme: Ae (U x mg-1) = ቀ  Enzyme activity  (U x mL
-1)
Protein concentration (mg x mL-1)  ቁ 
- Immobilized enzyme: Ae (U x mg-1) =ቀ Expressed activity  (U x g
1)
Protein loading (mg x g-1)  ቁ 
 
 Relative recovered specific activity. The percentage of specific activity which 
has been immobilized in comparision with the specific activity of the soluble 
enzyme which was offered to the carrier. 
Ar (%) = ቀ Ae immobilized enzyme Ae soluble enzyme ቁ  x 100 
 
2.2.8. Cofactor immobilization  
Ionic immobilization of phosphorylated cofactors was achieved by incubating 10 mL of 
soluble cofactor at the indicated concentration in 10 mM sodium phosphate at pH 7 
with 1 gram of agarose microbeads (with or without previously immobilized enzymes). 
The suspension was kept under orbital agitation for 1 hour at room temperature. 
Afterwards, the resin was filtered and washed three times with 1 mL of 10 mM sodium 
phosphate at pH 7. The concentration of the immobilized cofactors were calculated by 
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measuring the absorbance of the supernatant after the adsorption process and after 
each washing step at the proper wavelength (260 nm for NAD+, 340 nm for NADH and 
450 nm for FAD+) in the microplate-reader.  
 Cofactor load. The amount of cofactor that has been immobilized per gram of 
carrier. This parameter is defined as µmol x g-1. 
 
 Immobilization Yield. The percentage of cofactors that has been immobilized 
from the initial cofcator solution which was offered to the carrier. This parameter 
was calculated by using the values of cofactor concentration (µmol x g-1) as 
follows: 
  (%)= ቆ
 cofactoroffered-cofactorsupernatant
cofactoroffered
ቇ  x 100 
 
2.2.9. FlTC/Rhodamine-labeling of enzymes  
Enzymes were labeled with either fluorophore FITC or rhodamine B following the 
protocol described in Chapter 3 (page 58).   
 
2.2.10.   Spatial localization studies by fluorescence microscopy  
The immobilization of enzymes onto the microparticles was confirmed by using a 
Colibri LED illumination system incorporated into the fluorescence microscope to image 
rhodamine (λex: 530 nm, λem: 615-700 nm) and FITC (λex: 470 nm, λem: 500-557 nm). 
 
2.2.11. Single-microbead kinetics (In operando experiments)  
Reactions were performed under the fluorescence microscope using 8-well μslides. 
Images were processed with the software ZEN2012. 
 Tt-ADH and Cb-FDH. 180 µL of 1:200 (w/v) suspension of the self-sufficient 
heterogeneous biocatalyst (0.63 mgTt-ADH, 43.7 mgCb-FDH and 17.5 molNADH x 
gcarrier-1) in 10 mM sodium phosphate buffer at pH 7 were placed into the well. 
Reactions were triggered with 20 µL of substrate at a final concentration of 5 
mM TFAF, 10 mM formic acid and 5% acetonitrile in 10 mM sodium phosphate 
buffer pH 7. The fluorescence monitoring of NADH (λex: 365 nm, λem: 402-448 
nm) was carried out every 20 seconds during 15 minutes at room temperature. 
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 Tt-NOX. 184 µL of 1:200 (w/v) suspension of the immobilized enzyme (0.1 mgTt-
NOX x gcarrier-1) in 10 mM of sodium phosphate buffered solution pH 7 were placed 
into the well. Substrate mixtures with both substrates (111 µM NADH and 5.5 
µM FAD+), with 10 mM sodium phosphate buffer at pH 7, with only 5.5 µM FAD+ 
and with only 111 µM NADH were used to trigger different reactions. The 
fluorescence monitoring of NADH (λex: 365 nm, λem: 402-448 nm) and FAD+ (λex: 
470 nm, λem: 500-557 nm) was carried out every minute during 30 minutes at 
room temperature. 
 
3. RESULTS AND DISCUSSION 
3.1. Optimization of phosphorylated redox cofactor immobilization 
Firstly, the electrostatic adsorption of phosphorylated cofactors to solid porous 
microbeads was tested on two different anionic exchangers that have been broadly 
used in purification and immobilization of proteins.36, 41-44 AG-TEA and AG-G/PEI25 
were fabricated with agarose microbeads activated with triethylamine (TEA) and 
polyethyleneimine (PEI), respectively. The cationic groups were introduced by 
nucleophilic attack of the amine-containing molecule (TEA/PEI) to the epoxy or 
aldehyde groups, respectively, on the agarose surface followed by mild reduction that 
establishes covalent irreversible bonds. As a model phosphorylated cofactor, NAD+ 
was adsorbed on both cationic microbeads at different pH (Table 1).  
Table 1. Effect of the pH and chemistry bound in the immobilization of NAD+.  
 
Washing steps were performed by adding 10 volumes of 10 mM sodium phosphate or 
carbonate at pH 7 or 9, respectively.  
 
AG-G/PEI25 loaded 1.6-fold more NAD+ than AG-TEA and retained 4 µmolNADx g-1 after 
5 washing steps (10 volumes each), while 100% of NAD+ bound to AG-TEA was 
NAD+ (µmol x gcarrier-1)
AG-TEA AG-G/PEI25
Washing number pH 7 pH 9 pH 7 pH 9
0 11.2 18.4 17.5 18.2
1 0 1.9 6.7 3.0
2 0 0 4.9 1.0
3 0 0 4.4 0.4
4 0 0 4.0 0.2
5 0 0 3.8 0.1
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lixiviated under the same conditions. Although the pKa values of TEA and PEI are 
similar (around 10),45-47 PEI build a 3D-polymeric bed inside the pores displaying a 
larger and denser cationic surface that may explain its higher cofactor loading capacity 
compared to those surfaces modified with TEA. Noteworthy, although the cofactor 
adsorption was similar at both pHs, the cofactor lixiviation increased at pH 9 because 
alkaline conditions neutralize the positive charge of the amine groups, dramatically 
weakening NAD+-PEI interactions.  
Remarkably, the loading yield and cofactor lixiviation were not affected when PEI was 
irreversibly attached to polyacrylic porous microbeads (Pu-G/PEI25) or to agarose 
microbeads activated with vinyl groups (AG-DVS/PEI25). Figure 2 shows that 4-5 
µmolNAD+ x gcarrier-1 remained bound to the positively charged surfaces after 8 washing 
steps. 
 
Figure 2. Immobilization of NAD+ on different PEI-coated supports. In all cases washing 
steps were carried out by adding 10 volumes of 10 mM sodium phosphate buffer at pH 7. The 
initial immobilized NAD+ in each case corresponds to 24, 23 and 22 µmolNAD+ x gcarrier-1, 
respectively.  
 
In addition, AG-G/PEI25 was also able to efficiently bind another phosphorylated redox 
cofactors such as flavin adenine dinucleotide (FAD+) which is required for other 
industrially relevant enzymes (flavin-dependent oxidases3 and enoate reductases48). 
Figure 3A shows that the absorption yield of FAD+ was 3 times higher than NAD+. 
Nevertheless, more than 90% of the adsorbed FAD+ was lixiviated after 8 washing 
steps (Figure 3B).  
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Figure 3. Immobilization of phosphorylated cofactors on AG-G/PEI25. A) Cofactor loading 
(the offered cofactor was 100 μmolcofactor x gsupport-1). B) Residual cofactors which remain bound 
to AG-G/PEI25 after washing treatments. In all cases, the washing steps were carried out by 
adding 10 volumes of 10 mM sodium phosphate buffer at pH 7 per volume of AG-G/PEI25 
microbeads.  
 
We suggest that the cofactor lixiviation relies on the association-dissociation 
equilibrium of the cofactor-PEI interactions, and such interactions are specific for each 
cofactor. To prove this hypothesis, we determined the apparent dissociation constants 
(Kdapp) for the electrostatic binding of the cofactors to the AG-G/PEI25 (Table 2).  
Table 2. Apparent dissociation constants of redox cofactors ionically absorbed to AG-
G/PEI25.  
 
The Kdapp was calculated as described elsewhere.1 The free and bound cofactors were 
calculated by incubating 1 mL of 10 mM cofactor in 10 mM sodium phosphate buffer at pH 7 
with 0.1 gram of AG-G/PEI25 for 60 minutes when the concentration of the free cofactor was 
constant (equilibrium in batch).  
 
Actually, the Kdapp of FAD+ was 4.2 times lower than the Kdapp of NAD+. These results 
show a higher affinity of AG-G/PEI25 towards FAD+ according to the higher 
immobilization yield of FAD+ (Figure 3A). The adsorption of the cofactor to the 
microbeads is mainly driven by reversible ion-exchange interactions between the 
negatively charged phosphate groups of the cofactors and the positively charged 
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amine groups coating the agarose fibers. Therefore, the strength of such electrostatic 
interactions relies on the association-dissociation equilibrium that is affected by the 
ionization state (pH/cofactor-dependent) and the density of the amine groups coating 
the solid surface.  
 
3.2. Co-immobilization of two enzymes and one redox cofactor  
Having now in hand a versatile and simple strategy to incorporate phosphorylated 
cofactors to porous carriers, we tested the catalytic availability of these cofactors to 
carry out redox reactions by enzymes. Usually, enzymes display lower activity towards 
reversible or irreversible tethered cofactors on solid materials.13, 15, 17 To test the 
performance of these reversibly immobilized cofactors, steady-state kinetics of NAD+-
dependent formiate dehydrogenase (Cb-FDH) towards both soluble and immobilized 
cofactors were studied.  Using soluble NAD+, the KM of soluble Cb-FDH was 12 times 
lower than its immobilized form (Figure 4). Unfortunately, the apparent Michaelis-
Menten constant could not be calculated using the immobilized NAD+ because neither 
the soluble nor the immobilized enzymes were saturated at any concentration of 
immobilized cofactor. 
 
Figure 4. Kinetic parameters of soluble (A) and immobilized (B) Cb-FDH with soluble 
NAD+. 
 
The immobilized Cb-FDH showed the same specific activity by using either soluble or 
co-immobilized NAD+ (166 µM) (Table 3). This fact suggests that the available cofactor 
is nearly the same regardless NAD+ is in its free or immobilized form.  
 
0 1000 2000 3000 4000 5000
0,0
0,2
0,4
0,6
0,8
0.
0.
0.4
0.6
0.8
Sp
ec
ific
 a
ct
ivi
ty
 / 
U
 x
 m
g-
1
NAD+ / M
0 200 400 600 800 1000
0,0
0,5
1,0
1,5
2,0
2,5
3,0
0.0
.
1.
1.
2.0
2.5
3.0
Sp
ec
ifi
c 
ac
tiv
ity
 / 
U
 x
 m
g-
1   
 
NAD+ / M
KM = 85 ± 0.9
Vmax = 3.0 ± 0.004
KM = 1037 ± 109
Vmax = 0.88 ± 0.007
A B
Chapter 4 
- 99 - 
 
Table 3. Cofactor catalytic availability. 
Soluble and immobilized Cb-FDH with free (166 µM in bulk) and immobilized NAD+ (6.6 µmol x 
gcarrier-1 = 166 µmol in bulk). Ae = specific activity in U x mg-1, Vmax = maximum specific activity 
in U x mg-1 and KM = Michaelis-Menten constant in µM. [a] The specific activities were 
calculated by inserting 166 M of soluble NAD+ as substrate concentration in the Michaelis-
Menten equation using the corresponding kinetics parameters (Vmax and KM) experimentally 
determined. Ae = (Vmax x 166) / KM +166). [b] The specific activities were experimentally 
determined using 166 M of immobilized NAD+. [c] The catalytically available NAD+ 
concentration was calculated by inserting the specific activity experimentally determined [b] in 
the Michaelis-Menten equation using the corresponding kinetics parameters (Vmax and KM) for 
the soluble and the immobilized Cb-FDH experimentally determined. [NAD+] = (Ae x KM) / 
(Vmax - Ae), where [NAD+] is the catalytically available immobilized NAD+ concentration in µM.  
 
However, when the activity values of the Cb-FDH were introduced in the Michaelis-
Menten fitting corresponding to either the soluble or the immobilized enzyme, the 
estimated available concentration of immobilized NAD+ was 30-fold higher for the 
immobilized enzyme than for the soluble one. We suggest that the physical proximity 
between the enzymes and the cofactor molecules within the pores where both species 
are co-immobilized explains the higher available cofactor concentration, compared to 
the soluble enzyme that needs to diffuse into the pores to reach the cofactors.49 
Therefore, NAD+ bound to AG-G/PEI25 can be catalytically utilized and retained in the 
solid phase, demonstrating that the association-dissociation equilibrium directly 
impacts on the cofactor availability for the enzymes that determines the reaction 
kinetics.  
Due to these promising results, two different enzymes; alcohol dehydrogenase (Tt-
ADH) and Cb-FDH, were co-immobilized with the corresponding cofactor; NAD+ 
(Scheme 1), to develop a self-sufficient heterogeneous biocatalyst to carry out the 
asymmetric reduction of TFAF to yield S-(trifluoromethyl)bencylalcohol.  
Cb-FDH form Cofactor form Specific activity(U x mg-1)
NAD+ available
(M)
NAD+ available
(%)
Soluble
Soluble 1.97 ± 0.005 [a] 166 100
Immobilized 0.19 ± 0.06 [b] 5.8 ± 1.9 [c] 3.5 ± 1.1
Immobilized
Soluble 0.12 ± 0.01 [a] 166 100
Immobilized 0.13 ± 0.01 [b] 177 ± 21.2 [c] 107.2 ± 12.8
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Scheme 1. Co-immobilization process of two enzymes and one cofactor onto the same 
microbeads.  
 
Tt-ADH was firstly immobilized on AG-G50 and then the agarose fibers immobilizing the 
enzymes were coated with PEI through the same amine-aldehyde chemistry51, followed 
by a mild reduction step that turns the reversible imines resulted from the amine-
aldehyde interaction into irreversible secondary amines. Unfortunately, when Cb-FDH 
was immobilized by the aldehyde immobilization chemistry, the enzyme was 
inactivated. Thereby, this enzyme was co-immobilized by ionic adsorption on the PEI-
bed and subsequently cross-linked with BDE to assure its irreversible attachment. In 
this architecture, both enzymes and PEI are irreversibly bound to the agarose 
microbeads leaving the enzymes surrounded by the cationic polymer with the ionically 
adsorbed cofactor. The different enzymes were immobilized with yields ranging 79-
100% and recovering 52–100% of their specific activities upon the immobilization 
process (Table 4). 
Table 4. Immobilization yields and expressed activities of co-immobilized Tt-ADH and Cb-
FDH on AG-G/PEI25.  
 
 [a] After 5 washes with a mixture of 10 mM formic acid,  5 mM TFAF and 10 mM sodium 
phosphate buffer at pH 7, the heterogeneous biocatalyst maintained > 95% of residual Cb-FDH 
activity; and after a final wash with 0.5 M of NaCl, more than 85% of  the Cb-FDH activity was 
retained in the heterogeneous biocatalyst.  
 
The co-immobilization of two enzymes and NAD+ onto the porous carrier was confirmed 
by fluorescence microscopy. Figure 5 shows the localization of both cofactor and 
enzymes across the surface of the same agarose microbeads, without presence of 
fluorescence in the bulk. 
Enzymes Protein load 
(mg x gcarrier-1)
Immobilization
yield
(%)
Final 
expressed activity 
(U x gcarrier-1)
Relative recovered
specific activity
(%)
Tt-ADH 0.63 79 6.15 113
Cb-FDH 43.7 100 59.60 52
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Figure 5. Spatial localization of enzymes and cofactor by fluorescence microscopy. Tt-
ADH was labeled with FITC, Cb-FDH was labeled with rhodamine and NAD+ showed 
autofluorescence. 
 
Fluorescence microscopy techniques were also set up to monitor the enzyme kinetics 
at single-particle level. In operando monitoring of fluorescence at single-particle level 
was applied to demonstrate that the ionically adsorbed cofactors are available for the 
enzymes and remain inside the porous structure. To this end, single-particle 
experiments served to monitor the oxidation of formic acid in parallel with the 
asymmetric reduction of TFAF catalyzed by the co-immobilized bi-enzymatic system. 
The autofluorescence of NADH immobilized on single-agarose microbeads together 
the use of fluorescence microscopy (Figure 6B) allowed these single-particle studies. 
When the self-sufficient heterogeneous biocatalyst was operated under the microscope 
using formic acid as the only substrate, the fluorescence intensity within the 
microbeads increased due the concomitant production of NADH (which fluorescence is 
higher than the oxidized form NAD+) resulted from the Cb-FDH oxidation activity. Under 
the same conditions but in the presence of both TFAF and formic acid, the 
fluorescence intensity of the microbeads remained practically constant along the time 
because the oxidized cofactor was recycled inside the particle by the orthogonal 
activities of the two enzymes (Figure 6B). The in operando experiments demonstrated 
that the immobilized cofactor is available for the immobilized enzymes but does not 
diffuse out the porous microbeads during the reaction. This innovative but 
straightforward application of fluorescence microscopy opens new pathways for a 
better characterization of heterogeneous biocatalysts. 
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Figure 6. Single-particle monitoring redox biotransformations by self-sufficient 
heterogenous biocatalysts. A) Reaction scheme. B) In operando NADH production with 
(green circles) and without (red triangles) NAD+ recycling within a single microbead. The 
fluorescence value at each time point corresponds to average fluorescence of 10 microbeads. 
 
Afterwards, the efficiency of this self-sufficient multi-functional heterogeneous 
biocatalyst was tested for the asymmetric reduction of TFAF without addition of 
exogenous cofactor in batch mode (Figure 7). The conversion and reaction rates of the 
self-sufficient heterogeneous biocatalysts were similar than the co-immobilized Tt-ADH 
and Cb-FDH with exogenous NAD+ (Figure 7A).  
The next step was to test the reusability of the self-sufficient heterogeneous biocatalyst 
without adding exogenous NAD+. The self-sufficient heterogeneous biocatalyst was 
reused for 4 batch cycles achieving the maximum conversion in each cycle and 
accumulating a total turnovernumber (TTN) of 40 (the theoretical maximum) (Figure 7). 
In this system, the immobilized NAD+ performs as well as the soluble one with the 
advantage that the former can be reused for several reaction cycles increasing its TTN. 
When using porous microbeads, the cofactors must be co-immobilized with the 
enzymes on the same porous microbeads to guarantee the cofactor shuttling between 
the different enzyme active sites, enabling the intra-particle cofactor recycling and the 
operational reusing of the self-sufficient biocatalyst. In terms of cofactor recycling, the 
0 2 4 6 8 10 12 14
0
100
200
300
400
500
600
 Formic acid + TFAF
 Formic acid
Fl
uo
re
sc
en
ce
 / 
R
FU
Time / min
A
B
Chapter 4 
- 103 - 
 
architecture herein presented improves the reported TTNNADH of 10 after 10 reaction 
cycles for a multi-enzyme system co-entrapped with NADH into hollow nanofibers 
doped with polyallyamine.22 Alike, our system performs much better than the system 
where the enzymes and the cofactors are separately and irreversibly immobilized on 
non-porous polystyrene nanoparticles achieving an accumulated TTN <1 after 11 
operational cycles of methanol production.13 In this system, the cofactor is recycled by 
colloidal collisions between the nanoparticles unlike in our system where the cofactor 
shuttles between the active sites inside the porous surface, explaining the higher 
efficiency in the NAD+ recycling.  
 
Figure 7. Efficiency and reusability of the self-sufficient heterogeneous biocatalysts. A) 
Asymmetric reduction of TFAF catalyzed by co-immobilized NAD+, Tt-ADH and Cb-FDH (white 
bars and squares), by co-immobilized Tt-ADH and Cb-FDH using soluble NAD+ (grey bars and 
triangles) and by soluble enzymes and cofactor (dashed white bar). Reactions were carried out 
with 5 mM TFAF and 0.5 mM soluble or immobilized NAD+, 10 mM formic acid, 5% of acetonitrile 
in 10 mM phosphate buffer at pH 7 and 25 ºC. Bars correspond to conversion degree, while 
symbols correspond to the accumulated TTN. Accumulated TTN was calculated as µmol of 
released product  after each batch cycle per mol of immobilized cofactor. B) Catalytic efficiency 
and reuse of heterogeneous biocatalysts with soluble and immobilized cofactors. [1] Obtained 
specific activity or yield in the first cycle. [2] Accumulated TTN after 4 batch cycles. TOF was 
calculated as µmol of released product per µmol of cofactor in one hour.  
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3.3.    Co-immobilization of one enzyme and two redox cofactors  
In the context of design and engineering more efficient heterogeneous biocatalysts, the 
enzyme distribution across the porous particle is another important parameter to 
enhance the catalytic performance of the biocatalyst.33, 52-54 In the second part of the 
present chapter, the spatial organization of co-immobilized enzymes and cofactors was 
more profoundly studied using as a proof of concept an O2-dependent enzyme. Based 
on a previous work,55 the immobilization rate of NADH-dependent oxidase (Tt-NOX) on 
AG-G was tuned to obtain different distributions of the enzyme across the porous 
carrier. Hydroxilamine (HA) was added during the enzyme immobilization process as a 
competitor for the aldehyde groups of the carrier surface (Figure 8).  
 
Figure 8. Modulation of the immobilization rate of Tt-NOX on AG-G. A) Low protein 
concentration (protein offered: 0.1 mg x gcarrier-1 ). B) High protein concentration. (protein offered: 
1 mg x gcarrier-1 ). 
 
A slowdown of the immobilization rate was observed in presence of HA when Tt-NOX 
was offered to AG-G at 0.1 mg x gcarrier-1 (Figure 8A). Similar effects were obtained with 
a higher protein loading (Figure 8B). In this case, the influence of different 
concentrations of HA (10 and 100 mM) was negligible during the first phase of the 
immobilization, although the immobilization yield was lower at higher concentration of 
the competitor (100 mM HA). 
To study the effect of the immobilization rate on the protein distribution, Tt-NOX was 
labeled with rhodamine and further immobilized. The immobilized preparations were 
analyzed by CLSM56 (Figure 9). The fast immobilization rate (no adding HA) resulted in 
a heterogeneous distribution of the enzyme, while a homogenous distribution was 
achieved with a slower immobilization rate (adding HA). When the distribution was 
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heterogeneous, the enzyme was mainly immobilized on the outer phase of the 
microbeads. Same results were obtained when the intrinsic fluorescence of FAD+ 
bound to unlabeled Tt-NOX was analyzed.   
 
Figure 9. Spatial distribution of immobilized Tt-NOX on AG-G by CLSM.  The fluorescence 
of rhodamine-labeled enzyme was measured at λex: 561 nm, λem: filter LP565 nm. The intrinsic 
FAD+ of Tt-NOX showed autofluorescence and was detected at λex: 488 nm, λem: filter LP505 
nm. The initial protein offered was 1 mg x gcarrier-1 in all experiments. 
 
Different enzyme distributions have been found to have beneficial/detrimental effects in 
the performance of the biocatalysts. For instance, enzymes located at the outer phase 
of the microparticle suffer less diffusion limitations of the substrates.53, 57, 58 Conversely, 
when enzymes are distributed within the inner phase of the microparticle, they may be 
protected from inactivating agents that barely penetrate inside the porous particles.52, 59 
In this case, since Tt-NOX is an oxygen-dependent enzyme, a homogeneous 
distribution might be harmful for the catalytic efficiency of the biocatalyst due to 
diffusion limitations of the oxygen across the microstructure of the porous microbeads. 
In fact, biocatalysts with a uniform enzyme distribution showed a slower enzyme 
kinetics when the activity was tested, although the heterogeneous biocatalysts were 
tested at different protein loadings (Figure 10).  
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Figure 10. Monitoring enzyme kinetics. The protein loads were 1 mg x g-1 (black squares), 0.9 
mg x g-1 (light grey squares) and 0.72 mg x g-1 (dark grey triangles). 
 
According to the kinetic results, the final expressed activity of the biocatalyst with a 
heterogeneous distribution was 1.28 times higher than the expressed activity of the 
biocatalyst with a homogeneous distribution (Table 4).   
 
Table 4. Immobilization yields and expressed activities of immobilized Tt-NOX on AG-
G/PEI25. 
 
Once the enzyme distribution was optimized, our new cofactor co-immobilization 
strategy was also applied to fabricate self-sufficient heterogeneous biocatalysts with Tt-
NOX. Going a step further, two phosphorylated cofactors (NADH and FAD+) were co-
immobilized with Tt-NOX on agarose micromicrobeads (Scheme 2).  
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Scheme 2. Co-immobilization process of one enzyme and two cofactors onto the same 
microbeads.  
 
Since PEI is largely and successfully used for protein immobilization in biocatalyst 
design,60 the polymer was chosen again for the co-immobilization of two cofactors. 
Following the previously micro-architecture designed in this chapter, AG-G 
micromicrobeads were coated with PEI to enable the ion-exchange co-immobilization 
of NADH and FAD+ onto the same microbeads (Figure 11). Actually, when no PEI was 
coating the microbeads, the cofactors were found homogenously in both the bulk 
solution and the microbeads (Figure 11). This experiment evinces the essential role of 
PEI as a support for the reversible immobilization of cofactors on AG-G.  
 
Figure 11. CLSM imaging the co-immobilization of NADH and FAD+ by using PEI as 
coating agent. On the left side, colocalization of FAD+ (green) and NADH (blue) on agarose 
micromicrobeads coated with rhodamine-labeled PEI (red). On the right side, the addition of 
FAD+ (green) and NADH (blue) to AG-G without PEI-coating. The left columns are fluorescence 
images and the rigth columns are overlay of fluorescence and brigthfield signals. 
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Availing the autofluorescence of cofactors, the immobilization rate of NADH and FAD+ 
on AG-G/PEI25 was monitored by CLSM (Figure 12). In less than 1 minute, both 
cofactors were homogeneously immobilized across the microbeads. Moreover, the 
cofactor remained bound to the microbeads after 1 hour in 10 mM buffered solution 
without being lixiviated to the reaction bulk. 
 
Figure 12. Monitoring the immobilization of NADH and FAD+ on AG-G/PEI25 by CLSM. 
The offered cofactor was 20 µmol x gcarrier-1 and 15 µmol x gcarrier-1 of NADH and FAD+, 
respectively. All images show the overlay of fluorescence and brigthfield signals. 
 
After testing the co-immobilization of NADH and FAD+ on AG-G/PEI25, the self-
sufficient biocatalyst was fabricated. Firstly, Tt-NOX was immobilized on AG/G by imine 
bonds. After PEI-coating, a reduction step was carried out to become covalent the 
binding of both Tt-NOX and PEI to AG/G. Finally, both cofactors were simultaneously 
co-immobilized onto polymeric bed by ion-exchange with the amino groups from the 
PEI. The colocalization of both two cofactors and Tt-NOX onto the same microbeads 
was evinced by CLSM (Figure 13). As far as we know, this is the first heterogeneous 
biocatalyst where two different cofactors were co-immobilized with an oxidase enzyme. 
 
Figure 13. Colocalization of Tt-NOX, NADH and FAD+ on AG-G/PEI25. The load of 
rhodamine-labeled Tt-NOX (red) was 1 mg x gcarrier-1. The offered cofactor was 15 µmol x gcarrier-1    
and 20 µmol x gcarrier-1 of FAD+ (green) and NADH (blue), respectively. 
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Ultimately, in operando fuorescence microscopy analysis were employed not only to 
monitor the enzyme kinetics but also to follow the cofactor co-immobilization during the 
same experiment. To this end, a solution of free cofactors was added to a suspension 
of Tt-NOX immobilized on AG-G/PEI (Figure 14). As it was previously observed in 
Figure 12, most of the cofactor molecules (79.87 ± 0.64 % of NADH and 81.23 ± 5.96 
% of FAD+) were immobilized in less than 1 minute (Figure 14B, Figure 14C and Figure 
14D). When the only cofactor added to the suspension was NADH, the cofactor was 
immobilized on the microbead and the fluorescence inside the microparticle remained 
stable along the time (Figure 14B). In the same way, FAD+ persisted inside the 
microparticles without being lixiviated to the outside (Figure 14C). However, when both 
cofcators NADH and FAD+ were added, the biocatalytic reaction was triggered (Figure 
14D). 
Since both redox forms FADH2 and FAD+ displayed a similar autofluorescence,61 its 
autofluorescence inside the microparticles remained constant along the time after the 
cofactor immobilization. Contrarily, NADH fluorescence was diminished inside the 
microparticles due to the lower fluorescence of its oxidized form (NAD+). These results 
confirm the intraparticle NADH oxidation catalyzed by the immobilized Tt-NOX. 
Noteworthy, as soon as NADH was immobilized, the redox reaction started (Figure 
14D).  
Figure 14D also suggests that the enzymatic activity was faster than the cofactor 
immobilization under the assayed conditions. These observations support that the 
cofactor is catalytically available for the enzyme as soon as it is co-immobilized. 
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Figure 14. In operando monitoring of cofactors immobilization and NADH consumption 
by the self-sufficient heterogeneous biocatalysts. A) No cofactor was added to the 
suspension, only buffer. B) NADH was added. C) FAD+ was added. D) Both cofactors were 
added. On the left side, the fluorescence values of FAD+ (green squares) and NADH (blue 
circles) inside the microbeads (n=5) along the time. On the right side, fluorescence imaging 
during the reactions at different time points. The solution with the cofactors was added to the 
microbeads suspension just before the 1-minute image. White scale bars correspond to 100 
µm.  
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In order to demonstrate that NADH did not disappeared because of NADH diffusion 
outside the microparticle, NADH fluorescence from the reaction bulk was measured 
after filtration of the reaction suspension (Figure 15). 
 
 
 
 
 
 
Figure 15. Demonstrating that NADH remained bound to the microparticle during the 
reaction. The NADH control is the supernatant after 1 hour of incubating AG-G and 20 µM 
NADH. The reaction bulk corresponds to the supernatant after 1 hour of the reaction with both 
cofactors co-immobilized and Tt-NOX co-immobilized on AG-G/PEI25.  
 
4. CONCLUSION 
We have introduced the successful fabrication of self-sufficient heterogeneous 
biocatalysts integrating enzymes and phosphorylated cofactors within the same porous 
microbeads through an innovative architecture where the enzymes and PEI are 
irreversibly bound to the solid surface, while the negatively charged cofactors are 
reversibly adsorbed to the cationic polymers through ion-exchange interactions. The 
micro-architecture was functional for several reaction cycles without adding exogenous 
cofactors, demonstrating its feasibility for sustainable processes. This strategy was 
expanded to co-immobilize two cofactors with an enzyme for first time. Thus, the 
optimal control to organize immobilized enzymes on the carrier has been of 
outstanding relevance to achieve the best catalytic properties of heterogeneous 
biocatalysts. Likewise, single-particle studies have provided useful information to 
develop more rational, reliable and reproducible proceedings when characterizing self-
sufficient heterogeneous biocatalysts. Ultimately, the expansion of these co-
immobilization strategies and single-particle approaches for more complex multi-
enzymatic systems is a driving force to boost biocatalysis in different areas as chemical 
manufacturing, bioenergy and biosensing. 
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Chapter 5 
 
Expanding the concept of artificial metabolic cells to 
ketoreductase-based biocatalysts 
 
 
 
 
 
 
Cell-free and self-sufficient biocatalytic systems are here expanded to ketoreductases. 
Particularly, a commercially available NADPH-dependent ketoreductase was co-
immobilized with NADPH to catalyze the asymmetric reduction of prochiral ketones 
without exogenous addition of the cofactor. As a result, the immobilized cofactor is 
accessible and thus efficiently recycled by the same enzyme inside the porous 
structure without diffusing out to the bulk as demonstrated by single-particle in 
operando studies. As a proof-of-concept, the self-sufficient heterogeneous biocatalyst 
was integrated into a flow-plug reactor for the continuous synthesis of one model 
secondary alcohol, giving rise to 97-112 g x L-1 x day-1 space-time yield. Furthermore, 
the immobilized cofactor accumulated a total turnover number of 1076 for 120 hours. 
Encouraged by these results, the same biocatalyst architecture was also applied to 
another commercial ketoreductase exploited in the preparation of key optically pure 
pharmaceutical precursors. These examples contribute to the handful of self-sufficient 
heterogeneous biocatalysts co-immobilizing both enzyme and cofactor. 
 
This work was previously published in Chemistry - A European Journal1 and Advanced 
Synthesis and Catalysis.2 
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1. INTRODUCTION  
Asymmetric reduction of ketones is an elegant synthetic reaction because it enables to 
access highly-demanded secondary alcohols with quantitative yields without requiring 
deracemization steps.3 The greatest challenges of this reaction are finding highly 
selective catalysts that yield exclusively one enantiomer (ee > 99%) and performing the 
synthetic reaction in an economically viable fashion. The selectivity is extremely 
important for pharmaceutical chemistry where traces of the other enantiomer can 
cause fatalities in public health as sadly confirmed by the thalidomide tragedy.4 In this 
context, biocatalysis emerges as an enabling technology to address cost-effective 
asymmetric processes where enantiopurity of the products is compulsory.5 
Ketoreductases (KRED) (EC 1.1.1.X) have proven an excellent enantioselectivity for 
the asymmetric reduction of large variety of ketones with excellent yields and 
productivities.6, 7 Whole-cell biocatalysts are widely involved in low-cost reactions to 
produce chiral alcohols from ketones by using endogenous KREDs.8-11 However, 
whole-cell biotransformations are still time-consuming and often require purification 
steps that turn the process more expensive and hard to manage at industrial scale. 
Isolated KRED enzymes are an attractive alternative, but industrial implementation is 
often hampered by their cofactor dependency that requires the exogenous addition of 
very expensive redox cofactors endangering the economic viability of the process.12, 13 
This issue becomes even more dramatic considering that the most exploited KREDs14-
16 in large scale processes (i.e KRED from Lactobacillus kefiri)17 use NADPH whose 
price is an order of magnitude higher than the price of NADH.6 Moreover, the former 
cofactor is significantly less stable than the latter one. Therefore, both price and 
stability considerably limit the industrial application of NADPH-dependent enzymes.17, 18 
Utilization of synthetic and cheaper analogues of nicotinamide cofactors have emerged 
as alternative to NAD(P)H.19 Nevertheless, the enzymatic efficiencies towards these 
artificial cofactors are substantially lower than towards the natural ones. Alternatively, a 
more consolidated strategy is based on enzymatic or chemical cofactor regeneration 
that reduces the amount of needed cofactor at the expense of sacrificing reductants.18, 
20 In both strategies, we still need to exogenously add the cofactor increasing the 
process costs and complicating the work-up once the reaction is completed. In the 
80´s, chemical engineers started to tether cofactors to large polymers achieving the 
successful integration of enzymatic systems dependent upon NAD(P)H into 
ultrafiltration membrane reactors for continuous reduction processes without adding 
exogenous cofactors.13, 21-23 These systems reached cofactor total turnover numbers 
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(TTN) of up to 7000. Nevertheless, the high cost of the ultra- and nano-filtration 
membranes jeopardizes the economic viability of such processes. As shown in Chapter 
4, NAD+/NADH and enzymes can be efficiently co-immobilized on solid carriers giving 
raise to self-sufficient heterogeneous biocatalysts that do not require exogenous 
cofactor supply during the reaction.15, 24-30 Furthermore, the immobilization of enzyme 
eases the reaction work-up and may improve the biocatalyst properties when the 
immobilization protocol is properly selected. In an industrial context, the most promising 
approach to fabricate self-sufficient heterogeneous biocatalyst relies on the 
electrostatic adsorption of phosphorylated cofactors and enzymes to solid and porous 
materials.15, 26, 28, 29 This strategy has been proven successful for asymmetric reductions 
catalyzed by KREDs in organic media, but fails in aqueous media due to the lixiviation 
of both cofactors and enzymes.15 Hence, such equilibrium makes the cofactor 
accessible for the immobilized enzyme but simultaneously may cause the cofactor 
lixiviation to the reaction bulk, overall when buffered media is used. As explained in 
Chapter 4, our group has originally designed a versatile and simple architecture for the 
fabrication of self-sufficient heterogeneous biocatalysts based on commercial carriers 
coated with PEI. In this architecture, enzymes and PEI are irreversibly bound to the 
agarose microbeads leaving the enzymes surrounded by NAD+ ionically absorbed to 
cationic polymer.27  
In the present chapter, we have collaborated with the company EntreChem S.L. to 
optimize the co-immobilization of commercially available KREDs (P1-A04 and P2-D11). 
KRED P1-A04 presents a wide substrate scope, an exquisite R-selectivity and self-
regenerates the reduced cofactor by oxidizing IPA to acetone in a parallel reaction.6, 31 
By using porous agarose microbeads activated with tertiary amine groups, both KRED 
and NADPH were co-immobilized and co-localized on the same surface, enabling the 
enzymatic utilization of the cofactor and avoiding its lixiviation. Final operational studies 
demonstrated the re-usability and efficiency of these self-sufficient heterogeneous 
biocatalysts. 
 
2. EXPERIMENTAL SECTION 
 
2.1. Materials 
SYPRO® Orange Protein Gel Stain, PEI, ethylendiamine, FITC, 2,2,2-
trifluoroacetophenone (TFAF), 1-acetonaphtone (AN), isopropanol (IPA), DTT, 
polyethileneimine 600-1000 kDa (PEI600), sodium periodate and amicon ultra 0.5 mL 
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centrifugal filters 10 kDa were acquired from Sigma-Aldrich (St. Louis, IL). 
Ketoreductases P1-A04 and P2-D11 were purchased from Codexis. Nicotinamide-
adenine-dinucleotide-phosphate reduced sodium salt (NADPH) was purchased from 
GERBU Biotechnik GmbH (Wieblingen, Germany). Agarose 6BCL and 4BCL were 
purchased from ABT (Madrid, Spain), DEAE-sepharose (AG-DEAE) was purchased 
from GE-healthcare (Little Chalfont, UK) and epoxy methacrylate microbeads Lifetech 
ECR8204 were kindly donated by Purolite Ltd (Llantrisant, UK). Micro Bio-spinTM 
chromatographic columns were from BIORAD. 8-well μslides were purchased from ibidi 
(Planegg, Germany). All other salts and reagents were of analytical grade.  
 
2.2. Methods 
 
 
2.2.1. Activation of carriers: 
 
 AG-DVS (6BCL agarose activated with vinyl groups). This carrier was prepared 
by strictly following the protocol described by dos Santos et al.32 using plain 
agarose.  
 AG-DEAE/G (6BCL agarose activated with glyoxyl and tertiary amine groups). 
This heterofunctional carrier was prepared according to the protocol previously 
described by Mateo et al.33 using agarose as plain carrier that finally was 
activated with 23 mol of tertiary amines and 75 mol of glyoxyl groups per 
gram of carrier. 
 AG-PEI600 (4BCL agarose coated with high molecular weigth PEI 600-
1000kDa).This carrier was prepared using plain agarose as described 
elsewhere.34 
 Pu-G (Purolite lifetech ECR8204 microbead activated with glyoxyl groups). We 
followed an adapted protocol described elsewhere.33 In brief, 10 grams of 
commercial carrier were incubated with 100 mL of 0.5 M sulphuric acid for 2 
hours under gentle stirring at room temperature in order to hydrolyze the epoxy 
groups. Then, the carrier was thoroughly washed with distilled water and further 
incubated with 100 mL of 10 mM sodium periodate to oxidize the vicinal diols 
resulted from the acidic hydrolysis of the starting epoxy groups. Finally, the 
carrier was washed with excess of water and stored at 4 ºC. 
 Pu-DEAE/E (Purolite lifetech ECR8204 microbead activated with epoxy and 
diethyl-aminoethyl groups). This carrier was prepared and quantified by 
adapting the protocol described by Bolivar et al.35 10 grams of Purolite lifetech 
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ECR8204 microbeads were incubated with 100 mL of 1 M ethylendiamine at pH 
10 for 2 hours under gentle stirring at room temperature. Then, the solid 
material was washed with an excess of water to remove the unreacted 
ethylendiamine. The resulting carrier contained 29 mol of amino groups and 29 
mol of epoxy groups per gram of carrier. 
 
2.2.2. Protein immobilization  
Typically, 1 mL of 0.025-0.65 mg x mL-1 KRED P1-A04 were incubated with 100 mg of 
each carrier and incubated for 1 hour at room temperature and under the specific buffer 
conditions for each immobilization protocol. The immobilization on AG-DVS, AG-DEAE, 
AG-PEI600, AG-DEAE/G and Pu-DEAE/E was carried with an enzyme solution 
prepared in 10 mM sodium phosphate pH 7. For the immobilization on Pu-G, the 
enzyme was prepared in 100 mM sodium bicarbonate at pH 10 or in 100 mM sodium 
phosphate and 10 mM DTT at pH 8. Upon the enzyme immobilization on carrier 
containing glyoxyl groups, 100 mg of microbeads were incubated with 1 mL of NaBH4 
(1 mg x mL-1) in 100 mM sodium bicarbonate at pH 10 and 4 ºC for 30 minutes in order 
to reduce the enzyme-carrier imine bonds into irreversible secondary amine bonds. In 
case of KRED P2-D11, 1 gram of AG-DEAE was incubated with 10 mL of 0.1–0.65 mg 
x mL-1 enzyme in 10 mM sodium phosphate pH 7.0 for 1 hour at room temperature. For 
each immobilization experiment, the enzyme solution was incubated under the same 
immobilization conditions but without the carrier as blank sample.  
 
2.2.3. Parameters of immobilized enzymes  
The immobilization yield, the specific activity and the final expressed activity were 
calculated as described in Chapter 4 (page 93) unless otherwise specified. 
 
2.2.4. Protein quantification  
The Bradford assay was carried out following the protocol described in Chapter 4 (page 
91). 
 
2.2.5. Enzymatic assays  
The activity of KRED was spectrophotometrically measured by monitoring the 
absorbance at 340 nm along the time, which decreased because of the enzymatic 
reduction of NADPH. The enzymatic assays were carried out in a VarioskanTM Flash 
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Multimode Reader using 96-well plates. For both soluble and immobilized enzymes the 
activity was measured under orbital shaking integrated into the reader. One unit of 
activity was defined as the amount of enzyme that was required to either reduce or 
oxidize 1 μmol of NADPH at 25 ºC and the corresponding pH.  
 KRED P1-A04 activity. 200 µL of a reaction mixture containing 10 mM TFAF 
and 0.25 mM NADPH in 10mM sodium phosphate buffer  at pH 7 was 
incubated with 20 µL of enzymatic solution or suspension at 25 ºC.  
 KRED P2-D11 activity. 200 µL of a reaction mixture containing 1 mM AN, 1 mM 
MgCl2 and 0.25 mM NADPH in 10 mM sodium phosphate buffer  at pH 7 was 
incubated with 20 µL of enzymatic solution or suspension at 25 ºC. 
 
2.2.6. Thermal and isopropanol inactivation: 
 Thermal Stability. Thermal stability was determined by incubating soluble and 
immobilized KRED P1-A04 in 10 mM sodium phosphate buffer at pH 7 at 40 °C. 
Samples were withdrawn at different incubation times and the residual 
enzymatic activity was measured as described above. The experimental data 
were fitted to different first-kinetic equation and first-kinetic equation with 
residual activity using Origin 8.0. 
 Organic solvent stability. Enzyme stability against IPA was determined by 
incubating soluble and immobilized enzyme in 10 mM sodium phosphate buffer 
at pH 7 containing IPA. For KRED P1-A04, 1.55% of IPA was added to the 
incubation at 25 ºC. In case of KRED P2-D11, the incubation was carried out 
with 17% of IPA at 30 ºC. Samples were withdrawn at different times and the 
residual enzymatic activity was measured as described above.  
 
2.2.7. Co-immobilization of NADPH on AG-DEAE  
1 gram of AG-DEAE immobilizing KRED were incubated with 10 mL of 1 mM NADPH 
in 10 mM Tris-HCl at pH 7 and room temperature. Aliquots of supernatant were 
withdrawn after 1 hour and spectrophotometrically measured at 340 nm to quantify the 
adsorption of NADPH to the carrier. After the adsorption process, the solid samples 
were washed with 10 volumes of 10 mM Tris-HCl at pH 7 and utilized in further 
experiments. The cofactor load and the cofactor immobilization yield were calculated 
as described in Chapter 4 (page 94). 
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2.2.8. Fluorescence studies 
 FITC-labeling of KRED P1-A04. The enzyme was labeled with FITC following 
the protocol described in Chapter 3 (page 58).  The labeled KRED P1-A04 was 
used for further localization studies of the immobilized enzyme by CLSM. The 
images were analyzed with the softwares FIJI and ZEN2012. 
 Intrinsic protein fluorescence. Intrinsic fluorescence of 10 µg of soluble or 
immobilized KRED P1-A04 (1mgKRED x gcarrier-1) prepared in 25 mM sodium 
phosphate buffer at pH 7 was measured in 96-well plates. The study was 
performed by exciting at 280 nm and recording the emission spectrum at 300-
500 nm in a VarioskanTM Flash Multimode reader at 25º C.  
 Thermal shift assay. 0.5 g x mL-1 of soluble or 0.23 g x mL-1 of immobilized 
KRED P1-A04 in 25 mM sodium phosphate buffer and 0.3% of SYPRO® 
Orange at pH 7 were incubated in a StepOnePlus™ Real-Time PCR System by 
using a temperature ramp program from 25-95°C with a ramp rate of 0.5 °C x 
min-1. 
 
2.2.9. Single-microbead kinetics (in operando experiments)  
Different redox reactions were performed under the fluorescence microscope using 8-
well μslides. 184 µL of 1:200 (w/v) suspension of the self-sufficient heterogeneous 
biocatalyst (6.5mgKRED P1-A04 and 10 molNADPH x gcarrier-1) in 10 mM Tris-HCl, 1 mM 
MgCl2 at pH 7.3 were placed in the wells. Reactions were triggered with 36 µL of 
substrate mix to achieve a well concentration of 1 mM TFAF (in acetonitrile) and 17% 
IPA. Substrate mixtures with both substrates, with only buffer, with only TFAF and with 
only IPA were used to trigger different in operando experiments. The fluorescence 
measurements of NADPH were carried out every 20 seconds until 20 minutes in a cell 
axio observer microscope (λex: 365 nm, λem: 402-448 nm) at room temperature. Images 
were processed with the software ZEN2012. 
 Image analytics. The molecular imaging platform from CIC biomaGUNE carried 
out the following analysis. The 60 frames were analyzed by using MATLAB 
Release R2012b (The MathWorks, Inc., Natick, Massachusetts, United States). 
The reference area occupied by each microbead was calculated by segmenting 
the brightfield image, which was also considered as the functional area 
occupied by the autofluorescence of the immobilized NADPH. Pixel-wise time 
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courses extraction was performed and fitted to a first-order reaction equation 
(F=Fo*e-k*t; F is the fluorescence per pixel at each time, Fo is the fluorescence 
per pixel at t = 0 and t is the time of each frame). Statistically, only those pixels 
that present fittings with R2 > 0.95 were considered. Then, the pixel-wise initial 
rate (Vo) was determined from the linear regression fitting considering only the 
time frames where the microbead fluorescence was higher than 80% of the 
microbead fluorescence at time 0. The relative Vo per pixel were mapped by 
normalizing the Vo of each pixel regarding to the maximum Vo within the same 
microbead (see Figure 8).  
 
2.2.10.  General procedure for the continuous asymmetric reduction of TFAF by   
KRED P1-A04 
0.28 g of self-sufficient heterogeneous biocatalyst (6.5mgKRED and 10 molNADPH x 
gcarrier-1) were packed into a column (2 x 0.4 cm) and connected to a flow system driven 
by a syringe pump. A reaction mixture containing 10 mM TFAF, 1 mM MgCl2 and 17% 
IPA in 10 mM Tris-HCl at pH 7 passed through the column at different flow rates (50-
200 μL x min-1) and 25 ºC. Different samples were collected from the outlet of the 
system and analyzed by UPLC. 
 
2.2.11. In-batch asymmetric reduction of AN by KRED P2-D11  
In a micro-chromatographic column, a reaction mixture containing 27 mM AN, 17% IPA 
and 1 mM MgCl2 in 10 mM Tris-HCl at pH 7.0 was incubated with 30 mg of self-
sufficient heterogeneous biocatalysts (6.5 mgKRED and 10 mmolNADPH x gcarrier-1) and 
maintained under gentle rotational agitation (50 rpm) at 25 ºC. As control reaction, 
same amount of KRED immobilized on AG-DEAE and soluble and exogenous NADPH 
were mixed in the same conditions. The reaction was stopped by vacuum filtration. 
Next, the immobilized biocatalyst was washed with 10 volumes of 10 mM Tris-HCl at 
pH 7.0 to be reused in the next batch cycle. 
 
2.2.12. General procedure for the continuous asymmetric reduction of AN by 
KRED P2-D11  
1 gram of self-sufficient heterogeneous biocatalyst (5.85 mgKRED and 10 mmolNADPH x 
gcarrier-1) were packed into a column (230.4 cm) and connected to a flow system driven 
by a syringe pump. A reaction mixture containing 27 mM AN, 1 mM MgCl, 4.9% DMSO 
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and 17% IPA in a 10 mM Tris-HCl buffer solution at pH 7.0 passed through the column 
at different flow rates (50-200 μL x min-1) and 25 ºC. Different samples were collected 
from the outlet of the system and analyzed by UPLC. 
 
2.2.13. HPLC analysis: 
 Asymmetric reduction of TFAF: The reaction products were monitored by HPLC 
coupled to a spectrophotometer unit (UPLC Waters or 1120 compact LC 
Agilent). Isocratic flow of 0.3 mL x min-1 with a mobile phase of 0.1% formic acid 
in water/acetonitrile (65:35) through an ACQUITY UPLC BEH C18 column (50 x 
2.1 mm) was used to determine the conversion at 254 nm. The retention time of 
the product from the asymmetric reduction of TFAF was 3.8 minutes. 
 Asymmetric reduction of AN: The reaction products were monitored in an 
Agilent chromatographic system in collaboration with Prof. Berglund´s group. A 
reversed phase column (Zorbax Eclipse XDB-C18, RR, 1.8 µm, 4.6 x 50 mm, 
Agilent) was used with acetonitrile and 0.1% trifluoroacetic acid in water as 
solvents. Samples were eluted with three linear gradients from 10% to 60% 
acetonitrile during 5.70 min, followed by another from 60% to 100% Acetonitrile 
during 0.5 min and a third gradient from 100% to 10% acetonitrile during 1.90 
min, at flow rate of 2 mL x min-1. Detection and spectral characterization of 
peaks (UV absorption maximum at 210 nm) were performed with a diode array 
detector and ChemStation Rev.B.03.01 software (Agilent). The ee was 
determined by using an OJ-H column with 0.8 mL x min-1 flow rate and using 
90:60 Hex: i-PrOH at 40 ºC. The retention times were 13.8 minutes (S-product) 
and 18.8 minutes (R-product) at 215 nm. 
 
3. RESULTS AND DISCUSSION 
3.1. Immobilization of KRED on different porous carriers 
Even though the commercial supplier of KRED cannot disclose any sequence and 
structural information of these enzymes, KRED P1-A04 was immobilized on porous 
microbeads using 7 immobilization protocols that involved 6 different immobilization 
chemistries and two type of materials; crosslinked porous agarose and polyacrylic 
porous microbeads with different pore size and particle size (see Chapter 1, Table 1 for 
more information). Commercial agarose and methacrylate microbeads were activated 
Chapter 5 
- 127 - 
 
with one or two different reactive groups according to literature procedures.32-35 An 
empirical approach was followed until finding the best surface and the best 
immobilization chemistry to maximize the enzyme loading (mg x gcarrier-1) and the 
volumetric activity (U x gcarrier-1) for the asymmetric reduction of TFAF as model 
substrate and using IPA as sacrificing substrate for the in situ NADPH recycling (Table 
1). 
 
Table 1. Immobilization parameters of KRED P1-A04 on different carriers.  
In all cases 0.25 mg of KRED were offered per gram of carrier. Conversion was determined by 
incubating 100 mg of immobilized enzyme with 20 mM TFAF, 1 mM NADPH, 1 mM MgCl2 in 10 
mM KH2PO4 at pH 7 and 25 ºC during 14 hours (rotational shaking 50 rpm). Equal amount of 
soluble enzyme was incubated under the same reaction conditions achieving 87% of 
conversion.  
 
The immobilization of KRED P1-A04 on Pu-G (methacrylate microbeads activated with 
aldehyde groups) under alkaline conditions yielded 100%, but the immobilized enzyme 
lost all its initial activity. The alkaline pH may cause the enzyme inactivation as occurs 
with other enzymes immobilized on agarose microbeads through the same chemistry 
and under similar conditions.36 However, when KRED P1-A04 was immobilized on the 
same carrier at pH 8 in presence of thiols to favour the covalent immobilization through 
the aldehyde chemistry at neutral pH,37 the immobilization yield was >90% but 
immobilized enzyme also became inactive. Therefore, the enzyme inactivation must be 
due to other reasons rather than the pH. The aldehyde chemistry requires a mild 
Name Reactive group Immobilizationchemistry
Protein
load
(mg x g-1)
Immobilization
yield 
(%)
Conversion
(%)
Pu-G
Aldehyde
Covalent irreversible 
bonds at pH 10 followed 
by a reduction step 
0.24 95 0
Aldehyde in presence 
of thiols
Covalent irreversible 
bonds at pH 8 followed by 
reduction step
0.23 92 0
AG-DVS Divinyl-Sulphone Covalent irreversible bonds at pH 8 0.13 53 0
AG-DEAE Diethyl-aminoethyl
Reversible Ionic 
bonds
0.25 100 98
AG-PEI600 Poly-ethylenimine 0.15 62 9
Pu-A/E Primary amines and epoxy
Ionic and irreversible 
covalent bonds at pH 8 0.23 93 1.5
AG-DEAE/G Diethyl-aminoethyl and aldehydes
Ionic and irreversible 
covalent bonds at pH 10 
followed by reduction step
0.25 100 46
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reduction step upon immobilization to turn the reversible imine enzyme-carrier bonds 
into irreversible secondary amines. Such reduction step might cause the enzyme 
inactivation upon the immobilization as observed with other enzymes.15, 38 Furthermore, 
the enzyme could be dramatically inactivated upon their immobilization on polyacrilyc 
microbeads because of the hydrophobic nature of the carrier. In order to overcome 
these two issues, a more hydrophilic and biocompatible material such agarose 
microbeads with vinyl groups (AG-DVS) was activated in order to enable the enzyme 
immobilization under pH 8 avoiding the reduction step.32 Unfortunately, by using AG-
DVS, the immobilization yield was lower than 40% and reaction product was not 
observed (Table 1). These data indicate that the enzyme does not tolerate the covalent 
immobilization because it may lose some structural flexibility required for the catalysis, 
which may explain the dramatic activity reduction upon the immobilization.  
In the light of these unsatisfactory results, KRED P1-A04 was alternatively immobilized 
through a reversible chemistry based on ionic interactions between acid residues on 
the protein surface (Asp and Glu) and cationic groups on the carrier surface. To this 
end, two types of agarose-based cationic carriers were tested. Firstly, agarose 
microbeads activated with PEI600 containing a polymeric bed of primary, secondary 
and tertiary amine groups positively charged (AG-PEI600) were used, based in the 
previous architectures exposed in Chapter 4. Secondly, a commercial carrier based on 
a monolayer of tertiary amine groups (AG-DEAE) was tested. The positive surface 
allowed a rapid immobilization of KRED P1-A04 with high yields although the type of 
surface was decisive to recover high enzyme activity upon the immobilization process.  
While the KRED P1-A04 immobilized on AG-PEI600 only transformed 9% of substrate 
after 14 hours, the same enzyme immobilized on AG-DEAE achieved 98% conversion 
under the same conditions (Table 1). Noteworthy, the same amount of soluble enzyme 
under the same conditions reached 82% conversion. It has been widely demonstrated 
that AG-PEI600 binds proteins stronger and more three-dimensionally than AG-DEAE 
though the immobilization on both carriers is driven by reversible ionic interactions.34 
Such stronger and 3D binding promoted by the PEI bed may either limit the protein 
conformational flexibility required for the enzymatic catalysis or cause negative 
structural distortions that reduce enzyme activity. However, the monolayer of tertiary 
amine groups displayed in the AG-DEAE surface seems to establish protein-carrier 
interactions strong enough to anchor the protein to the solid phase, but weak enough to 
provide KRED P1-A04 with some conformational flexibility for its optimal performance, 
without inducing negative structural rearrangements. Similar insights were found for 
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other oxidoreductases whose catalytic mechanism demands high structural flexibility 
such as the nitrate reductase that was significantly more active when immobilized on 
AG-DEAE than on AG-PEI600.39 To support that KRED P1-A04 did not undergo any 
structural distortion upon its immobilization on AG-DEAE, we measured the intrinsic 
fluorescence spectrum of this protein in both soluble and immobilized forms (Figure 
1A). The fluorescence studies clearly show that protein conformations of both soluble 
and immobilized enzymes are practically identical with similar maximum emission 
wavelengths (λmax) and spectrum widths.  
One of the main concerns about the immobilization of KRED P1-A04 on AG-DEAE was 
the enzyme lixiviation during the operational process due to reversible protein-carrier 
interactions, threatening the process purity and the operational stability of the 
heterogeneous biocatalysts. As solution, we incorporated other reactive groups such 
as aldehydes and epoxy groups besides the amine monolayer to establish irreversible 
protein-carrier attachments. 
 
Figure 1. Fluorescence assays of KRED. A) Relative intrinsic protein fluorescence of soluble 
(blue line) and immobilized KRED (red line) before (solid) and after (dashed line) being 
incubated at 40 ºC during 290 minutes. B) Thermal shift assay of soluble (blue line) and 
immobilized (red line) KRED. C) Analysis of Figure 1A and Figure 1B. [a] Intrinsic fluorescence 
of soluble and immobilized KRED. [b] Intrinsic fluorescence of soluble and immobilized KRED 
after being incubated for 290 min at 40ºC [c] Thermal-shift assay based on SYPRO 
fluorescence. The parameters were calculated from three independent measurements being the 
mean values represented in Figure 1B.  
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The fabrication of tailor-made heterofunctional carriers have been widely used to 
optimally and irreversibly orient the enzymes on the solid surface through a two-step 
mechanism.35 Unfortunately, although this heterofunctional chemistry gave rise active 
immobilized preparations, conversions were lower than 50% for the asymmetric 
reduction of TFAF (Table 1). As described above, KRED P1-A04 seems to be very 
sensitive to the formation of a multivalent and irreversible attachment with the solid 
surface, which drives to the enzyme inactivation. Actually, inactivation of KRED P1-A04 
by irreversibly immobilization has been also observed when a similar enzyme was 
attached to Sepabead EC resins activated with epoxy groups.15 Hence, only those 
immobilization chemistries where the interactions protein-carrier is weak and reversible 
enough seem to retain an active conformation of the enzyme. SDS-PAGE analysis 
demonstrates that the 29 kDa major band of the commercial preparation is 
quantitatively absorbed to the carrier surface and partially eluted after incubation under 
denaturing conditions, demonstrating a reversible but stable protein immobilization on 
AG-DEAE (Figure 2). In the light of these results, homofunctional AG-DEAE was 
chosen as best functionalized carrier to continue working with since it results in a highly 
active heterogeneous biocatalyst.  
 
Figure 2. The SDS-PAGE analysis of KRED P1-A04 immobilization on AG-DEAE. Line 1 is 
the initial commercial extract of KRED P1-A04 before immobilization. Line 2 corresponds to the 
supernatant of KRED P1-A04 immobilized on AG-DEAE incubated with Laemmli buffer under 
denaturing conditions. The molecular weight marker is from BioRad (Precision Plus Protein All 
Blue Standard). 
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3.2. Apparent Kinetic parameters of soluble and immobilized KREDP1-A04 
The apparent kinetic parameters of KRED P1-A04 immobilized on AG-DEAE were 
evaluated towards different NADPH concentrations and compared with the real 
parameters obtained for the soluble enzyme. Table 2 shows that KMapp of the 
immobilized enzyme is approximately 4-fold higher towards NADPH than its soluble 
counterpart under saturating conditions of TFAF. 
Table 2. Michaelis-Menten kinetic parameters of soluble and immobilized KRED towards 
NADPH.  
 
The kinetic parameters were measured with 10 mM TFAF at pH 7 and 25ºC varying the NADPH 
concentration. [1] Apparent kinetic parameters.  
 
The Michaelis-Menten plots indicate that immobilized KRED P1-A04 requires a much 
higher concentration of NADPH than the soluble one to become saturated and 
consequently reach the maximum velocity (Figure 3). 
 
Figure 3. Michaelis-Menten plots. The reactions were carried out with 10 mM TFAF at pH 7 
and 25 ºC varying the NADPH concentration. Ae means the specific activity of the enzyme. A) 
Soluble KRED P1-A04. B) Immobilized KRED P1-A04 on AG-DEAE.  
 
On the contrary, the immobilized KRED P1-A04 on AG-DEAE presented an apparent 
Vmax 1.8 times higher than the soluble one. Nevertheless, such higher catalytic activity 
Parameters Soluble Immobilized
Vmax (U x mg-1) 0.46  0.01 0.69  0.18 [1]
KM (mM) 0.47  0.06 1.81  0.69 [1]
kcat (s-1) 0.40  0.01 0.52  0.06 [1]
kcat/KM (M-1 x s-1) 0.86  0.10 0.37  0.08 [1]
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under cofactor saturating conditions cannot be explained by major structural distortions 
according to the fluorescence studies in absence of cofactor (Figure 1A). Therefore, 
the 2.3-fold lower apparent catalytic efficiency of the immobilized enzyme relies on the 
high KMapp value; this fact suggests a lower effective NADPH concentration surrounding 
the immobilized enzymes than surrounding the enzymes in solution. The confinement 
of enzymes within the porous environment of AG-DEAE may impose mass transfer 
limitations to the enzymatic reaction that notably hamper the diffusion of the soluble 
cofactor across the pores of the carrier to access the enzyme active sites. These 
issues can explain the high KMapp towards NADPH when the KRED P1-A04 is 
immobilized on porous microbeads even when the enzyme does not suffer dramatic 
structural distortions upon the immobilization. High KMapp values towards redox 
cofactors are a common pattern when using immobilized oxidoreductases on porous 
carriers.27, 39, 40 
 
3.3. Stability of KRED P1-A04 immobilized on AG-DEAE 
Soluble and immobilized KRED P1-A04 were incubated at high temperature and in 
presence of IPA (Figure 4).The inactivation constant (ki) of soluble KRED P1-A04 at 40 
ºC was 10  2 h-1, while the immobilized enzyme presented a ki = 0.8 0.1 h-1 under the 
same conditions. Based on such inactivation kinetics, the half-life times of soluble and 
immobilized KRED P1-A04 are 0.06 and 0.88 hours, respectively, which means that 
the enzyme immobilized on AG-DEAE is thermally stabilized by a factor of 15 (Figure 
4A).  
 
Figure 4. Stability studies of KRED P1-A04 against temperature and solvent. A) Thermal 
stability at 40 ºC. B) Stability against 1.55% of IPA.  
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The immobilized KRED P1-A04 was also more stable in presence of organic solvent 
such as IPA. In this case, the stability of the enzyme in presence of IPA is highly 
important because this enzyme uses IPA as sacrificing substrate to self-replenish the 
NADPH pool during the asymmetric reduction reactions.14, 15, 41 Figure 4B shows that 
immobilized enzyme preserves 50% of its initial activity after 18 hours of incubation 
with 1.5% IPA, but the soluble enzyme loses 90% activity under the same conditions. 
Therefore, the ionic interactions of KRED P1-A04 with the cationic surface of AG-DEAE 
seem to increase the intrinsic stability of the protein against different denaturing agents. 
Surprisingly, the kinetic thermal inactivation does not match with the thermodynamic 
denaturalization since both soluble and immobilized enzymes presented similar melting 
temperatures (Tm) using a thermal-shift assay (Figure 1B). Unlike other proteins,40, 42 
the thermal inactivation of soluble KRED P1-A04 does not alter its intrinsic 
fluorescence spectrum. In contrast, the temperature shifted the fluorescence spectrum 
of the immobilized protein towards red wavelengths (Figure 1A). These temperature-
induced conformational changes have been previously observed with other enzymes 
immobilized on AG-DEAE that were similarly stabilized by this immobilization 
chemistry.39 Hence, the structural distortions observed when the immobilized KRED 
P1-A04 is exposed to moderate temperatures might induce more stable protein 
conformations. 
 
3.4. Co-immobilization of NADPH and KRED P1-A04 on AG-DEAE: Single-
particle studies of the resulting self-sufficient heterogeneous biocatalyst 
The excellent stability and activity of KREDP1-A04 immobilized on AG-DEAE made 
this immobilization protocol suitable to fabricate self-sufficient heterogeneous 
biocatalysts. Considering the cationic nature of this carrier, a similar architecture as 
those ones recently reported in the previous Chapter 430 was here developed to co-
immobilize the cofactor. In these architectures the enzyme must be strongly or 
irreversibly bound to the carrier, while the cofactor needs to be ionically adsorbed 
establishing an association-dissociation equilibrium that allows the cofactor shuttling 
from the solid surface to the enzyme active sites without leaving the porous 
microstructure of the microbead. To this aim, 6.5 mg of KRED P1-A04 and 10 μmol of 
NADPH per gram of carrier were quantitatively immobilized. Figure 5A shows that the 
cofactor remained bound to the solid surface after washing the resin with 10 volumes of 
buffer.  
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Figure 5. Reversible co-immobilization of KRED P1-A04 and NADPH onto AG-DEAE. A) 
Immobilization of NADPH on AG-DEAE. The immobilization was monitored by measuring the 
NADPH absorbance at 340 nm. After immobilization, the supernatant (flow-through) was 
collected and the resin immobilizing the cofactor was washed with 10 volumes of 10 mM Tris-
HCl at pH 7. No cofactor was detected in the flow-through or in the washing supernatant. 
NADPH immobilized on AG-DEAE shows a maximum absorbance at 340 nm as well as the 
soluble one. B) Elution of co-immobilized KREDP1-A04 and NADPH from AG-DEAE. NADPH 
absorbance at 340 nm (top) and enzymatic activity of biocatalyst (bar graph) after 1 hour in 
presence of different ionic strengths. 
 
Both the enzyme and the cofactor were ionically immobilized on AG-DEAE, as 
demonstrated by releasing them in presence of high ionic strength (Figure 5B). Hence, 
the reversible immobilization enables the reuse of the carrier once the enzyme become 
inactive. 
To demonstrate that both enzyme and cofactor co-localize inside the same particle, the 
spatial distribution of the autofluorescence NADPH and the fluorophore-labeled 
KREDP1-A04 across the porous microbeads was analyzed by using CLSM. The 
microscopic images demonstrate that both enzyme and cofactor were uniformly 
distributed within microbeads. Nonetheless, the protein density was higher within the 
small microbeads than withinin the large ones (Figure 6). 
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Figure 6. Single-particle analysis of the spatial localization and distribution of co-
immobilized KRED P1-A04 and NAPH. A) Confocal microscopy images of immobilized 
cofactor (blue) and FITC-labeled enzyme (green) on AG-DEA. B) Effect of the microbead size 
on the protein density of the immobilized KRED P1-A04. The average diameter was calculated 
from the microscopy images of large (n=8) and small (n=9) microbeads. 
 
Then, the catalytic utilization of the cofactor within the porous microstructure of the 
agarose microbeads was proven by in operando fluorescence studies where different 
substrates were incubated with the self-sufficient heterogeneous biocatalyst under the 
microscope (Figure 7). Primarily, lixiviation of NADPH to the reaction medium resulted 
negligible since fluorescence within the particles was constant during the operation 
time in a control experiment without adding the substrates (Figure 7A). When TFAF 
was added to the reaction media, the autofluorescence of NADPH decayed along the 
time, indicating that immobilized KRED P1-A04 utilizes the immobilized NADPH to 
produce (S)-(+)-α-(Trifluoromethyl)benzyl alcohol (product detected in the bulk after the 
in operando experiment). By contrast, when both substrates TFAF and IPA were added 
to the reaction media, >90% of the cofactor fluorescence was detected within the 
particles during the reaction, indicating that the NADPH consumed by KRED P1-A04 
during the asymmetric reduction of TFAF is replenished by the same enzyme using IPA 
as electron donor and yielding acetone as by-product. Using the two substrates, the 
cofactor fluorescence slightly decreased along the time. This effect suggests that 
KRED P1-A04 is more efficient reducing ketones than oxidizing alcohols under these 
assay conditions. Besides, the hypothesis that such fluorescence decreasing may be 
attributed to the cofactor lixiviation was discarded since no fluorescence was detected 
in the bulk.  
These experiments demonstrate that the cofactor shuttles between the solid phase and 
the enzyme active sites, but it never diffuses out the porous microbeads. Remarkably, 
the aqueous media reaction was not a hindrance for the proper cofactor immobilization 
unlike former studies where high concentrations of solvents were needed to avoid the 
lixiviation of the ionically-immobilized cofactor.15, 27, 29 
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Figure 7. Single-particle kinetics of KRED P1-A04 and NADPH co-immobilized on AG-
DEAE. A) Reactions were triggered with different substrates. Control reaction was triggered 
without substrate. Data are the mean value of 5 microbeads (diameter = 92  13 m). B) 
Fluorescence microscopy images at the beginning and the end of the reaction. Left side, 
autofluorescence signal of NADPH; right side, overlay of the signals of NADPH and brightfield. 
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Additionally, image analytics reveal two main microbead populations with different 
diameters that present different catalytic performance (Figure 8). The smallest 
microbeads (diameter = 71  10 m) present a uniform distribution of the initial reaction 
rate across the sub-micrometrical area of a single microbead. Conversely, in the 
largest microbeads (diameter = 112  16 m), the enzymes immobilized on the inner 
surface showed 20-30% lower initial reaction rate than the enzymes located at inner 
positions within the same particle. Moreover, Figure 8 shows a clear trend between the 
enzyme activity and the microbead size; the smaller the microbead diameter, the 
higher the initial reaction rate. This trend can be attributed to the lower protein density 
found in larger particles (Figure 8), but also suggests that the immobilized KRED P1-
A04 on larger microbeads undergoes more severe external mass transport limitations 
of substrate TFAF. These diffusion restrictions are aligned with the engineering 
principles that rule the catalytic efficiency of any enzyme immobilized on porous 
carriers.43 For example, D-amino acid oxidase immobilized on large porous silica 
particles suffered significant mass transfer restrictions due to the limitations in the 
diffusion of one of the substrates; the oxygen.44 Actually, a similar mass restriction 
influence on enzyme kinetics has been pointed out when Tt-NOX was immobilized on 
agarose microbeads in the previous Chapter 4.  
Figure 8. Image analytics of in operando asymmetric reduction of TFAF without IPA 
catalyzed by KRED P1-A04 co-immobilized with NADPH on AG-DEAE. Maps of initial 
reaction rates of microbeads with different diameters (up) and the reaction courses at inner and 
outer pixels (down). White lines corresponds to 20 µm. 
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3.5. Re-utilization of the self-sufficient heterogeneous biocatalyst in batch  
Once we demonstrated that reduction and oxidation reactions occurred simultaneously 
inside the same porous microbeads where NADPH and KRED were co-immobilized, 
this self-sufficient heterogeneous biocatalyst was used to perform the asymmetric 
reduction of TFAF without exogenous addition of the redox cofactor. Firstly, the 
asymmetric reduction was performed with KRED immobilized on Ag-DEAE but using 
soluble cofactor. To achieve the maximum yields, we optimized the load of the 
heterogeneous catalyst at 2% of biocatalyst. Using the immobilized enzymes and the 
soluble cofactor, the reaction yield was 100%, obtaining ee >99%. Moreover, the 
immobilized enzyme was reused up to 5 operational cycles without losing 
effectiveness. When the reactions were catalyzed by the enzyme and the cofactor co-
immobilized on the same microbead and without exogenous addition of NADPH, the 
conversion reached a quantitative yield of 100% (Table 3). Expectedly, the selectivity of 
the process was maintained (ee >99%) regardless of using soluble or immobilized 
NADPH. Finally, this self-sufficient heterogeneous biocatalyst was reused for up to 5 
cycles without adding exogenous NADPH and obtaining the maximum yield in each 
cycle. 
Table 3. Recycling of KRED P1-A04 and NADPH co-immobilized on AG-DEAE for the 
reduction of TFAF.  
 
The reutilization of the self-sufficient heterogeneous biocatalyst significantly increased 
the total turnover number (TTN) of both enzyme and cofactor (Table 4). The TTN 
values reached are closed to industrial demands. Another important parameter that can 
be withdrawn from the batch experiments is the turnover frequency (TOF) of NADPH 
per cycle that gives an idea about how fast the utilization of the cofactor inside the 
porous environment occurs (Table 4).  
 
Cycle
Time
(h)
Conversion
(%)
ee
(S)-1-(1-naphtyl)ethanol
(%)
1 24 >99 >99 
2 24 >99 >99 
3 24 >99 >99
4 24 >99 >99
5 24 >99 >99
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Table 4. Total turnover of KRED and NADPH co-immobilized on Ag-DEAE during the 
asymmetric reduction of TFAF.  
 
[a] TTNNADPH = mol of product accumulated during 5 cycles/mol of immobilized NADPH.  
[b] TTNKRED = mol of product accumulated during 5 cycles/mol of immobilized KRED.  
[c] TTNNADPH/reaction time (hours) in every cycle.  
 
The efficient re-utilization of immobilized NADPH and product yields may rely on the 
excellent activity of KRED P1-A04 to self-regenerate NADPH under extremely low 
cofactor concentrations using excess of IPA as hydride donor.45 Using a similar 
approach, Merk et al. co-immobilized NADPH and a different KRED from the same 
commercial source on commercial methacrylate porous microbeads, obtaining good 
reusability using high IPA concentration (90%).15 Unfortunately, the immobilization of 
the KRED P1-A04 in such resin inactivated the 95% of the immobilized protein unlike 
the immobilization on AG-DEAE where KRED P1-A04 showed 43% catalytic efficiency 
(Table 2) and 100% product yield (Table 1) compared to the soluble enzyme. 
Additionally, using methacrylate resin, the enzyme was covalently and irreversibly 
attached to the microbeads and the cofactor was ionically absorbed to the amine 
groups. Therefore, once the enzyme becomes inactive the carrier cannot be reused. 
Contrarily, in the system presented in this work, the enzyme can be removed from the 
matrix under drastic conditions after the enzyme inactivation. The vast majority of 
systems where the cofactors are ionically absorbed to the solid materials efficiently 
work under high solvent concentration15, 27, 29 (conditions where cofactor-carrier 
interactions are favoured) but fail in buffered reaction media because of the cofactor 
lixiviation. Remarkably, the cofactor absorbed on Ag-DEAE remains adsorbed in a 
stable manner to the matrix, even with IPA concentrations as low as 17%. 
 
3.6. Continuous synthesis of a model chiral alcohol using a mini-column 
packed with the self-sufficient heterogeneous biocatalyst.  
The excellent operational stability in batch of the self-sufficient heterogeneous 
biocatalysts was the motivation to carry out the continuous asymmetric reduction of 
TFAF in packed-bed flow minireactors. To this aim, 280 mg of self-sufficient 
heterogeneous biocatalyst were packed into a plug-flow minicolumn and fed the reactor 
with the corresponding reaction mixture without exogenous NADPH. Figure 9A shows 
TTNNADPH[a] TTNKRED[b] TOFNADPH/cycle (h-1) [c]
333 19980 2.8
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the effect of the flow rate in the conversion, expectedly the faster the flow, the lower the 
product yield because the residence times are shorter and consequently the enzyme-
substrate contact was briefer. 80% of conversion was achieved using 50 μL x min-1 
flow giving rise to space-time yield (STY) of 104 g x L-1 x day-1.  
 
Figure 9. Operational characterization in flow. A) Effect of flow rate on the conversion (grey 
bars, left Y axis) and space time yield (black line with squares, right Y axis) of continuous 
asymmetric reduction of TFAF catalyzed by KRED P1-A04 and NADPH co-immobilized on AG-
DEAE. B) Effect of flow rate on the specific activity of the KRED P1-A04 co-immobilized with 
NADPH on AG-DEAE during the continuous asymmetric reduction of TFAF.  
 
Although the conversion dropped to 50%, both the STY and the apparent specific 
activity of the enzyme increased by a factor of 2.4 when the flow was four times faster 
(Figure 9).  
By using a flow rate of 50 μL x min-1, the reactor operated for 120 hours constantly 
yielding around 80% of product, observing neither enzyme inactivation nor cofactor 
lixiviation as supported by the constant specific activity of the enzyme during the whole 
operation time (Figure 10). Under these conditions, 1275 residence volumes were 
flushed through the self-sufficient heterogeneous biocatalyst giving rise to an 
accumulated TTNNADPH of 1076. In this experiment, 2912 mol of product were 
detected with 2.8 mol of immobilized NADPH, while producing the same amount of 
product requires 54.6 mol of exogenously added cofactor (0.15 mM NADPH in the 
reaction mixture). In addition, The STY range of 97-112 g x L-1 x day-1 remained 
unaltered for 120 hours of continuous operation (Figure 10B). This STY values falls in 
the range of the reported STY values for other continuous asymmetric reduction 
reactions catalyzed with either soluble or immobilized enzymes.21-23, 46 The continuous 
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asymmetric reduction reaction demonstrates that neither the enzyme nor the cofactor 
are inactivated or lixiviated during the process, this behaviour aligns with the previous 
in operando single-particle studies (Figure 7). 
 
Figure 10. Continuous flow asymmetric reduction of TFAF catalyzed by KRED P1-A04 
and NADPH co-immobilized on AG-DEAE. A) Conversion of TFAF into (S)-(+)-α-
(Trifluoromethyl)benzyl alcohol (full squares) and accumulated TTN of NADPH (open circles) 
were determined at different times. B) Evolution of STY (full squares) of the reaction and 
specific activity (open circles) of KRED P1-A04. The STY was defined as grams of desired 
product released per liter of reaction during one day. 
 
The accumulated TTN of NADPH under flow conditions was approximately 10-fold 
higher than the values found for NADH co-immobilized with two alcohol 
dehydrogenases onto AG-G/PEI25 (Chapter 4).30 Unlike the KRED systems, the two 
alcohol dehydrogenases are irreversibly bound to the solid surface and must work in 
coordination to recycle the immobilized cofactor. Consequently, the regeneration of 
cofactors attached to solid surface by using recycling enzymes seems to be less 
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efficient than when the same enzyme catalyzes the main reaction and self-recycles the 
cofactor. In fact, this strategy has been elected for the process development and scale-
up of many industrially relevant chiral alcohols.14-16, 41, 47, 48 Hence, this heterogeneous 
self-sufficient biocatalyst meets the industrial requirements since the accumulated 
TTNNADPH was higher than 1000. Remarkably, this system presents an even slightly 
better accumulated TTN for NADPH than those systems using ultrafiltration membrane 
reactors with soluble enzymes and polymeric cofactors.21, 22, 46 For example, a 
membrane reactor containing NADPH tethered to polyethyelenglycol and two soluble 
alcohol deydrogenases was able to be re-cycled up to 540 times in 5 days, 2 times less 
than this system operated in the same time-span.21 
 
3.7. Broadening the scope of KRED-based biocatalysts 
Since stereoselective reduction of ketones is one of the most useful reactions in 
organic synthesis, it is not surprising that ketoreductases have become crucial in 
synthesis of chiral alcohols.49 Therefore, a wide spectrum of biocatalysts with different 
operational stabilities and properties are desired. To this purpose, another promising 
ketoreductase variant (KRED P2-D11) was studied. Encouraged by the results 
obtained for KRED P1-A04, we followed the same protocol for immobilizing KRED P2-
D11 on AG-DEAE through ion-exchange. The immobilized enzyme show a high 
expressed activity compared to those reported for other KREDs.1, 15, 50 Remarkably, the 
immobilized enzyme was 9 times more thermostable than its soluble counterpart under 
the operational conditions tested (Table 5). 
Table 5. Immobilization and stability parameters of KRED P2-D11 on AG-DEAE.  
 
[a] Stability parameters were calculated by non-linear fitting of inactivation.  
[b] Stabilization factor = Half-life time immobilized enzyme / Half-life time soluble enzyme.  
Parameters Soluble Immobilized
Protein loading (mg x g-1) - 0.96
Immobilization yield (%) - 96
Specif ic activity (U x mg-1) 2.26 2.25
Final expressed activity (%) - 105 ± 10
Inactivation constant (h-1) [a] 0.33 0.07
Half -life time (h) [a] 4.47 40.2
Stabilization factor [b] - 9
Chapter 5 
- 143 - 
 
Moreover, the stability of the cofactor-dependent KRED P2-D11 against organic 
solvent was assessed. Since IPA is used as sacrificing molecule for cofactor recycling, 
the stability of KRED P2-D11 against IPA has a major significance for the development 
of an optimal biocatalyst. Fortunately, both soluble and immobilized KRED P2-D11 
showed a high stability in presence of 17% IPA (Figure 11). In fact, soluble KRED P2-
D11 only loses 38% of activity after 2 hours of incubation with 17% IPA while soluble 
KRED P1-A04 loses 85% during the same time (Figure 4B). These results demonstrate 
that KRED P2-D11 is significantly more robust than KRED P1-A04. Besides, the 
immobilized KRED P2-D11 retains more than 60% of initial activity after 18 hours 
(Figure 11) while KRED P1-A04 retains 50% of activity with 11 times lower 
concentration of IPA (Figure 4B). 
 
 
Figure 11. Stability of KRED P2-D11 against organic solvent (IPA). 
 
The high activity and stability of the immobilized KRED P2-D11 was the incentive to 
develop self-sufficient heterogeneous biocatalysts that co-immobilize the enzyme (6.5 
mg x gcarrier-1) with NADPH (10 µmolNADPH x gcarrier-1). Then, the resulting self-sufficient 
heterogeneous biocatalyst was tested for the reduction of AN containing 3% of 
biocatalyst (0.195 mgKRED P2-D11 x mL-1) and IPA as reductant agent. We found a 
conversion of >99% after 24 h preserving the enantioselectivity of the KRED P2-D11 
(>99% ee for S-1-(1-naphtyl)ethanol) without exogenous supply of NADPH. Moreover, 
this self-sufficient biocatalyst was reused up in 5 consecutive batch cycles without 
losing effectiveness (Table 6). The recyclability of the biocatalyst significantly increased 
the total turnover number (TTN) of both enzyme and cofactor. Hence, the co-
immobilized NADPH accumulated a TTN of 675 whereas the KRED P2-D11 did 5400. 
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Table 6. Recycling of KRED P2-D11 and NADPH co-immobilized on AG-DEAE for the 
reduction of AN. 
 
Going one step further, the continuous asymmetric reduction of AN was performed in a 
packed-bed flow minireactor using the self-sufficient heterogeneous biocatalysts based 
on KRED P2-D11. Unpleasantly, the system failed observing conversions < 5% at 50-
200 µL x min-1 flow rates.  
Unlike KRED P1-A04 immobilized on AG-DEAE, KRED P2-D11 immobilized on the 
same matrix was incapable to efficiently recycle the immobilized redox cofactor which 
burdened the continuous production of S-1-(1-naphtyl)ethanol. This hypothesis was 
supported by measuring the fluorescence of NADPH before and after the flow-reaction 
was accomplished. Immobilized NADPH was reduced to NADP+ during the operation of 
the packed-bed reactor, but could not be regenerated in presence of IPA as sacrificing 
reductant. No NADPH fluorescence was detected on the microbeads after the flow-
reaction (Figure 12A). Furthermore, the addition of soluble KRED P1-A04 that is 
inactive towards AN but highly active towards IPA, was able to regenerate the NADPH 
pool within the agarose microbead (Figure 12B). This fact was demonstrated by 
measuring the activity of the biocatalysts after the flow-reaction was accomplished. 
Therefore, these insights suggest that under flow conditions the quantitative conversion 
of AN is limited by the low oxidation rate of KRED P2-D11 towards IPA required to 
recycle the intraparticle pool of NADPH.    
Cycle
Time
(h)
Conversion
(%)
ee
(S)-1-(1-naphtyl)ethanol
(%)
1 24 >99 >99 
2 24 >99 >99 
3 24 >99 >99
4 24 >99 >99
5 24 >99 >99
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Figure 12. Inefficiency of KRED P2-D11 reducing NADP+. A) Absorbance spectra before and 
after operating the packed-bed minireactor. NADPH immobilized on AG-DEAE shows a 
maximum absorbance at 340 nm before the flow-reaction. B) Activity measurement of the co-
immobilized KRED P2-D11 and NADPH on AG-DEAE and the same biocatalyst adding soluble 
KRED P1-A04 after the operating packed-bed reaction.  
 
4. CONCLUSIONS 
In this chapter, the approach of self-sufficient heterogeneous biocatalysts was tried for 
the asymmetric reduction of carbonyl compounds without the addition of exogenous 
cofactors. Two biocatalysts with different operational stabilities were engineered by 
optimally co-immobilizing NADPH and KRED on commercially available agarose 
microbeads activated with tertiary amine groups. The first immobilized biocatalyst 
based on a versatile R-selective and NADPH-dependent KRED P1-A04, catalyzes the 
main reaction (carbonyl reduction) and self-recycles the cofactor (oxidation of isopropyl 
alcohol). As a result, this heterogeneous biocatalyst was successfully operated in a 
plug-flow minireactor during more than 200 hours without addition of exogenous 
NADPH. The integration of NADPH into the solid phase for the continuous synthesis of 
chiral alcohol has decreased almost 20 times the contribution of NADPH to the process 
costs since the TTN values are 333 and near 20000 for the cofactor and the enzyme, 
respectively. The second heterogeneous biocatalyst containing KRED P2-D11 
presents a higher stability but fails recycling the cofactor during flow reaction. These 
results firmly confirm the cofactor as part of the biocatalyst avoiding the exogenous 
addition of costly cofactors to the reaction media and expanding the spectrum of 
enzymatic activities of self-sufficient heterogeneous biocatalysts. 
 
A B
Activity (slope) 
AG-DEAE-KRED (P2-D11) 0.001
AG-DEAE-KRED(P2-D11) + KRED(P1-A04) 0.016
300 350 400 450 500
0,0
0,2
0,4
0,6
0,8
1,0
1,2
.
.
.
.
.
.
.
 
 
Ab
so
rb
an
ce
Wavelength / nm
 Before flow-reaction
 After flow-reaction
Chapter 5 
 
- 146 - 
 
REFERENCES 
1. Benítez-Mateos, A. I., San Sebastian, E., Ríos-Lombardía, N., Morís, F., 
González-Sabín, J., López-Gallego, F. Asymmetric reduction of prochiral 
ketones by using self-sufficient heterogeneous biocatalysts based on NADPH-
dependent ketoreductases. Chemistry – A European Journal. 2017, 23: 16843-
16852.  
 
2. Marx, L. et al. Chemoenzymatic approaches to the synthesis of the calcimimetic 
agent cinacalcet employing transaminases and ketoreductases. Advanced 
Synthesis & Catalysis. 2018, 360: 2157-2165.  
 
3. Nakamura, K., Yamanaka, R., Matsuda, T., Harada, T. Recent developments in 
asymmetric reduction of ketones with biocatalysts. Tetrahedron: Asymmetry. 
2003, 14: 2659-2681.  
 
4. Kim, J. H., Scialli, A. R. Thalidomide: the tragedy of birth defects and the 
effective treatment of disease. Toxicological Sciences. 2011, 122: 1-6.  
 
5. Nestl, B. M., Hammer, S. C., Nebel, B. A., Hauer, B. New generation of 
biocatalysts for organic synthesis. Angewandte Chemie International Edition. 
2014, 53: 3070-3095.  
 
6. Sorgedrager, M. J., Van Rantwijk, F., Huisman, G. W., Sheldon, R. A. 
Asymmetric carbonyl reductions with microbial ketoreductases. Advanced 
Synthesis & Catalysis. 2008, 350: 2322-2328.  
 
7. Matsuda, T., Yamanaka, R., Nakamura, K. Recent progress in biocatalysis for 
asymmetric oxidation and reduction. Tetrahedron: Asymmetry. 2009, 20: 513-
557.  
 
8. Haq, S. F. et al. A strategy to identify a ketoreductase that preferentially 
synthesizes pharmaceutically relevant (S)-alcohols using whole-cell 
biotransformation. Microbial Cell Factories. 2018, 17: 1-14.  
 
9. Li, B. et al. Whole-cell biotransformation systems for reduction of prochiral 
carbonyl compounds to chiral alcohol in Escherichia coli. Scientific Reports. 
2014, 4: 1-5.  
 
10. Liu, H., Chen, B.-S., De Souza, F. Z. R., Liu, L. A comparative study on 
asymmetric reduction of ketones using the growing and resting cells of marine-
derived fungi. Marine drugs. 2018, 16: 1-15.  
 
11. Milner, S. E., Maguire, A. R. Recent trends in whole cell and isolated enzymes 
in enantioselective synthesis. Reviews and Accounts. 2012, i: 321-382.  
 
12. Wichmann, R., Vasic-Racki, D. Cofactor regeneration at the lab scale. 
Advances in biochemical engineering/biotechnology. 2005, 225-260.  
 
13. Liu, W., Wang, P. Cofactor regeneration for sustainable enzymatic biosynthesis. 
Biotechnology Advances. 2007, 25: 369-384.  
 
Chapter 5 
- 147 - 
 
14. Liang, J. et al. Development of a biocatalytic process as an alternative to the 
(−)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast. 
Organic Process Research & Development. 2010, 14: 193-198.  
 
15. Li, H., Moncecchi, J., Truppo, M. D. Development of an Immobilized 
Ketoreductase for Enzymatic (R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanol 
Production. Organic Process Research & Development. 2015, 19: 695-700.  
 
16. Zuhse, R., Leggewie, C., Hollmann, F., Kara, S. Scaling-up of “smart 
cosubstrate” 1,4-butanediol promoted asymmetric reduction of ethyl-4,4,4-
trifluoroacetoacetate in organic media. Organic Process Research & 
Development. 2015, 19: 369-372.  
 
17. Noey, E. L. et al. Origins of stereoselectivity in evolved ketoreductases. 
Proceedings of the National Academy of Sciences. 2015, 112: 7065-7072.  
 
18. Truppo, M. D. Cofactor recycling for enzyme catalyzed processes. In 
Comprehensive chirality. Elsevier Science. 2012.   
 
19. Knaus, T. et al. Better than nature: nicotinamide biomimetics that outperform 
natural coenzymes. Journal of the American Chemical Society. 2016, 138: 
1033-1039.  
 
20. Wang, X., Saba, T., Yiu, H. H. P., Howe, R. F., Anderson, J. A., Shi, J. Cofactor 
NAD(P)H regeneration inspired by heterogeneous pathways. Chem. 2017, 2: 
621-654.  
 
21. Wichmann, R., Wandrey, C., Bückmann, A. F., Kula, M. R. Continuous 
enzymatic transformation in an enzyme membrane reactor with simultaneous 
NAD(H) regeneration. Biotechnology and Bioengineering. 1981, 23: 2789-2802.  
 
22. Obón, J., Almagro, M. J., Manjón, A., Iborra, J. Continuous retention of native 
NADP(H) in an enzyme membrane reactor for gluconate and glutamate 
production. Journal of Biotechnology. 1996, 50: 27-36.  
 
23. Seelbach, K., Kragl, U. Nanofiltration membranes for cofactor retention in 
continuous enzymatic synthesis. Enzyme and Microbial Technology. 1997, 20: 
389-392.  
 
24. El-Zahab, B., Donnelly, D., Wang, P. Particle-tethered NADH for production of 
methanol from CO2 catalyzed by coimmobilized enzymes. Biotechnology and 
Bioengineering. 2008, 99: 508-514.  
 
25. Fu, J. et al. Multi-enzyme complexes on DNA scaffolds capable of substrate 
channelling with an artificial swinging arm. Nature Nanotechnology. 2014, 9: 
531-536.  
 
26. Garcia-Galan, C., Berenguer-Murcia, Á., Fernandez-Lafuente, R., Rodrigues, R. 
C. Potential of different enzyme immobilization strategies to improve enzyme 
performance. Advanced Synthesis & Catalysis. 2011, 353: 2885-2904.  
 
27. Heidlindemann, M., Rulli, G., Berkessel, A., Hummel, W., Gröger, H. 
Combination of asymmetric organo- and biocatalytic reactions in organic media 
Chapter 5 
 
- 148 - 
 
using immobilized catalysts in different compartments. ACS Catalysis. 2014, 4: 
1099-1103.  
 
28. Ji, X., Su, Z., Wang, P., Ma, G., Zhang, S. Tethering of nicotinamide adenine 
dinucleotide inside hollow nanofibers for high-yield synthesis of methanol from 
carbon dioxide catalyzed by coencapsulated multienzymes. ACS Nano. 2015, 
9: 4600-4610.  
 
29. Rulli, G., Heidlindemann, M., Berkessel, A., Hummel, W., Gröger, H. Towards 
catalyst compartimentation in combined chemo- and biocatalytic processes: 
Immobilization of alcohol dehydrogenases for the diastereoselective reduction 
of a β-hydroxy ketone obtained from an organocatalytic aldol reaction. Journal 
of Biotechnology. 2013, 168: 271-276.  
 
30. Velasco-Lozano, S., Benítez-Mateos, A. I., López-Gallego, F. Co-immobilized 
phosphorylated cofactors and enzymes as self-sufficient heterogeneous 
biocatalysts for chemical processes. Angewandte Chemie International Edition. 
2017, 56: 771-775.  
 
31. Dicosimo, R., Mcauliffe, J., Poulose, A. J., Bohlmann, G. Industrial use of 
immobilized enzymes. Chemical Society Reviews. 2013, 42: 6437-6474.  
 
32. Dos Santos, J. C. S. et al. Characterization of supports activated with divinyl 
sulfone as a tool to immobilize and stabilize enzymes via multipoint covalent 
attachment. Application to chymotrypsin. RSC Advances. 2015, 5: 20639-
20649.  
 
33. Mateo, C. et al. Improvement of enzyme properties with a two-step 
immobilizaton process on novel heterofunctional supports. Biomacromolecules. 
2010, 11: 3112-3117.  
 
34. Mateo, C., Abian, O., Fernandez-Lafuente, R., Guisan, J. M. Reversible 
enzyme immobilization via a very strong and nondistorting ionic adsorption on 
support–polyethylenimine composites. Biotechnology and Bioengineering. 
2000, 68: 98-105.  
 
35. Bolivar, J. M., Mateo, C., Grazu, V., Carrascosa, A. V., Pessela, B. C., Guisan, 
J. M. Heterofunctional supports for the one-step purification, immobilization and 
stabilization of large multimeric enzymes: Amino-glyoxyl versus amino-epoxy 
supports. Process Biochemistry. 2010, 45: 1692-1698.  
 
36. Rivero, C. W., Palomo, J. M. Covalent immobilization of candida rugosa lipase 
at alkaline pH and their application in the regioselective deprotection of per-O-
acetylated thymidine. Catalysts. 2016, 6: 115.  
 
37. Bolivar, J. M. et al. The presence of thiolated compounds allows the 
immobilization of enzymes on glyoxyl agarose at mild pH values: New 
strategies of stabilization by multipoint covalent attachment. Enzyme and 
Microbial Technology. 2009, 45: 477-483.  
 
38. López-Gallego, F. et al. Preparation of a robust biocatalyst of d-amino acid 
oxidase on sepabeads supports using the glutaraldehyde crosslinking method. 
Enzyme and Microbial Technology. 2005, 37: 750-756.  
 
Chapter 5 
- 149 - 
 
39. Da Silva, E. S., Gómez-Vallejo, V., Llop, J., López-Gallego, F. Efficient 
nitrogen-13 radiochemistry catalyzed by a highly stable immobilized biocatalyst. 
Catalysis Science & Technology. 2015, 5: 2705-2713.  
 
40. Da Silva, E. S., Gómez-Vallejo, V., Llop, J., López-Gallego, F. Structural, kinetic 
and operational characterization of an immobilized l-aminoacid dehydrogenase. 
Process Biochemistry. 2017, 57: 80-86.  
 
41. Ju, X., Tang, Y., Liang, X., Hou, M., Wan, Z., Tao, J. Development of a 
biocatalytic process to prepare (S)-N-boc-3-hydroxypiperidine. Organic Process 
Research & Development. 2014, 18: 827-830.  
 
42. Gouda, M. D., Singh, S. A., Rao, A. G. A., Thakur, M. S., Karanth, N. G. 
Thermal inactivation of glucose oxidase: mechanism and stabilization using 
additives. Journal of Biological Chemistry. 2003, 278: 24324-24333.  
 
43. Liese, A., Hilterhaus, L. Evaluation of immobilized enzymes for industrial 
applications. Chemical Society Reviews. 2013, 42: 6236-6249.  
 
44. Bolivar, J. M., Schelch, S., Mayr, T., Nidetzky, B. Mesoporous silica materials 
labeled for optical oxygen sensing and their application to development of a 
silica-supported oxidoreductase biocatalyst. ACS Catalysis. 2015, 5: 5984-
5993.  
 
45. Ríos-Lombardía, N., Vidal, C., Liardo, E., Morís, F., García-Álvarez, J., 
González-Sabín, J. From a sequential to a concurrent reaction in aqueous 
medium: ruthenium-catalyzed allylic alcohol isomerization and asymmetric 
bioreduction. Angewandte Chemie International Edition. 2016, 55: 8691-8695.  
 
46. Hummel, W., Schütte, H., Kula, M.-R. d-(-)-Mandelic acid dehydrogenase from 
Lactobacillus curvatus. Applied microbiology and biotechnology. 1988, 28: 433-
439.  
 
47. Villela Filho, M., Stillger, T., Müller, M., Liese, A., Wandrey, C. Is log P a 
convenient criterion to guide the choice of solvents for biphasic enzymatic 
reactions? Angewandte Chemie International Edition. 2003, 115: 3101-3104.  
 
48. Wolberg, M. et al. Chemoenzymatic synthesis of the chiral side-chain of statins: 
application of an alcohol dehydrogenase catalysed ketone reduction on a large 
scale. Bioprocess and Biosystems Engineering. 2008, 31: 183-191.  
 
49. Kaluzna, I. A., David Rozzell, J., Kambourakis, S. Ketoreductases: 
stereoselective catalysts for the facile synthesis of chiral alcohols. Tetrahedron: 
Asymmetry. 2005, 16: 3682-3689.  
 
50. Petkova, G. A., Záruba, K., Král, V. Synthesis of silica particles and their 
application as supports for alcohol dehydrogenases and cofactor 
immobilizations: conformational changes that lead to switch in enzyme 
stereoselectivity. Biochimica et biophysica acta. 2012, 1824: 792-801.  
 
 
 

 - 151 - 
 
 
Chapter 6 
 
Self-sufficient heterogeneous biocatalysts based on -
transaminases and PLP for flow-biocatalysis 
 
 
The design of artificial metabolic cells was here applied for flow transaminations. Since 
transaminases are an attractive alternative for chemical synthesis, a -transaminase 
from Halomonas elongata was co-immobilized with PLP onto porous methacrylate-
based carriers coated with polyethyleneimine. The packed-bed reactor was operated 
continuously for up to 10 column volumes at 1.45 mL x min-1 in the enantioselective 
deamination of model amines yielding >90% conversion in all cycles without 
exogenous addition of cofactor. The architecture of self-sufficient heterogeneous 
biocatalysts was expanded to other -transaminases such as the ones from 
Chromobacterium violaceum and Pseudomonas fluorescens. We found that enzymes 
with lower affinities towards PLP present lower operational stabilities in flow, even 
when co-immobilizing PLP. Finally, these self-sufficient heterogeneous biocatalysts 
were successfully implemented for the synthesis of chiral amines exploiting the concept 
of artificial metabolic cells under industrial-like continuous transaminations. 
Amino donor Amino acceptor
Collection and analysis
TA PLP
Artificial metabolic cells
 
This chapter was previously published in ACS Sustainable Chemistry and Engineering.1 
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1. INTRODUCTION  
In the last few decades, the application of enzymes on traditional chemical processes 
has already proven as an essential solution for sustainable chemistry.2-4 However, 
there are still several drawbacks in terms of process intensification when scaling-up the 
biocatalytic reactions. In this scenario, continuous-flow biocatalysis has emerged as a 
powerful instrument to shorten reaction times, increase conversion yields and remove 
undesired by-products, making the process economically more attractive too.5, 6 Due to 
its easy-to-use and low-cost properties, the use of whole cell biocatalysis was foremost 
implemented in flow chemistry.7, 8 Later, purified enzymes were found to offer more 
advantages avoiding the generation of toxic by-products and the mass transfer 
limitations posed by cell membranes.9 But either expensive cofactors or exogenous 
partners must be exogenously added to the reaction. The artificial metabolic cells 
concept pursues meeting an intermediate state harnessing benefits provided by the co-
immobilization of purified multi-enzyme systems and their cofactors on the same 
carrier.10 
Aminations and de-aminations are important reactions in industrial processes. More 
specifically, the synthesis of optically pure amines is gaining momentum in the 
manufacturing of a plethora of commodities, agrochemicals and pharmaceuticals.11 In 
the last decade, biocatalysis has offered efficient and environmentally sustainable 
solutions to incorporate amine groups into organic molecules under mild conditions 
with exquisite region and stereoselectivies.12-14 Amidases,15 transaminases,16, 17 
ammonia lyases,18 amino acid dehydrogenases19 and the recently engineered amine 
dehydrogenases20 are among the most relevant enzymes exploited for the synthesis of 
chiral amines. PLP-dependent -transaminases (EC 2.6.1.X.) efficiently transfers 
amino groups from sacrificing amines or amino acids to the starting ketones or 
aldehydes with quantitative yields.21, 22 There are dozens of examples where different 
TAs have been engineered to aminate industrially relevant molecules.21, 23 Although 
the PLP is bound to TAs through a reversible imine bond, scaled-up 
biotransformations using high substrate concentrations require exogenous PLP to 
achieve high amine yields (50-100 mM).24, 25 Like other cofactor-dependent enzymes, 
the exogenous addition of PLP complicates the work-up because it must be primarily 
added to the reaction and then separated from the final products increasing the 
process costs. Fortunately, catalytic amounts of PLP (0.1-2 mM) are enough to 
accomplish the amine transfer reaction because TAs recycle such cofactor during 
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their catalytic cycle. Nevertheless, the separation of both soluble cofactors and 
biocatalysts beside the low stability of TA pose important hurdles to scale-up 
processes.   
Immobilization of TAs is proven an efficient approach to increase the operational 
stability of these biocatalysts as well as to intensify the amination process with the aim 
of achieving both higher productivities and yields.26 Several TAs have been 
immobilized onto a great variety of carriers and using different immobilization 
strategies, but some of them dramatically failed to keep the enzyme active and stable. 
In some cases the performance of the immobilized TA was significantly worse than its 
soluble counterpart.26-29 This fact means that the immobilization protocol must be 
carefully selected to keep catalytic efficiency and gain enzyme stability.30 In the 
particular case of TAs, their immobilization is challenging because a random multi-
point covalent attachment through short irreversible bonds often distort their 3D 
structures, dramatically inactivating them. In spite of these difficulties, some 
immobilization protocols provided highly robust heterogeneous biocatalysts enabling 
process intensification of amine synthesis using packed-bed reactors (PBR).28, 29 Flow-
biocatalysis can lead the development of more sustainable chemical synthesis since it 
gains control over several key reactor and reaction parameters. For example, the 
oriented immobilization and further covalent attachment of TA from Halomonas 
elongata31 onto methacrylate porous beads has been integrated into a continuous 
process coupled with a scavenger for the in-line synthesis and purification of different 
optically pure amines.29 
Continuous operation of enzymatic transaminations contributes to process 
intensification so far. However, those systems still require the exogenous addition of 
PLP that can limit their economic feasibility for the synthesis of low-added value 
products.28, 29 Ideally, PLP and enzyme should be co-reused to increase their 
operational life-span and thus increasing the cost efficiency of the processes. Just one 
example has been reported where PLP has been incorporated into the solid phase of 
heterogeneous biocatalysts to continuously synthesize amines.32 Andrade et al. used 
whole cells harboring a TA physically adsorbed together with PLP onto methacrylate 
polymeric beads. The newly generated biocatalyst was able to synthesize optically 
pure α-alkoxy- and α-aryloxy isopropyl amines in flow with negligible lixiviation of PLP. 
However, this system was limited to organic reaction environment to avoid the cofactor 
lixiviation.  
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In this chapter, several TAs from Halomonas elongata (He-TA)31 Chromobacterium 
violaceum (Cv-TA)33 and Pseudomonas fluorescens (Pf-TA),34 have been co-
immobilized with PLP and exploited for flow transaminations. TA and PLP were co-
immobilized onto commercial methacrylate beads functionalized with different reactive 
groups; cobalt-chelates, epoxy groups and positively charged amines (Table 1). These 
self-sufficient heterogeneous biocatalysts have been successfully integrated into flow 
PBR to perform the synthesis of chiral amines in buffer environment and without 
exogenous supply of PLP. 
 
2. EXPERIMENTAL SECTION 
2.1.   Materials 
LifetechPurolite ECR 8215F and Sepabeads EC-EP/S were kindly donated by Purolite 
Ltd. (Llantrisant, U.K.) and Resindion S.R.L., respectively. Polyethyleneimine 60 kDa 
50%wt aq. solution, branched (PEI60) was purchased from ACROS OrganicsTM. 
Ethanolamine, hydroxylamine, (S)-phenylethylamine, rhodamine B isothiocyanate, IDA, 
cobalt (II) chloride, trans-cinnamaldehyde, p-nitrobenzaldehyde, sodium borate, sodium 
pyruvate, S-(α)-Methylbenzylamine (S-MBA), kanamycin, ampicillin, amicon ultra 0.5 
mL centrifugal filters 10 kDa, Supelcosil LC-18-T column (250 mm x 4.6 mm, 5 μm 
particle size; Supelco) and PLP were acquired from Sigma-Aldrich (St. Louis, IL). UV 
transparent 96-well plates and 1 mL cuvettes were purchased from Thermo Fisher 
Scientific. µ-Slides with 8 wells were purchased from ibidi (Planegg, Germany). All 
other salts and reagents were of analytical grade. 
 
2.2.   Methods 
2.2.1. Activation of Purolite-based carriers 
Epoxy-purolite (Pu-E) was incubated with 0.5 M IDA at pH 11.0 for 3 hours at room 
temperature and orbital shaking. Afterwards, samples were intensively washed with 
distilled H2O. A solution of 30 mg x mL-1 CoCl2 was added (1:10 w/v) and incubated for 
1 hour. After a washing step, Pu-Co2+/eA and Pu-Co2+/hA were prepared adding 0.5 M 
ethanolamine and 0.5 M hydroxylamine at pH 11.0 and incubated overnight under 
orbital shaking. Finally, the resin was intensively washed with distilled water, filtered 
and stored at 4 ºC until use 
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Figure 1. Protocol for the activation of Purolite-based carriers. 
 
2.2.2. Activation of Sepabead-based carriers  
Epoxy-sepabeads were firstly activated with cobalt as previously described.29 Briefly, 5 
g of epoxy-sepabeads were treated with 10 mL of modification buffer (100 mM sodium 
borate and 2 M IDA in 50 mM Tris-HCl buffer pH 8.5) under gentile shaking for two 
hours at room temperature. The sample was then filtered and washed with distilled 
water. 25 mL of metal buffer (1 M of sodium chloride and 5 mg x mL-1 CoCl2 in 50 mM 
phosphate buffer at pH 6.0) applied for two hours. The sample was then filtered and 
washed with distilled water. EC-Co2+/eA was prepared by adding 0.5 M ethanolamine 
at pH 11.0 and incubating overnight under orbital shaking. For preparation of EC-
Co2+/PEI60, a solution of 10 mg x mL-1 PEI60 (50% v/v in water) in 100 mM sodium 
bicarbonate buffer at pH 10.0 was added after protein immobilization and incubated for 
1 hour under orbital shaking. In all cases, the resins were finally intensively washed 
with distilled water, filtered and stored at 4 ºC until use. 
 
 
 
 
 
 
Figure 2. Protocol for the activation of Sepabead-based carriers. 
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2.2.3.   Expression and purification of enzymes  
He-TA and Cv-TA were expressed and purified following a modified version of a 
previously reported protocol.31 Concisely, the cells were grown in 50 mL of ZYM-5052 
medium for auto-induction at 37 ºC overnight. Then, the cells were harvested by 
centrifugation (4211 g, 4 ºC, 30 min). The pellet was resuspended in 7.5 mL of the lysis 
buffer (50 mM potassium phosphate buffer pH 8.0 and 0.1 mM PLP). The cells were 
disrupted by sonication at 4 °C using Sonics VCX 130 with 10 cycles of 30 sec ON and 
30 sec OFF. After centrifugation (38.000 g, 4 °C, 45 min), the supernatant was clarified 
by filtration (0.45 μm filter). For the expression of Pf-TA, cells were grown in 50 mL of 
LB medium at 37 °C with energetic shaking until the OD600nm reached 0.6. At that point, 
the culture was induced with 0.01 mM IPTG. Cells were grown at 21 °C for 16 hours 
and then harvested by centrifugation (4211 g, 4 ºC, 30 min). The resulting pellet was 
resuspended in 5 mL of 10 mM sodium phosphate buffer at pH 7.3 containing 0.1 mM 
PLP. Cells were sonicated (Sonics Vibracell VCX750) at amplitude= 20 %, during 15 
min of 5 sec ON, 5 sec OFF. After centrifugation (10528 g, 30 min, 4 ºC), the 
supernatant was collected and stored at 4 ºC. The protein purification was followed by 
SDS-PAGE (Figure 3). 
 
Figure 3. SDS-PAGE of protein purifications. The molecular weight markers are BioRad 
Precision Plus Protein All Blue Standard for (A) and NEB (Broad Range 10-200 kDa) for (B) and 
(C). A) Pf-TA. Line A1: affinity column flow-through, line A2: soluble fraction after cell 
disruption by sonication and line A3: purified Pf-TA. B) He-TA. Line B1: crude extract, line 
B2: pellet after sonication and line B3: purified He-TA. C) Cv-TA. Line C1: crude extract, line 
C2: soluble fraction after sonication, line C3: insoluble fraction after sonication and line C4: 
purified Cv-TA.  
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2.2.4.   Protein quantification  
The protein concentration was quantified by Bradford assay as described in Chapter 4 
(page 91). 
 
2.2.5.   Enzyme immobilization  
10 mL of enzyme solution (0.1 – 0.5 mg x mL-1) containing 0.1 mM PLP in 50 mM 
sodium phosphate buffer at pH 8, were added to 1 g of carrier and incubated under 
orbital shaking for 4 hours (He-TA and Cv-TA), or for 1 hour (Pf-TA) at room 
temperature. Then, the suspension was filtered and washed 3 times with 10 volumes of 
phosphate buffer. When the enzyme was immobilized on EC-Co2+/PEI60, the PEI 
coating was performed after protein immobilization, as described in Chapter 4. 
 
2.2.6.    Parameters of immobilized enzymes  
The immobilization yield and the specific activity were calculated as described in 
Chapter 4 (page 93) unless otherwise specified. 
 
2.2.7.   Cofactor immobilization  
Immobilization of PLP was achieved as described by Velasco-Lozano et al.35 Briefly, 10 
mL of 1 mM PLP in 10 mM sodium phosphate buffer at pH 7.3 were incubated with 1 
gram of methacrylate beads with previously immobilized enzymes. The suspension 
was kept under orbital shaking for 1 hour at room temperature. The sample was then 
filtered and washed three times with 10 mM sodium phosphate buffer at pH 7.3. The 
immobilized PLP was determined by measuring the absorbance at 390 nm of 100 µL of 
the flow-through in a 96-well microplate using a Varian Cary 50 scan UV-visible 
spectrophotometer. The cofactor load and the cofactor immobilization yield were 
calculated as described in Chapter 4 (page 94). 
 
2.2.8.   Enzyme activity assays  
The activity of immobilized ω-TAs was determined by mixing 50 mg of biocatalyst and 
10 mL of reaction mixture (2.5 mM pyruvate, 2.5 mM S-MBA and 0.25 % DMSO in 10 
mM phosphate buffer pH 7.3) in a 15 mL reaction tube cap. The final reaction mixture 
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was incubated at room temperature under orbital shaking. The absorbance at 245 nm 
was measured along the time as single readings using Brand UV-cuvettes in a Varian 
Cary 50 scan UV-visible spectrophotometer. One unit of ω-transaminase activity was 
defined as the amount of enzyme required for the production of 1 µmol of 
acetophenone per minute. 
 
2.2.9.   Rhodamine-labeling of He-TA  
The enzyme was labeled as described in Chapter 3 (page 58). 
 
2.2.10.   CLSM imaging 
Enzyme distribution was analyzed using a ZEISS confocal microscope LSM510 using 
λex: 514 nm and the emission filter LP550. Since PLP exhibits autofluorescence, the 
spatial distribution of PLP across the EC-Co2+/PEI60 beads was determined using an 
UV excitation laser (405 nm) and the emission filter LP420. Images were processed 
with the software ZEN2012. 
 Spatial distribution study. The labeled enzyme was further immobilized at 1 mg 
x g-1 onto EC-Co2+ beads. After PEI coating, PLP was co-immobilized at 7.5 
µmol x g-1. The beads suspension was filtered and placed on a microscope 
slide. In order to improve the match in refractive index between the medium and 
the opaque beads, a drop of glycerol was added to the filtered beads onto the 
slide. 
 PLP immobilization kinetics. 20 mg of EC-Co2+/PEI60 were incubated with 200 
µL of 1 mM PLP solution containing 50% glycerol in sodium phosphate buffer 
pH 7.3 in a 8-well µslide. PLP autofluorescence was monitored along the time. 
 Desorption experiments. Three desorption experiments of PLP were carried out 
using different buffer compositions. 50 mg of EC-Co2+/PEI60 with immobilized 
PLP were incubated with 500 µL of 4 M NaCl, 1 M ethanolamine or a mixed 
solution with 4 M NaCl and 1 M ethanolamine. The suspensions were incubated 
at room temperature for 1 hour. After filtration, three washing steps with 
phosphate buffer were performed. The beads were observed by adding a drop 
of glycerol. Finally, PLP was immobilized for second time by adding 400 µL of 1 
mM PLP solution to 40 mg of EC-Co2+/PEI60 (previously treated with 
ethanolamine). 
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2.2.11.   Flow deamination reactions  
The continuous flow biotransformations were performed in collaboration with Prof. 
Paradisi’s group by using a R2+/R4 flow reactor commercially available from Vapourtec 
equipped with an Omnifit glass column (6.6 mm i.d x 100 mm lenght) filled with 1 gram 
of biocatalyst. An amino acceptor substrate solution (20 mM pyruvate in phosphate 
buffer) and an amino donor solution (50 mM S-MBA and 5% DMSO in phosphate 
buffer) were prepared. After mixing with a T-tube the resulting concentrations were 10 
mM for the amino acceptor and 25 mM for the amino donor. 50 mM phosphate buffer at 
pH 8.0 was used for flow-reactions with exogenously added PLP (0.1 mM) and when 
no PLP was added. 10 mM phosphate buffer at pH 7.3 was used for flow-reactions 
when PLP was co-immobilized. The resulting flow stream was driven to the column 
packed-bed reactor with the biocatalyst (PBR volume: 1.3 - 1.45 mL). A first washing 
step with a flow rate of 0.4 mL x min-1 was performed for 30 minutes. Then, the flow 
rate was varied in order to obtain the desired residence time. The resulting flow product 
was analysed by HPLC following a previously reported protocol.29 In short, 100 μL 
aliquots were quenched with 50% of acetonitrile, 50% of HCl (0.2% v/v) and then 
analysed by HPLC equipped with a Supelcosil LC-18-T column. The compounds were 
detected using an UV detector at 210 nm or 250 nm after an isocratic run with 25% 
acetonitrile / 75% water with TFA (0.1% v/v) at 45 °C with a flow rate of 1 mL x min-1. 
The retention times were: (S)-(−)-1-phenylethylamine (1.9 min), acetophenone (2.1 
min). 
 
2.2.12.   Flow synthesis of amines  
The continuous flow synthesis of cinnamylamine and p-nitrobenzylamine were 
performed in collaboration with Prof. Paradisi´s group by using the equipment 
described above. The synthesis of cinnamylamine was performed preparing two 
solutions; solution 1: 20 mM trans-cinnamaldehyde, and 10% of DMSO in phosphate 
buffer and solution 2: 1 M L-alanine in 10 mM phosphate buffer. After the mixing, the 
concentrations of trans-cinnamaldehyde and L-alanine were 10 mM and 500 mM, 
respectively. In the synthesis of p-nitrobenzylamine, the amino acceptor solution (10 
mM p-nitrobenzaldehyde and 20 % of DMSO in phosphate buffer) was mixed with the 
amino donor solution (1 M L-alanine in phosphate buffer). After the mixing, the 
concentrations of p-nitrobenzaldehyde and L-alanine were 5 mM and 500 mM, 
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respectively. The resulting flow product was analysed by HPLC as described in the 
previous section.  
3. RESULTS AND DISCUSSION 
3.1. Optimization of the micro-architecture for the co-immobilization of ω-TA 
and PLP 
Expanding the concept of self-sufficient heterogeneous biocatalysts to amine synthesis 
using PLP-dependent TAs, commercial porous methacrylate beads activated with 
epoxy groups were firstly functionalized with cobalt-chelates and then blocked with 
either hydroxylamine or ethanolamine (Figure 1, Table 1), giving rise to carriers named 
as Pu-Co2+/hA and Pu-Co2+/eA, respectively. The immobilization conditions were 
optimized using these Purolite-based resins as carriers. 
Table 1. Different architectures of self-sufficient heterogeneous biocatalysts based on 
co-immobilized TA and PLP. 
 
Pu-Co2+ and EC-Co2+ carriers were activated with different aminated molecules; hydroxylamine 
(/hA), ethanolamine (/eA) and polyethileneimine (PEI60). Red dashed bonds are the 
coordination bonds between His-tag and cobalt chelates. Red dashed lines represent the metal 
coordination bond between the enzyme and the cobalt groups. Red asterisk show the dual 
binding mode of PLP immobilization (see Figure 11 for more details). 
 
 
In our group, we previously achieved the co-immobilization of an TA and PLP onto 
agarose beads by using low ionic strength (10 mM) phosphate buffer at pH 7 to favour 
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the ionic interactions between PLP and the positively charged surface of the carrier.35 
However, flow-reactions using immobilized He-TA were performed in 50 mM 
phosphate buffer at pH 8 at Prof. Paradisi´s laboratory.29 These conditions match with 
another work which showed that an increased buffer concentration might prevent PLP 
release from the enzyme, and hence enhance the structural holoform stability of TA 
from Vibrio fluvialis.36 But, paradoxically, an increased buffer concentration could also 
result in decreased enzyme residual activity.37 Therefore, different conditions to co-
immobilize the enzyme and the cofactor were tested to avoid its lixiviation into the 
reaction medium. To this aim, He-TA and PLP were co-immobilized onto Pu-Co2+/eA 
under several buffered solutions. It must point out that both enzyme and cofactor were 
reversibly bound to this carrier through coordination and ionic bonds, respectively. As 
expectedly, 10 mM phosphate buffer and Tris-HCl buffer at pH 7.3 were the most 
effective conditions to minimize PLP and enzyme lixiviation after 3 consecutive washes 
(Figure 4). The use of phosphate buffer instead Tris-HCl buffer is indeed beneficial for 
the process since phosphate promotes the stability of the apoenzyme and prevents its 
irreversible unfolding.38 For these reasons, phosphate buffer was selected to carry out 
the enzymatic reactions.   
 
Figure 4. Optimization of ionic strength and pH of the buffer for the PLP immobilization. 
Pu-Co2+/eA beads were incubated with 1 mM PLP prepared in different buffered solutions for 1 
hour at room temperature. 
 
Afterwards, different functionalizations of Purolite-based carriers (Pu-Co2+/hA and Pu-
Co2+/eA) were analyzed for the co-immobilization of PLP. Once tested the deamination 
activity of the immobilized biocatalyst towards S-MBA, the activity of He-TA was 
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significantly lower when PLP was adsorbed onto Pu-Co2+/hA than onto Pu-Co2+/eA 
(Figure 5), indicating that the cofactor was catalytically more available when the solid 
surface was activated with ethanolamine. Due to the higher pKa of ethanolamine (pKa: 
9.5) compared with hydroxylamine (pKa: 6.03), the ionic exchange between PLP and 
amines groups could be better maintained on Pu-Co2+/eA. 
 
Figure 5. Effect of amine group on the enzyme kinetics. He-TA was immobilized onto Pu-
Co2+/eA and Pu-Co2+/hA beads at 1 mg x g-1. PLP was co-immobilized at 1.7 ± 0.09 µmol x g-1 
onto Pu-Co2+/eA and 6.5 ± 0.01 µmol x g-1onto Pu-Co2+/hA. 
 
Finally, we tested the effect of the carrier architecture on PLP binding by using 
methacrylate carriers activated with ethanolamine at two different pore sizes (Table 1).  
Methacrylate beads (EC-Co2+/eA) with smaller pores (size = 10-20 nm) loaded up to 
8.6 µmolPLP x gcarrier-1 and 90% of the cofactor remained bound to the carrier after three 
washes. On the contrary, Pu-Co2+/eA with larger pores (size = 120-180 nm) loaded 3 
times less PLP (2.8µmolPLP x gcarrier-1) than EC-Co2+/eA and the 43% of the bound 
cofactor was lixiviated after three washing steps (Figure 6A). Although the carriers 
were loaded with different amounts of PLP, co-immobilized He-TA expressed similar 
deamination rate and ketone yield without adding exogenous cofactor after the first 
batch cycle (Figure 6B). 
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Figure 6. Effect of pore size on PLP immobilization yield and biocatalytic activity. A) Co-
immobilization of PLP. EC-Co2+/eA and Pu-Co2+/eA were incubated with 1 mM PLP (1:10 v/w) in 
10 mM phosphate buffer at pH 7.3. Washing steps were carried out with the same buffer. B) 
Enzyme kinetics of co-immobilized He-TA and PLP. The protein loading was 1 mg x g-1. PLP 
was at 1.7 ± 0.09 µmol x g-1 onto Pu-Co2+/eA and 7.8 ± 0.03 µmol x g-1 onto EC-Co2+/eA. 
 
3.2.   Stability tests for deamination flow reactions 
The final goal of the work developed in this chapter is the secondment of artificial 
metabolic cells to flow biocatalysis. For this purpose, the above described micro-
architectures were tested in flow for the deamination reaction of S-MBA. After the first 
column volume in flow, He-TA co-immobilized with the cofactor on both EC-Co2+/eA 
and Pu-Co2+/eA showed a similar conversion yield (Figure 7). However, EC-Co2+/eA 
biocatalyst presented a longer operational half-life time (133 minutes) in flow than the 
Pu-Co2+/eA one (115 minutes). Nevertheless, the activation of methacrylate beads with 
ethanolamine and cobalt chelates (EC-Co2+/eA) was not enough to operate the self-
sufficient heterogeneous biocatalyst for longer times with high yields (Figure 7).  
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Figure 7. Stability test of different self-sufficient biocatalysts operating in flow at 0.3 mL x 
min-1.He-TA was immobilized at 1 mg x g-1 onto three different carriers; Pu-Co2+/eA, EC-
Co2+/eA and EC-Co2+/PEI, that loaded 1.7, 7.8 and 7.5 µmolPLP x gcarrier-1, respectively. Each 
column volume corresponds to 5 minutes. A) Deamination reaction scheme. B) Conversion 
yields along the time. 
 
PLP was observed in the flow-through after 20 minutes, suggesting that its lixiviation 
might explain the activity lost of the packed biocatalyst. In order to recover the activity 
of this self-sufficient biocatalyst, a new and fresh solution of PLP was offered to the 
EC-Co2+/eA biocatalyst. Unfortunately, the biocatalytic activity was less than 11% for 
the flow deamination reaction, suggesting that the cofactor lixiviation inactivation was 
also explained by either the enzyme lixiviation or inactivation (Figure 8). The enzyme 
was immobilized through reversible metal coordination bonds between the poly-(6x)His 
at the N-terminal and the cobalt-chelates groups of the carrier surface (Figure 1). This 
well-known strategy for protein purification has been recently exploited for a ten-minute 
protein purification followed by an efficient continuous-flow production of p-nitrophenol 
by a bi-enzimatic (alkaline phosphatase and phosphodiesterase) immobilized system.39 
However, in our case the reversible immobilization of He-TA could be reverted during 
the operational process, provoking the enzyme release and causing the yield decay 
observed in Figure 8. The immobilization of proteins through one-point and long spacer 
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arms does not lead to high stabilization factors as Orrego et al. previously 
demonstrated by fluorescence anisotropy.40 
 
Figure 8. Stability test of EC-Co2+/eA biocatalyst after second co-immobilization of PLP. 
The cofactor was again loaded at 7.8 µmolPLP x gcarrier-1, respectively. Flow reactor operated at 
0.3 mL x min-1. Each column volume corresponds to 5 minutes. 
 
To avoid both enzyme and cofactor lixiviation, and consequently improve the 
performance of the biocatalyst, we modified the functionalization of the carrier to 
establish irreversible bonds between the enzyme and the solid surface and optimize 
the reversible interactions between PLP and the surface matrix. Firstly, the His-tagged 
enzyme was driven towards the carrier surface by cobalt-chelates. Secondly, amino 
groups from the enzyme stablished a covalent bond with the epoxy groups of the 
carrier. After site-directed immobilization of He-TA, the remaining epoxy groups were 
exploited to allow the PEI coating upon the immobilization (EC-Co2+/PEI60, Table 1). In 
this thesis, similar approaches using PEI coating have been already described for 
efficient co-immobilization of cofactors on agarose beads (Chapter 435). Herein, PLP 
was also co-immobilized onto PEI coated-methacrylate beads containing covalently 
immobilized He-TA. This architecture was utilized in continuous deamination 
reactions, significantly increasing the operational life of the self-sufficient 
heterogeneous biocatalyst since the reaction conversion decayed less than 20% after 
200 minutes (40 column volumes) (Figure 9). 
Flow rate is also another crucial parameter that governs productivity of continuous 
operations. Once both PLP and He-TA were optimally co-immobilized onto EC-
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Co2+/PEI60, this self-sufficient heterogeneous biocatalyst was tested at two different 
flow rates; 0.3 and 1.45 mL x min-1 (Figure 9).  
 
Figure 9. Stability test of He-TA and PLP co-immobilized on EC-Co2+/PEI60 at different 
flow rates. Enzyme and cofactor loading were 5 mg x g-1 and 7.8 µmol x g-1, respectively. For 
the flow rate at 0.308 mL x min-1, each column volume corresponds to 5 minutes and for the 
flow rate at 1.45 mL x min-1, each column volume took 1 minute. 
 
Operating the PBR at higher flows, the specific productivity of He-TA increased from 
6.79 to 33.95 µmolproduct x min-1 x mgenzyme-1 and remained constant after processing 56 
mL of reaction mixture (40 column volumes). This result clearly indicates that bound 
PLP is not lixiviated even under high flow rates, strongly favouring enzymatic 
productivity. Therefore, this PBR successfully operated at 1.45 mL x min-1, the highest 
flow rate ever reported using co-immobilized enzyme and cofactor32, 35, 41 and one of 
the highest (0.1-1.7 mL x min-1) using immobilized enzymes supplied with exogenous 
cofactor.27-29, 42 
 
3.3. Single-particle analysis of EC-Co2+/PEI60 biocatalyst and PLP  
immobilization 
In order to understand the performance of the EC-Co2+/PEI60 self-sufficient 
heterogeneous biocatalysts under flow conditions, the sub-particle environment was 
deeply analyzed to better understand the properties of those biocatalysts. PLP binding 
monitored by time-lapse fluorescence microscopy demonstrates the reversible nature 
of PLP interaction since such cofactor is primarily adsorbed to the outer surface of the 
beads (when immobilizing in short times), to further migrate across their porous 
structures along the time (Figure 10).  
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Figure 10. Reversible PLP immobilization. Single-particle studies of PLP immobilization 
kinetics by CLSM imaging. Images show the overlay of fluorescence and brightfield signals.  
 
The cofactor migration proves that PLP molecules can reach enzyme active sites within 
the carrier microstructure but without diffusing out to the reaction bulk. Functional data 
together with microscopic analysis indicate that the nature and the density of positively 
charged groups as well as the pore size of the methacrylate beads are determinant 
parameters to allow the PLP shuttling between the enzyme active sites without leaving 
the pore microenvironment. 
As mentioned above, the enzyme was oriented and irreversibly immobilized through a 
multivalent attachment, while PLP established an association-dissociation equilibrium 
with the PEI layer, through both ionic bridges and reversible imine bonds (Schiff´s 
bases) (Figure 11). Such dual interaction was supported by desorption experiments 
that demonstrate quantitative PLP elution from EC-Co2+/PEI60 requires both high salt 
and ethanolamine concentrations to break ionic bonds and Schiff´s bases, respectively 
(Figure 10). Unlike other phosphorylated cofactor such as NAD(P)H, aldehyde groups 
and phosphate groups in PLP can establish that dual interaction with the primary 
amines and the positively charged amine groups of PEI, respectively (Figure 11). The 
reversible imines bonds between PLP and PEI mimic the chemistry that anchors such 
cofactor into the TA active site.43 Moreover, once PLP is fully eluted, the carrier can 
be equilibrated and re-charged with fresh PLP (Figure 10). 
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Figure 11. Scheme of the dual-binding mode of PLP on EC-Co2+/PEI60.  
 
The higher capacity of EC-Co2+/PEI60 to reversibly bound PLP through a dual binding 
is supported by its Kd = 20.4 ± 0.9 µmol x g-1, which is significantly lower than Kd values 
determined for EC-Co2+/eA (Kd = 27.4 ± 1.2 µmolx g-1) and Pu-Co2+/hA (Kd = 121.4 ± 
5.8 µmol x g-1) carriers. These equilibrium constants were determined by fitting 
experimental data to Langmuir isotherm equation (Figure 12). The PLP adsorbed in 
EC-Co2+/PEI60 falls in the same order or magnitude that the PLP equilibrium constants 
determined with similar positively charged surfaces.35 Hence, the nature of the 
interaction between PLP and carrier surface dictates how strong PLP is bound to the 
matrix. Therefore, PEI containing primary, secondary and tertiary amines are capable 
to establish two type of interactions with PLP, salt bridges and imine bonds retaining 
more efficiently the cofactor that surfaces only activated with secondary amines (EC-
Co2+/hA and eA) that limit PLP adsorption to ionic interactions.  
 
Figure 12. Adsorption isotherms of PLP. Three methacrylate-based carriers activated with 
different aminated groups (PEI60, ethanolamine, and hydroxylamine) were used to immobilize 
PLP. The X-axis shows the PLP load at the equilibrium (Ce) and the Y-axis the free PLP at the 
equilibrium (qe) in the supernatant.  
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Additionally, confocal microscopy of EC-Co2+/PEI60 co-immobilizing PLP and He-TA 
revealed that both molecules co-localized within the same particle but with different 
spatial distributions (Figure 13). The spatial organization of both PLP and enzyme 
remained stable even after one-week storages at 4 ºC, demonstrating that the enzyme 
cannot migrate inside the porous surface because it is irreversibly bound, while the 
cofactor is unable to diffuse out of the beads (Figure 13). While He-TA is located at 
the outer surface of the porous beads, PLP is homogenously distributed across the 
whole carrier surface. As it was revealed in Chapter 4, the heterogeneous distribution 
of the enzyme across the porous particles influences the enzyme kinetics of the 
biocatalyst. The enzyme localization in the outer phase of the particle may benefit the 
substrate-product exchange between the biocatalysts and the external reaction media. 
 
Figure 13. Single-particle studies of EC-Co2+/PEI60 by CLSM imaging along the time. 
Spatial distribution of rhodamine-labeled He-TA (red) and PLP (blue) within the porous 
particles. The left side image of each panel shows the fluorescence signal and the right one 
merges the fluorescence and the brightfield signals.  
 
3.4.  Expanding the scope of TA-based artificial metabolic cells for flow 
reactions 
In principle, this promising approach may be expanded to other TAs in order to 
fabricate a battery of self-sufficient heterogeneous biocatalysts with different catalytic 
properties (stability, selectivity, kinetics). Based on the same architecture, two 
additional N-terminal His-tagged TAs, Cv-TA and Pf-TA, were immobilized onto 
EC-Co2+ and further coated with PEI to finally absorb PLP as described above. In all 
cases, >90 % of offered activity (5 mgenzyme x gcarrier-1) was immobilized and each 
heterogeneous biocatalyst loaded 7-7.5 µmolPLP x gcarrier-1 (Table 2).  
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Table 2. Immobilization yields and specific activities of immobilized ω-transaminases 
onto EC-Co2+/PEI60. 
Protein load of He-TA and Cv-TA was determined by Bradford assay. SDS-PAGE analysis 
by using ImageJ was carried out to determine the Pf-TA load. The enzymatic activities were 
measured in 96-well plates by monitoring absorbance at 245 nm. Briefly, 200 µL of a reaction 
mixture (2.5 mM pyruvate, 2.5 mM S-MBA, 0.25% of DMSO and 37.5 µM PLP in 10 mM sodium 
phosphate buffer at pH 7.3) were incubated with 10 µL of enzymatic solution or suspension 
(1:10 w/v). 
 
As shown in Table 1, the enzymes were oriented and irreversibly immobilized through 
a multi-valent attachment, while cofactor establishes an association-dissociation 
equilibrium with the PEI layer. Upon the immobilization process, the three TAs 
recovered 8-11% of their specific activity in solution (Table 2). The low recovered 
activities might be caused by mass transport restrictions underlying the measurement 
set up. Enzyme activities were determined by spectrophotometric analysis using plate 
readers whose orbital shaking is not optimized to measure highly dense carriers with 
large particle size such as the porous methacrylate beads utilized in this work. In this 
context, the substrate likely suffers important diffusion barriers for being transported 
from the reaction bulk to the porous surface of the carrier, where both enzyme and 
cofactor are located. In fact, when enzyme activity was further measured under more 
vigorous shaking, the expressed activity of TA upon immobilization was increased up 
to 90% (Table 3) compared with the previous results (Table 2).  
Table 3. Immobilization and activity parameters of co-immobilized Pf-TA and PLP on 
EC-Co2+/PEI60. 
 
The activity was monitored at high shaking orbital speed (800 rpm).  
Enzyme
Protein
load
(mg x g-1)
Immobilization
yield 
(%)
Cofactor 
load
(µmolPLP x gcarrier-1)
Immobilized specific activity 
(U x mg-1) and 
[Relative recovered activity (%)]
Free PLP Co-immobilized PLP
He-TA 4.95 99 ± 1.81 7.5 ± 0.08 0.29 ± 0.02 [11] 0.27 ± 0.02 [10]
Cv-TA 4.62 92 ± 3.42 7.4 ± 0.15 0.13 ± 0.03 [7] 0.11 ± 0.00 [6]
Pf-TA 5 100 ± 0.90 7 ± 0.21 0.16 ± 0.00  [8] 0.14 ± 0.01 [7]
Enzyme Cofactor load (µmolPLP x gcarrier-1)
Immobilization yield
(%)
Relative recovered
activity
(%)
Pf-ωTA
0 92 ± 0.26 78 ± 1.2
1 91 ± 0.04 120 ± 10
10 94 ± 0.22 111 ± 15
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Noteworthy, the three TAs herein studied showed similar specific activity towards 
soluble and immobilized PLP, which demonstrates that the cofactor is fully available 
and can access to the TA active sites (Table 2). 
Encouraged by the excellent enzymatic activity towards the immobilized cofactor, we 
tested the three different self-sufficient heterogeneous biocatalysts in the continuous 
deamination of S-MBA at 1.45 mL x min-1 (Figure 14A).  
 
Figure 14. Stability test of the biocatalysts immobilizing ω-TA and with co-immobilized 
PLP (A) or without PLP at all (B). -transaminases were immobilized at 5 mg x g-1 onto EC-
Co2+/PEI60. The flow reactions were performed at 1.45 mL x min-1. Each reaction cycle 
corresponds to 1 minute. 
 
Interestingly, the operational performance of each biocatalyst relied on which TA was 
immobilized onto. He-TA maintained maximum conversion during the whole 
operational test producing 70 mL of 25 mM product after 10 column volumes. On the 
contrary, when the reactor was packed with Cv-TA co-immobilized with PLP, we 
observed a linear decay of conversion down to 30% after 10 column volumes (Figure 
14A). Under the same conditions, Pf-TA performed notably better than Cv-TA but 
slightly worse than He-TA. Such differences on deamination efficiencies may rely on 
the affinity of each enzyme towards PLP. In fact, when flow reactions were performed 
using the different immobilized TAs with naturally bound PLP (not exogenously 
added), we observed a similar trend: He-TA preserved the highest conversion 
whereas Cv-TA showed the lowest one after 50 cycles (Figure 14B). These results 
suggest that high flows can detach more easily the natively bound PLP from Cv-TA 
than from He-TA. The unsatisfactory performance of Cv-TA can be explained by the 
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low affinity of this enzyme towards PLP (Kd = 78 µM)37 compared to other TAs (Kd = 
0.25-10 µM).44 Hence, the operational stabilities shown in Figure 14, suggest that Pf-
TA binds PLP better than Cv-TA but worse than He-TA. Actually, comparing 
conversion yields showed in Figure 14, Cv-TA biocatalyst increased 102% its stability 
after 50 cycles when the cofactor was co-immobilized while Pf-TA and He-TA only 
improved 45% and 6% respectively.  
These results motivated us to understand whether the enzyme is stabilized by the 
immobilization itself, by the high effective PLP concentration in the enzyme vicinity or 
by a synergy of both effects. To answer that question, we immobilized Pf-TA with and 
without PLP on porous carriers functionalized with PEI, and the resulting preparations 
were thermally inactivated (Figure 15). Likewise, soluble enzyme was inactivated either 
in presence or absence of PLP.  Soluble Pf-TA suffered a dramatic inactivation in 
absence of PLP, as well as the enzyme immobilized without the cofactor. Conversely, 
the co-immobilization of Pf-TA and PLP significantly stabilizes the enzyme against 
high temperatures (Figure 15).  
 
Figure 15. Stability of Pf-TA at different PLP concentrations. Bars represent the residual 
activity of the biocatalysts after 30 min of incubation at 65ºC: A) Soluble Pf-TA. B) Soluble Pf-
TA at 0.1 mM PLP. C) Immobilized Pf-TA on EC-Co2+/PEI60. D) Co-immobilized Pf-TA and 
PLP on EC-Co2+/PEI60 at 1 µmolPLP x gcarrier-1and E) Co-immobilized Pf-TA and PLP on EC-
Co2+/PEI60 at 10 µmolPLP x gcarrier-1.  
 
In fact, we observed a trend between the concentration of immobilized PLP and the 
enzyme thermal stability. When TA was surrounded by the highest PLP intraparticle 
concentration tested herein, the enzyme was 10 times more stable (Figure 15). This 
result indicates that the available concentration of PLP for TA relies on the 
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concentration of bound PLP. Hence, enzymes surrounded by more molecules of PLP 
are more stable (comparing C-E samples), because this cofactor stabilizes protein 
quaternary structure avoiding subunit dissociation.29 When soluble PLP was incubated 
with soluble Pf-TA (comparing A and B samples), we observed a similar stabilization 
effect in agreement with the data published elsewhere for Cv-TA.37 These 
experimental evidences point out that immobilization itself is not significantly stabilizing 
the enzyme (see soluble (sample A) and immobilized (sample B) preparation without 
being incubated with PLP), while the presence of PLP (both soluble (sample A) and co-
immobilized forms (sample D and E)) enormously enhances the enzyme stability. 
 
3.5.   Flow-synthesis of chiral amines 
Finally, to expand the application scope of this self-sufficient system, we performed the 
continuous synthesis of highly-valuable amines without exogenous supply of PLP 
(Figure 16).  
 
Figure 16. Synthesis of amines by EC-Co2+/PEI60 biocatalysts. On the top side, the reaction 
schemes. On the bottom side, the conversion yields along the time. He-TA was immobilized 
onto EC-Co2+/PEI60 at 5 mg x g-1. The flow reactions were performed at flow-rate 0.725 mL x 
min-1. Each column volume corresponds to 2 minutes. A) Synthesis of cinnamylamine. B) 
Synthesis of p-nitrobenzylamine. 
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A column packed with He-TA and co-immobilized PLP onto EC-Co2+/PEI60 was fed 
with cinnamaldehyde to continuously synthesize cinnamylamine, a starting substrate 
for the synthesis of biologically active molecules.45 Figure 14 shows as the self-
sufficient heterogeneous biocatalyst is operationally slightly more stable than the 
system supplied with exogenous PLP. A similar trend was found for the synthesis of p-
nitrobenzylamine (Figure 16B). The amine synthesis required double residence times 
than the deamination reaction to achieve a complete conversion, according to recently 
reported results with immobilized He-TA for the synthesis of chiral amines.29 In 
addition, the operational stability under amination conditions was significantly lower 
than under deamination conditions. Likely, such decreased stability was due to the high 
concentration of L-Ala that may elute some of the bound PLP, since amine donor 
molecules contains amine and carboxylic groups that can compete with the dual 
interaction mode of PLP; imine and ionic bonds, respectively. Hence, the alanine would 
provoke the cofactor lixiviation which may explain the lower yields for the amination 
reaction compared to the deamination one. 
 
4. CONCLUSIONS 
In summary, the fabrication of self-sufficient biocatalytic systems has been 
prosperously implemented for transamination reactions in flow. To this aim, the co-
immobilization of TAs from different origins with PLP was optimized onto the same 
porous methacrylate beads. Within these solid materials, His-tagged TA is irreversibly 
and multivalently attached to the carrier surface, whereas PLP is bound on a polymeric 
bed through reversible interactions (ionic bridges and imine bonds). As result, PBRs 
were operated using TAs from different sources with different operational stability 
results. We suggest that such stability relies on the affinity of each immobilized enzyme 
towards PLP. Finally, these self-sufficient heterogeneous biocatalysts were also 
applied for the continuous synthesis of valuable amines, obtaining high amine yields 
along the column volumes. This work proved that the architecture of artificial metabolic 
cells base on ωTAs and PLP is a functional and appealing alternative for chemical 
manufacturing of amines in flow. Moreover, these advances make up the path towards 
more environmentally-friendly industrial processes.  
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The main contribution of this PhD thesis is the microscopic approach to efficiently 
design and engineer self-sufficient heterogeneous biocatalysts mimicking the internal 
architecture of living cells. The design of immobilized multi-enzyme systems integrating 
cofactors in the solid phase together the exploitation of single-particle studies have 
opened new opportunities for applied biocatalysis. Ultimately, these self-sufficient 
heterogeneous biocatalysts have proven their efficiency in continuous flow reactions, 
getting a step closer to industrial biocatalysis in a more cost-effective and sustainable 
fashion.  
The major findings of the work conducted during this PhD thesis are summarized as 
follows: 
 The innovative strategy for the synthesis and immobilization of proteins in one 
pot (CFPS-i) was applied to quickly test the immobilization of different proteins 
onto several types of materials functionalized with different reactive groups. A 
set of plasmids encoding the target protein fused to a battery of polypeptide 
tags was combined with CFPS-i to drive the protein immobilization. This mix-
and-go strategy was applied for the synthesis of protein-based biomaterials 
saving time and costs in comparison with traditional expression and 
immobilization strategies. 
 The immobilization of phosphorylated cofactors onto aminated surfaces by 
electrostatic interactions was successfully applied during the engineering 
process of heterogeneous biocatalysts. NADPH, NAD+, NADH, FAD+ and PLP 
were some examples of the broad range of applicability of this technique. PEI-
coating has been revealed as the best strategy to establish an association-
dissociation equilibrium that allows the intraparticle availability of the cofactors 
but avoids their lixiviation to the reaction bulk.  
 The spatial distribution of immobilized enzymes was demonstrated to be a key 
parameter to maximize the performance of the heterogeneous biocatalyst. This 
fact was even more relevant for oxidases whose activity is strongly affected by 
both oxygen and cofactor mass transport issues. 
 Rational co-immobilization of different enzymes and cofactors onto solid 
carriers was achieved to build artificial metabolic cells, based on the molecular 
organization and crowding found in living cells. A repertoire of cofactor-
dependent enzymes (dehydrogenases, ketoreductases, oxidases and 
transaminases) from different organisms was successfully tested for the co-
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immobilization with their corresponding cofactor to fabricate cell-free artificial 
metabolic systems. Different structural organizations and micro-architectures 
were studied to find the most advantageous assembly of molecules. 
 Single-particle analysis has demonstrated to be paramount for the functional 
characterization of immobilized enzymes and cofactors. The application of real-
time spectroscopic techniques with spatio-temporal resolution could decipher 
the kinetics of enzymes at intraparticle scale. 
 Highly-demanded chiral alcohols and amines were synthesized reaching 
maximum of 100% yield and 99% ee by using these artificial metabolic cells. 
 The integration of self-sufficient heterogeneous biocatalysts into flow-systems 
for process intensification was addressed responding to industrial demands (> 
90% of conversion for several reaction cycles). A packed-bed reactor was 
operated for the synthesis of amines at the high flow-rate (1.45 mL x min-1) ever 
reported for co-immobilized enzyme and cofactor. 
 The high cost of cofactor-dependent processes at industry could be overcome 
due to the recycling and reuse of enzymes, cofactors and carriers (accumulated 
TTN values until 1076 and 19980 for the cofactor and enzyme, respectively). 
 These promising results are the first step towards more complex multi-enzyme 
systems which can be more easily assembled and analyzed by using the 
strategies developed in this PhD thesis. Although a quite unexplored road lies 
ahead, we envision the fabrication of artificial metabolic cells to make an 
important contribution to the development of the of biocatalytic systems of the 
future. 
 
“The best is yet to come…” 
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LIST OF ABBREVIATIONS 
AG-Co Agarose microbeads activated with cobalt chelates groups 
AG-Co/S Agarose microbeads activated with both cobalt-chelates and disulfide groups 
AG-DEAE Agarose microbeads activated with tertiary amine groups 
AG-DEAE/G Agarose microbeads activated with glyoxyl and tertiary amine groups 
AG-DVS Agarose microbeads activated with vinyl groups 
AG-DVS/PEI25 Agarose microbeads activated with vinyl groups and coated with polyethileneimine 25 kDa 
Ae Specific activity of an enzyme 
AG-G/PEI25 Agarose microbeads activated with glyoxyl groups and coated with polyethileneimine 25 kDa 
AG-Oct Agarose microbeads activated with cyclooctyne groups 
AG-PEI600 Agarose microbeads coated with polyethileneimine 600-1000 kDa 
AG-TEA Agarose microbeads activated with triethylamine 
AN 1-acetonaphtone 
AP-IgG-Rh Inmunoglobulin G chemically conjugated with both rhodamine B and alkaline phosphatase 
AuNRs Gold nanorods 
BDE 1,4-butanediol diglycidyl ether 
Cb-FDH Formate dehydrogenase from Candida boidinii 
CFPS Cell-free protein synthesis 
CFPS-i Cell-free protein synthesis and immobilization 
CLSM Confocal laser scanning microscopy 
CoCl2 Cobalt (II) chloride hexahydrate salt 
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Cv-TA -transaminase from Chromobacterium violaceum tagged with poly-(6X)His 
Cys-sGFP sGFP tagged with poly-(6x)Cys 
DTNB 5,5’-Dithiobis(2-nitrobenzoic acid) or Ellman´s Reagent 
DTT 1,4-Dithiothreitol 
EC-Co2+ Sepabeads EC-EP/S microbeads activated with cobalt chelates 
EC-Co2+/eA Sepabeads EC-EP/S microbeads activated with both cobalt chelates and ethanolamine 
EC-Co2+/PEI60 Sepabeads EC-EP/S microbeads activated with cobalt chelates and coated with polyethileneimine 60 kDa 
EDTA 2-2’-2’’-2’’’-(ethane-1,2-diyldinitrilo)tetraacetic acid 
ee Enantioselectivity 
FAD+ Flavin-adenine-dinucleotide sodium salt 
FITC Fluorescein isothiocyanate 
He-TA -transaminase from Halomonas elongata tagged with poly-(6X)His 
His-BsADH Alcohol dehydrogenase from Bacillus stearothermophilus tagged with poly-(6X)His 
His-ProA Protein A tagged with poly-(6X)His 
His-sGFP sGFP tagged with poly-(6X)His 
HRP Horseradish peroxidase 
IDA Iminodiacetic acid 
IgG Inmunoglobulin G 
IPA Isopropanol 
IPTG 1-thio-β-d-galactopyranoside 
Kcat Catalytic constant 
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Kd Dissociation constant 
KM Michaleis-Menten constant 
KRED P1-A04 Ketoreductase from Lactobacillus kefiri mutant P1-A04 
KRED P2-D11 Ketoreductase from Lactobacillus kefiri mutant P2-D11 
L-AHA L-azidohomoalanine 
Lys-sGFP sGFP tagged with poly-(6x)Lys 
NAD+ Nicotinamide-adenine-dinucleotide sodium salt 
NADH Nicotinamide-adenine-dinucleotide reduced sodium salt 
NADPH Nicotinamide-adenine-dinucleotide-phosphate reduced sodium salt 
Na2S Sodium sulfide 
PBR Packed-bed reactors 
PEI Polyethyleneimine 
Pf-TA -transaminase from Pseudomonas fluorescens tagged with poly-(6X)His 
PLP Pyridoxal 5´-phosphate 
pNPP p-nitrophenyl phosphate 
Pu-Co2+ Purolite microbeads activated with cobalt chelates 
Pu-Co2+/eA Purolite microbeads activated with both cobalt chelates and ethanolamine 
Pu-Co2+/hA Purolite microbeads activated with both cobalt chelates and hydroxylamine 
Pu-DEAE/E Purolite microbeads activated with epoxy and tertiary amine groups 
Pu-E Purolite microbeads activated with epoxy groups 
Pu-G Purolite microbeads activated with glyoxyl groups 
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Pu-G/PEI25 Purolite microbeads activated with glyoxyl groups and coated with polyethileneimine 25 kDa 
sGFP superfolded Green Fluorescent Protein 
S-MBA S-(α)-methylbenzylamine 
SiO2NPs Silica nanoparticles 
STY Space-Time Yied 
TEA Triethylamine 
TFA Trifluoroacetic acid 
TFAF 2,2,2-trifluoroacetophenone 
TOF Turnover Frequency 
Tt-ADH Alcohol dehydrogenase from Thermus thermophilus tagged with poly-(6X)His 
TTN Total Turnover Number 
Tt-NOX NADH oxidase from Thermus thermophilus 
Vmax Maximun initial velocity of the enzyme-catalyzed reaction 
TAs -transaminases 
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metabolic cells for chemical manufacturing” 
EMBO Workshop. Enzymes, Biocatalysis and Chemical Biology (Pavia, Italy) 
Oral presentation: “Self-sufficient biocatalysts co-immobilizing PLP-dependent ω-
transaminases and cofactor for flow-biocatalysis” 
BIOCAT18. 9th International Congress on Biocatalysis (Hamburg, Germany) 
Poster presentation: “Understanding the effects of spatial distribution on 
immobilized enzyme kinetics” 
JEB18. II Jornadas Españolas en Biocatálisis  (Oviedo,  Spain)  
Poster presentation: “Single-bead kinetics of immobilized enzymes”
BIOTRANS17. 13th International Symposium on Biocatalysis and 
Biotransformations (Budapest, Hungary) 
Oral presentation: “Expanding on-demand fabrication of biomaterials by coupling 
cell-free protein synthesis and immobilization in one-pot” 
BIOTEC17. National Congress on Biotechnology (Murcia, Spain) 
Oral presentation: “On-demand fabrication of biomaterials by coupling cell-free 
protein synthesis and immobilization in one-pot” 
BIOMAPP17. 2nd Workshop on Biomaterials and Applications (Santiago de 
Compostela, Spain) 
09/2018 
08/2018 
10/2017 
04/2016 
09/2018 
08/2018 
06/2018 
07/2017 
06/2017 
04/2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
